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Eukaryotic cells have evolved molecular mechanisms that control organelle size, number and 
position. Molecular tethers are required for organelle positioning, multiplication and 
establishment of interorganellar contact sites. The balance between organelle tethering and 
motility determines the intracellular distribution of organelles and their segregation during 
cell division. In Saccharomyces cerevisiae, correct peroxisome distribution is achieved by the 
opposing processes of cortical anchoring in the mother cell and Myosin-dependent transport 
towards the bud. The Inp1-Pex3 tethering complex is required for peroxisome retention 
during cell division and for peroxisome positioning along the mother cortex. 
 
As has been postulated for other organelles, yeast peroxisomes interact with many cellular 
structures including the plasma membrane, ER, vacuole, mitochondria and lipid bodies. 
Components of some interorganellar peroxisomal contact sites have recently been identified 
whereas others are still completely uncharacterised including the plasma membrane-
peroxisome (PM-PER) contact site. The work presented in this thesis identifies Inp1 as the first 
known plasma membrane-peroxisome (PM-PER) tether by demonstrating that Inp1 meets the 
predefined criteria which a contact site tether protein must adhere to. 
 
This thesis first describes a conserved Pex3 binding motif in the C-terminal region of Inp1. This 
motif bears a striking resemblance to the Pex3 binding site present on Pex19 and both in vitro 
and in vivo evidence is presented which illustrates that Pex19 and Inp1 can compete for 
binding to Pex3. In addition, the N-terminal 100 amino acids of Inp1 are shown to localise to 
the plasma membrane, bind to phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) and, when 
artificially attached to the peroxisomal membrane, restore retention by relocating 
peroxisomes to the cell periphery in inp1Δ cells. 
 
In this study, Inp1 is shown to be present in the correct sub-cellular location to interact with 
both the plasma membrane and peroxisomal membrane and the data illustrates the 
structural and functional capacity of Inp1 to be a PM-PER tether. Through detailed analysis of 
the molecular function of Inp1, the work in this thesis identifies a novel role for Inp1 as a PM-
PER tether and concludes that tethering of peroxisomes to the plasma membrane is required 
for peroxisome retention. This is the first molecular characterisation of the PM-PER tether 
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Peroxisomes are single-membrane bound organelles and are present in almost all eukaryotic 
cells. Their discovery is attributed to Rhodin who, in 1954, observed cytoplasmic particles in 
mouse renal cells which he morphologically described as ‘microbodies’ (Rhodin, 1954). These 
sub-cellular particles were later isolated in equilibrium density gradients and assigned a 
biochemical identity by Christian de Duve and his group. Enzymes were identified within the 
microbodies which catalyse reactions resultant in the production and subsequent 
degradation of hydrogen peroxide, for example catalase, hence the term ‘peroxisome’ was 
introduced (Baudhuin et al., 1965; De Duve and Baudhuin, 1966).  
 
Peroxisomes are extremely plastic organelles and their size, number, contents and 
morphology can be rapidly altered in response to intracellular and extracellular changes. They 
have essential roles in a diverse array of biochemical pathways and contain a wide variety of 
enzymes which are required for a range of metabolic processes. Some peroxisomal reactions 
are organism specific such as in the firefly Photinus pyralis where luciferase, an oxidative 
enzyme which produces the bioluminescence which causes fireflies to ‘glow’, is localised to 
peroxisomes (Keller et al., 1987). Other peroxisomal pathways such as the degradation of 
fatty acids via the b-oxidation cycle are highly conserved across almost all eukaryotes 
(reviewed by Lazarow & Fujiki, 1985). 
 
In plants and many fungi, β-oxidation of fatty acids occurs exclusively in peroxisomes whereas 
in higher eukaryotes, β-oxidation also takes place in the mitochondria. Until the 1980’s it was 
assumed that mammalian peroxisomes are only required for β-oxidation of fatty acids when 
the oxidative capacity of the mitochondria within the cell is reached (Poirier et al., 2006). 
However, this idea was challenged upon observations that tissue from patients with 
peroxisomal disorders contains accumulations of very long chain fatty acids (VLCFA) (more 
than 22 carbon atoms in chain length) but not long or medium chain fatty acids. In the absence 
of functioning peroxisomes, VLCFA are not degraded by β-oxidation despite the presence of 
functioning mitochondria (Brown et al., 1982). It is now established that in higher eukaryotes, 
mitochondria and peroxisomes exhibit differential substrate specificity of the fatty acids they 
β-oxidise (reviewed by Wanders and Waterham, 2006). 
 
The importance of peroxisomes in relation to human health is evidenced by the number of 
diseases which are resultant of an absence of functioning peroxisomes. Peroxisomal disorders 
arise when peroxisomal biogenesis or function is impaired and are generally classified into 
two distinct groups, peroxisome biogenesis disorders and single enzyme deficiencies 




1.2 Peroxisomal disorders 
 
1.2.1 Peroxisome biogenesis disorders 
 
The most severe of the peroxisomal diseases are peroxisome biogenesis disorders (PBDs), a 
group of heterogeneous, autosomal recessive diseases. The most common subtype of PBD is 
the Zellweger spectrum disorders (ZSD) (reviewed by Waterham et al., 2016). The Zellweger 
spectrum can be divided into several phenotypes ranging from mild to severe: Heimler 
syndrome, Infantile Refsum disease (IRD), Neonatal adrenoleukodystrophy (NALD) and 
Zellweger syndrome (ZS). Initially these were clinically described as separate diseases, but 
biochemical characterization means that they are now recognised as different presentations 
of disorders on the same clinical spectrum (Poll-The et al., 1987; Klouwer et al., 2015).  
 
In mammalian peroxisome biogenesis there are 16 PEX genes which encode PEX proteins 
(peroxins). These peroxins are highly conserved throughout eukaryotes from yeast to humans 
and their co-ordinated activity is required for peroxisome formation and peroxisomal protein 
import. Biallelic, pathogenic mutations in any one of 14 of these PEX genes (most commonly, 
PEX1) have been found to result in disorders of peroxisome assembly. A full or partial block 
in peroxisome biogenesis consequently impairs many metabolic pathways and so results in 
metabolic abnormalities within patients (reviewed by Braverman et al., 2013). 
 
1.2.2 Peroxisomal enzyme/transporter deficiencies 
 
Peroxisomal enzyme deficiencies (PEDs) arise when peroxisomes are intact but there is an 
absence or dysfunction of an enzyme or pathway resulting in a biochemical abnormality. 
These disorders often involve just one affected enzyme but the diseases which manifest may 
be as clinically severe as a PBD (reviewed by Fidaleo, 2010). PEDs affect metabolic pathways 
such as ether-phospholipid synthesis, peroxisomal α-oxidation and peroxisomal β-oxidation 
and can also be subdivided into distinct subgroups (reviewed by Wanders and Waterham, 
2006). 
 
1.3 Peroxins and peroxisome biogenesis 
 
Research into peroxisome biogenesis was initiated upon the discovery that growing the 
budding yeast Saccharomyces cerevisiae on media containing oleic acid results in peroxisome 
proliferation (Veenhuis et al., 1987). Further research showed that peroxisomes are essential 
for growth of S. cerevisiae on media where oleic acid is the sole carbon source. This 
observation was able to form the basis of a negative selection assay whereby peroxisome 
biogenesis mutants devoid of peroxisomal structures could be identified due to their inability 
to grow on oleic acid medium (Erdmann et al., 1989). This research was furthered in other 
yeast species such as Pichia pastoris (Liu et al., 1992; Gould et al., 1992), and in CHO (Chinese 
hamster ovary) cells where peroxisomes are essential for plasmalogen biosynthesis, thus 
providing another negative selection screen for the identification of peroxisome biogenesis 
mutants (Tsukamoto et al., 1990; Morand et al., 1990). 
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Further peroxisome biogenesis mutants were identified using positive selection screens. In 
one such assay, a chimeric protein comprised of the bleomycin antibiotic resistance gene and 
the peroxisomal matrix enzyme luciferase, was expressed in S. cerevisiae. The assay worked 
on the premise that if the chimeric protein was transported into peroxisomes, the cells would 
not be resistant to phleomycin. In mutants devoid of peroxisomal structures, the chimeric 
phleomycin resistance protein would be present in the cytosol and so peroxisome biogenesis 
mutants could be positively selected due to their phleomycin resistance (Elgersma et al., 
1993). 
 
The genes identified over this period were initially named and characterised with respect to 
their function or the order in which they were identified. The system under which they are 
now recognised were summarised by Distel et al., and the proteins were named peroxins, 
encoded by PEX genes (Distel et al., 1996). Further identification of PEX genes has been 
achieved using DNA microarray techniques for oleic-induced yeast genes and proteomic 
approaches and to date, 36 peroxins have been identified. The peroxins which have been 
identified in S. cerevisiae are described with their associated functions in Table 1.1. 
 
 
Table 1.1 - The known peroxins in S. cerevisiae and their associated functions. Modified 
from (Smith and Aitchison, 2013). 
Peroxin Functional category 
Targeting of matrix proteins  
Pex5 PTS1 cargo shuttling receptor 
Pex7 PTS2 cargo shuttling receptor 
Pex18 PTS2 cargo co-receptor 
Pex21 PTS2 cargo co-receptor 
Pex9 PTS1 cargo shuttling receptor 
Matrix protein import machinery  
Pex13, Pex14, Pex17 Receptor docking complex 
Pex8 Bridging of the docking and export complex, assembly of 
importer 
Pex4 Ubiquitylation in receptor export, ubiquitin conjugating 
enzyme 
Pex22 Pex4 anchor, receptor export 
Pex2, Pex10, Pex12 Form the RING finger complex, receptor export 
Pex1, Pex6 AAA-type ATPase, receptor recycling 
Pex15 Membrane receptor for Pex1 and Pex6 
Direct targeting of peroxisomal 
membrane proteins 
 
Pex3 Docking of Pex19, insertion of PMPs 
Pex19 Soluble PMP receptor and chaperone 
Formation of peroxisomal membrane 
from the ER 
 
Pex3, Pex19 Forms a complex required for de novo biogenesis of 
peroxisomes 
Pex25 Required for de novo biogenesis of peroxisomes 
Pex30 Regulates de novo biogenesis of peroxisomes 
Fission  
Pex11 Membrane elongation, recruits fission machinery 
Pex25 Membrane elongation and remodelling 
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Pex27, Pex34 Positive regulators of peroxisome fission 
Regulation of peroxisome biogenesis  
Pex28, Pex29, Pex31, Pex32 Forms a complex with reticulon homology domain-containing 
proteins, establishes peroxisome contact sites as ER 
subdomains 
Pex35 Interacts with Arf1 and regulates peroxisome abundance 
 
1.4 Peroxisomal matrix protein import 
 
Peroxisomal matrix proteins are synthesised on cytosolic ribosomes and post-translationally 
imported into peroxisomes (reviewed by Lazarow and Fujiki, 1985). Most peroxisomal matrix 
proteins contain one of two peroxisomal targeting signal (PTS) sequences within their 
polypeptide chains. The most common is PTS1, a conserved, tripeptide consensus sequence 
of (S/A/C)-(K/R/H)-L which is found at the extreme C-terminus of matrix proteins (Gould et 
al., 1989). The PTS2 is much less common. It is found near the N-terminus of the protein and 
is comprised of the consensus sequence (R/K)-(L/V/I/Q)-X-X-(L/V/I/H/Q)-(L/S/G/A/K)-X-
(H/Q)-(L/A/F) (Swinkels et al., 1992; Petriv et al., 2004). The addition of a PTS sequence is 
sufficient to target even non-peroxisomal proteins to the peroxisomal matrix. The PTS1 in 
particular is often exploited for the creation of fluorescent peroxisomal matrix markers by the 
addition of the amino acids -SKL to the extreme C-terminus of a fluorescent protein. 
 
Matrix proteins with a PTS1 or PTS2 bind to the soluble cytosolic receptors Pex5 and Pex7 
respectively. In S. cerevisiae, Pex7 interactions with PTS2 proteins also requires the partially 
redundant co-receptors Pex18 and Pex21 or the orthologue Pex20 in Pichia pastoris 
(Titorenko et al., 1998). In mammalian peroxisome protein import, the function of co-
receptor for PTS2 proteins is fulfilled by alternative splicing of Pex5 into a long and short 
isoform, PEX5L and PEX5S. PEX5L binds to Pex7 and is the place of conversion between the 
PTS1 and PTS2 pathways in mammalian cells (Braverman et al., 1998). 
 
PTS1 and PTS2 receptor-cargo complexes assemble in the cytosol and are targeted to the 
docking complex (Pex13/Pex14/Pex17) on the peroxisomal membrane (Urquhart et al., 2000). 
Once assembled with Pex14 at the docking complex, a transient pore is formed from either 
Pex5 (PTS1 pathway) or Pex18 (PTS2 pathway) (Gouveia et al., 2000; Erdmann and Schliebs, 
2005) It is through this pore that cargo proteins are released into the peroxisomal lumen, 
although the exact mechanisms behind this are not known (Meinecke et al., 2010; reviewed 
by Meinecke et al., 2016). 
 
The PTS receptors are then recycled. This occurs through mono-ubiquitination of the receptor 
at a conserved cysteine by the E2-enzyme complex Pex4/Pex22 and the E3-ligases of the RING 
complex which consists of Pex2, Pex10 and Pex12 (reviewed by Platta and Erdmann, 2007; 
Williams et al., 2008; Platta et al., 2009; El Magraoui et al., 2012). Ubiquitination of the 
receptors primes them for release from the peroxisomal membrane and their release to the 
cytosol is carried out by the AAA-peroxins Pex1 and Pex6 in an ATP-dependent manner 
(Miyata and Fujiki, 2005; Platta et al., 2005). Pex1 and Pex6 form an heterohexameric complex 
anchored to the peroxisomal membrane by Pex15 or the orthologue Pex26 in humans 
(Matsumoto et al., 2003; Birschmann et al., 2003). Finally, the ubiquitin moiety is removed 









Figure 1.1 – A schematic diagram representing the model of events which are involved in 
the import of peroxisomal matrix proteins in S. cerevisiae (Hettema et al., 2014). (I) Proteins 
with a peroxisomal targeting signal of type 1 (PTS1) are recognised and bound by the import 
receptor Pex5 in the cytosol. (II) The cargo-loaded receptor is then directed to the 
peroxisomal membrane, binds to the docking complex and (III) forms a transient pore with 
Pex14. (IV) Cargo proteins are imported into the peroxisome in an unknown manner before 
being released from the receptor. (V) The import receptor is then mono-ubiquitinated and 











1.5 Peroxisome membrane protein import 
 
Peroxisomal membrane proteins (PMPs) have alternative pathways to peroxisomal matrix 
proteins for their insertion into the peroxisomal membrane. This is evident due to the 
existence of peroxisome ‘ghosts’ which were first observed in cells of Zellweger’s patients. 
These empty peroxisomal membrane compartments contain PMPs but lack peroxisomal 
matrix proteins (Santos et al., 1988). 
 
Pex3 and Pex19 are essential for peroxisomal membrane biogenesis and in cells where either 
of these genes are absent, there is a lack of typical peroxisomal membrane structures and 
most PMPs are mislocalised to the cytosol or other membrane compartments such as the ER 
or mitochondrial outer membrane (Gotte et al., 1998; Matsuzono et al., 1999; Hettema et al., 
2000; Shimozawa et al., 2000; Muntau et al., 2000). In mammals and other higher eukaryotes, 
Pex16 is also found to play a key role in peroxisomal membrane biogenesis (Honsho et al., 
1998; South and Gould, 1999). However, Pex16 is not functionally or structurally conserved 
and most yeast including S. cerevisiae lack a Pex16 orthologue.  
 
Pex19 is a farnesylated protein which is predominantly found in the cytosol with a small 
amount present on the peroxisomal membrane (Gotte et al., 1998; Matsuzono et al., 1999; 
Sacksteder et al., 2000). Pex19 functions as both a PMP chaperone in the cytosol and an 
import receptor by binding to specific peroxisome targeting signals of PMPs known as 
membrane protein targeting signals (mPTSs) (Jones et al., 2004). These mPTSs generally 
consist of a stretch of hydrophobic and basic amino acids flanked by one or two 
transmembrane domains (Dyer et al., 1996; Honsho and Fujiki, 2001). Once bound to Pex19, 
the PMP is stabilised and released into the peroxisomal membrane bilayer when Pex19 docks 
with Pex3 on the peroxisomal membrane (Fig. 1.2) (Muntau et al., 2003; Fang et al., 2004; 
Matsuzono et al., 2006). The majority of PMPs are directly and post translationally inserted 
into peroxisomal membrane via Pex19 and these are referred to as Class I PMPs. 
 
Class II PMPs are proposed to be targeted to the peroxisomal membrane via the ER, 
independent of Pex19. Of the few identified Class II PMPs, one of the best characterised is 
Pex3. Pex19 does not bind the mPTS of Pex3 and is not required for Pex3 import to 
peroxisomes, indicative that Pex3 is imported differently from other PMPs (Jones et al., 2004). 
This may be due to its essential role in peroxisome biogenesis, which is further discussed in 















Figure 1.2 - The model of events which are involved in the import of peroxisomal membrane 
proteins into peroxisomes. In the cytosol, the peroxisomal membrane protein (PMP) docks 
with the chaperone protein Pex19 through interaction of its membrane PTS (mPTS). Pex19 
chaperones the PMP through the cytosol before docking with Pex3 at the peroxisomal 
membrane via its conserved N-terminal domain. The PMP inserts into the peroxisomal 
membrane and Pex19 is released back to the cytosol. Diagram is not to scale. 
 
 
1.6 Maintenance of peroxisomes and the role of Pex3 
 
Pex3 is a highly conserved peroxisomal membrane protein and acts in a range of genetically 
separate, peroxisomal processes through its interactions with various proteins. It can be 
described as a hub-like protein, orchestrating diverse peroxisomal functions such as 
biogenesis, membrane protein import, retention and targeted degradation of peroxisomes 
(pexophagy) (Fig. 1.6). 
 
1.6.1 Peroxisome biogenesis – Pex3 and Pex19 
 
The biogenesis of peroxisomes has been a central theme of peroxisome research for several 
decades. This work has resulted in two main models of biogenesis for yeast peroxisomes 
which both centre around the emergence of peroxisomes from the ER and the essential 
interaction between the highly conserved peroxins Pex3 and Pex19. There is an additional 
model for mammalian peroxisome biogenesis which identifies a role for mitochondria. This 
work reports that peroxisomes can be derived from pre-peroxisomal vesicles which emerge 
from the ER and mitochondria (Sugiura et al., 2017). For the purpose of this thesis, the 
following sections will focus on the two models of yeast peroxisome biogenesis, with 

















The growth and division model 
 
The growth and division model is based upon the idea that that peroxisomes form from pre-
existing ones by growth from ER derived lipids, insertion of cytosolic PMPs into the 
peroxisomal membrane and subsequent fission to form a daughter peroxisome (Fig. 1.3) 
(Lazarow and Fujiki, 1985; Motley and Hettema, 2007). As described in Section 1.5, PMPs are 
synthesised in the cytosol and post-translationally chaperoned to peroxisomes by Pex19.  
Pex19 has a high affinity N-terminal binding site for Pex3 and docks with Pex3 at the 
peroxisomal membrane where Class I PMPs are subsequently inserted into the membrane 
bilayer (Fang et al., 2004; Matsuzono et al., 2006; Schmidt et al., 2010). The two proteins can 
form a structural and functional unit as the mPTS of Pex3 is different to the mPTS binding sites 
of other PMPs which allows for the formation of Pex3-Pex19-PMP complexes (Shibata et al., 
2004). Furthermore, the amino acid domain required for Pex19 docking has been identified 
in Human Pex3 (Muntau et al., 2003; Fang et al., 2004).  
 
To produce the daughter peroxisome, fission occurs via three steps, elongation, constriction 
and scission. The Pex11 family proteins, Pex11a, Pex11b and Pex11g in mammalian cells and 
Pex11, Pex25 and Pex27 in S. cerevisiae, are central to this process (reviewed by Kiel et al., 
2006). S. cerevisiae Pex11 and its mammalian a, b, g-isoforms cause tubulation of 
peroxisomes during peroxisome elongation. Following constriction, Pex11 (or mammalian 
Pex11b) binds to the tail anchored adaptor protein Fis1 which in turn recruits the yeast 
peripheral membrane receptors Caf4 or Mdv1 or the mitochondrial fission factor Mff1 in 
mammalian cells (Motley et al., 2008; Gandre-Babbe and van der Bliek, 2008). The yeast 
dynamin-related protein (Drp) GTPase Dnm1, or mammalian Dlp1, are subsequently localised 
to the site of constriction and GTP hydrolysis leads to peroxisome scission (Li and Gould, 2003; 
Kuravi et al., 2006). In yeast, the Drp Vps1 is also recruited for fission  and contributes more 
to peroxisome fission under normal growth conditions than Dnm1 based fission, but this 
occurs independently of Fis1 (Hoefpner et al., 2001; Motley et al., 2008). 
 
The de novo biogenesis model 
 
The importance of the Pex3-Pex19 interaction is highlighted when it is considered that cells 
lacking functional Pex3 or Pex19 are devoid of peroxisomes (Hettema et al., 2000). In 
peroxisome biogenesis mutants or peroxisome inheritance mutants that lack peroxisomes, 
complementation by the missing gene allows peroxisomes to form without pre-existing 
peroxisomal membrane structures (Höhfeld et al., 1991). This observation gave rise to the de 
novo peroxisome biogenesis model, a process by which peroxisomes are generated from 
domains in the ER in a Pex3 and Pex19 dependent manner (Fig. 1.4) (Hoepfner et al., 2005). 
 
In the absence of peroxisomal structures, Pex3 accumulates in specialised domains of the ER 
referred to as the pre-peroxisomal ER (Hoepfner et al., 2005; Kragt et al., 2005; Tam et al., 
2005; Motley and Hettema, 2007). Many PMPs including Pex3 itself are co-translationally 
inserted into the pre-peroxisomal subdomains of the ER by the Sec61 complex whilst 
peroxisomal tail anchored proteins are inserted post-translationally and dependent upon 
Get1, 2 and 3 of the GET complex (Guided Entry of Tail-anchors) and Pex19 (Schuldiner et al., 
2008; Thoms et al., 2012; Mayerhofer et al., 2016). 
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The release of pre-peroxisomal vesicles from the ER is Pex19 dependent although the 
mechanisms by which Pex19 releases Pex3 are unknown and any other essential molecular 
machinery has yet to be characterised (Van Der Zand et al., 2010; Lam et al., 2011). The 
endosomal sorting complexes required for transport (ESCRT)-III proteins Vps20 and Snf7 are 
proposed to play a role in pre-peroxisome vesicle scission (Mast et al., 2018). The pre-
peroxisomal vesicles then fuse with each other to form a pre-peroxisome which is capable of 
matrix protein import and can subsequently mature into a functional peroxisome (Van Der 
Zand et al., 2012). 
 
Some studies do suggest that de novo formation of peroxisomes occurs in all cells (Kim et al., 
2006; Van Der Zand et al., 2012), however the majority of yeast studies indicate that growth 
and division is the default mode of peroxisome multiplication and that de novo formation is 
observed when a cell is temporarily devoid of peroxisomes (Motley and Hettema, 2007; 





Figure 1.3  – The peroxisome growth and division model. The growth and division model 
proposes that peroxisomes receive lipids and a subset of PMPs from the ER via vesicular 
transport and fusion. Additionally, peroxisomes receive newly synthesised peroxisomal 
matrix and membrane proteins from the cytosol. These processes contribute to peroxisomal 
growth and so once a peroxisome reaches a certain size it undergoes elongation, constriction 




















Figure 1.4 - The peroxisome de novo biogenesis model. PMPs are co-translationally inserted 
into the ER via the Sec61 complex or post-translationally inserted via the GET complex. The 
PMPs are targeted to sub-domains of the ER known as the peroxisomal ER (pER). These areas 
then form into pre-peroxisomal vesicles (pPV) which bud from the ER in a Pex19-dependent 
manner. The pre-peroxisomal vesicles are of two distinct types, one comprised of Pex3, Pex2 
and Pex11 and the other comprised of Pex3, Pex13, Pex14, Pex17, Pex10 and Pex12. These 
pPVs then fuse with each other and form a pre-peroxisome which is capable of matrix protein 


















1.6.2 Pexophagy – Pex3 and Atg36 
 
Selective autophagic breakdown of peroxisomes, pexophagy, requires an interaction 
between Pex3 and Atg36 in S. cerevisiae and its orthologue Atg30 in Pichia pastoris. Atg36 
and Atg30 function as specific pexophagy adaptors and through interactions with Atg8 and 
Atg11, couple peroxisomes to the autophagic machinery (Motley et al., 2012; Burnett et al., 
2015). The interaction between Atg36 and Atg11 is dependent upon phosphorylation of Atg36 
by Hrr25 but as yet, the exact mechanisms by which the Atg36-Pex3 interaction is regulated 
remain unclear and a higher eukaryotic orthologue of Atg36 is yet to be identified (Tanaka et 
al., 2014). 
 
1.6.3 Peroxisome retention and inheritance 
 
Pex3 and Inp1 
 
A full complement of organelles is important for cellular function and eukaryotic cells have 
evolved molecular mechanisms that control organelle size, number and position. Molecular 
tethers are required for organelle positioning, multiplication and establishment of inter-
organellar contact sites, a topic which will be further discussed in Section 1.7. Spatial and 
temporal control of organelle location requires a tightly regulated system and the balance 
between organelle tethering and motility determines the intracellular distribution of 
organelles and their segregation during cell division (Fagarasanu et al., 2010). The inheritance 
of some organelles during cell division is crucial, such as the mitochondria and nucleus which 
contain essential genetic material and cannot be formed de novo. Other organelles such as 
peroxisomes can be formed de novo, but as discussed in Section 1.6.1, this is not an 
energetically favourable process and does not appear to be the preferred process by which 
cells form peroxisomes. 
 
S. cerevisiae is a budding yeast that undergoes asymmetric cell division during asexual 
reproduction. As such, organelles must be actively and vectorially transported to the growing 
bud. Correct peroxisome inheritance is achieved by a balance between the opposing 
processes of cortical anchoring in the mother cell and Myosin-dependent transport towards 
the bud (Hoepfner et al., 2001; Fagarasanu et al., 2006; Knoblach et al., 2013; Knoblach and 
Rachubinski, 2019). It is the direct interaction between Pex3 and Inp1 which is essential for 
retention of a subset of peroxisomes during cell division and correct peroxisome positioning 
along the mother cortex (Fagarasanu et al., 2005; Munck et al., 2009; Knoblach et al., 2013). 
 
Inp1 (Inheritance of peroxisomes 1) is a peripheral membrane protein identified in yeast. It 
was first implicated in peroxisome retention as cells devoid of Inp1 have an abnormal 
distribution of peroxisomes, with almost all peroxisomes present in the bud. These cells also 
exhibit a phenotype of a reduced number of enlarged peroxisomes (Fagarasanu et al., 2005). 
Conversely, overexpression of Inp1 leads to almost all peroxisomes being retained in the 
mother cell (Fagarasanu et al., 2005). The recruitment of Inp1 to peroxisomes is due to its 





The current model for the peroxisome tethering function of Inp1 proposes that Inp1 acts as a 
molecular bridge between peroxisomes and the ER by interacting in trans with peroxisomal 
Pex3 and cortical ER-associated Pex3 via N and C-terminal Pex3 binding domains (Fig. 1.5) 
(Knoblach et al., 2013). However, recent work by the same group has shed doubt on the 
simplicity of this model with the suggestion that the ER-peroxisome tether is likely to involve 
additional cortical factors. The authors also suggest that contact sites between the ER and 
peroxisomes may occur independently of Inp1 and that Inp1 may function as a tether 
between peroxisomes and other organelles (Knoblach and Rachubinski, 2019). 
 
Transport of peroxisomes to the bud is facilitated by Inp2, an integral peroxisomal membrane 
protein which functions antagonistically to Inp1 (Fagarasanu et al., 2006). Inp2 is a specific 
peroxisomal receptor for the class V myosin, Myo2, a myosin motor which binds to Inp2 via 
its C-terminal cargo binding domain (CBD) and transports peroxisomes along actin cables to 
the bud (Fig. 1.5) (Hoepfner et al., 2001; Sellers and Veigel, 2006; Fagarasanu et al., 2006; 
Knoblach and Rachubinski, 2015). As with Inp1, Inp2 is thought to be a poorly conserved 
protein with orthologues yet to be identified in higher eukaryotes. However, residues in the 
CBD of Myo2 which are considered relevant for its interaction with Inp2 have been found to 
be conserved in the CBD’s of mammalian MyoVa and MyoVb. This implies a highly conserved 
function among class V myosin motors from yeast to humans and perhaps points to the 
existence of a human Inp2 equivalent (Nascimento et al., 2013). 
 
In cells lacking Inp2, peroxisome inheritance is abolished or delayed and results in buds devoid 
of peroxisomes whilst overexpression of Inp2 results in a depletion of peroxisomes from 
mother cells as they are all transported into the bud (Fagarasanu et al., 2006). By anchoring 
peroxisomes at the cortex of the mother cell, it is ensured that a population of peroxisomes 
are retained in the mother. Additionally, anchoring of peroxisomes to the bud cortex, once 
transported there, prevents against backtracking of peroxisomes into the mother cell  
(Fagarasanu et al., 2005). Pex19 has also been shown to contribute to peroxisome delivery to 
the bud by binding to Inp2 and in H. polymorpha, Pex19 is essential for Inp2’s interaction with 
Myo2 (Otzen et al., 2012; Saraya et al., 2010). 
 
The peroxisomal locations of Inp1 and Inp2 during growth, division and fission have been 
distinguished using the mutant Ddnm1/Dvps1. In these cells peroxisome fission is abolished, 
and peroxisomes appear elongated and ‘sausage-like’. On these peroxisomes, Inp1 is 
observed at the tip of the peroxisome proximal to the mother cell whilst Inp2 is present on 
the tip of the peroxisome which resides in the bud (Knoblach et al., 2013).  
 
Cortical tethering of peroxisomes and active transport of peroxisomes to the bud are required 
during asymmetric cell division to ensure that the peroxisomal population is properly 
maintained as cell division occurs. Inp1 and Inp2 are central to this process as they define the 
spatial and temporal distribution of peroxisomes by performing antagonistic functions and 
ensuring proper peroxisome segregation along the mother-bud axis (Fagarasanu et al., 2005; 







Pex3 and Myo2 in Yarrowia lipolytica 
 
At present, there are no identified higher eukaryotic orthologues of Inp1, but orthologues of 
Inp1 are present in other yeasts such as Yarrowia lipolytica. YlInp1 has also been shown to be 
required for peroxisome retention, although it has not been shown that this is due to a direct 
interaction with YlPex3 (Chang et al., 2007). Y. lipolytica is unique in that it contains Pex3 and 
a paralogue of Pex3 which has been named Pex3B. YlPex3 and YlPex3B have been shown to 
bind to the class V Myosin MyoV and are reported to have roles as peroxisome-specific myosin 
adaptors which contribute to the transport of peroxisomes to the bud during cell division. 
Additionally, YlPex3 and YlPex3B are able to interact with ScMyo2 which is suggestive that 
they are functional equivalents of Inp2 in S. cerevisiae (Chang et al., 2009). It is reasonable to 
predict that, as is known for other orthologues of Inp1, YlInp1 directly interacts with a 
paralogue of YlPex3. This therefore implies that in Y. lipolytica, Pex3 is directly involved in 
both peroxisome retention and transport. Due to the evolution of two members of the Pex3 
protein family, Y. lipolytica allows for the unique observation of the contribution of Pex3 to 
the movement of peroxisomes. Although it is not yet reported in any other species, the 
observations made in Y. lipolytica give rise to the idea that Pex3 is able to play a direct role in 


































































Figure 1.5 – The existing model of peroxisome inheritance and retention in S. cerevisiae. 
Transport of peroxisomes to the bud requires Inp2 (orange) which is a peroxisome-specific 
receptor for the Class V Myosin, Myo2 (pink). The myosin motor binds to Inp2 through its C-
terminal cargo binding domain and transports peroxisomes along actin cables towards the 
bud. Retention of peroxisomes is currently proposed to occur via Inp1 (green) which binds to 
peroxisomal and cortical ER-associated Pex3 (purple) in trans. It is suggested that by acting as 
a molecular bridge, Inp1 ensures peroxisome retention at the mother cell cortex during 
asymmetric cell division. Diagram is not to scale. 
 









1.6.4 Pex3 and the vacuole 
 
A recent study in the yeast Hansenula polymorpha implicated Pex3 as a factor involved in the 
formation of peroxisome-vacuole contact sites under conditions of rapid peroxisome 
development. Pex3 accumulates at sites of vacuole-peroxisome contact during growth on 
methanol and overexpression of Pex3 was found to result in the formation of peroxisome-
vacuole contact sites in conditions where these sites do not usually occur (Wu et al., 2019). 
Whether Pex3 directly interacts with proteins or lipids on the vacuolar membrane is unclear 
but this gives rise to an additional role of Pex3 in organelle contact site formation, a topic 































Figure 1.6 – Pex3 is central to a range of roles in peroxisome biology. This schematic diagram 
represents the role of S. cerevisiae Pex3 in peroxisome membrane import via Pex19, 
peroxisome retention via Inp1, peroxisome autophagy via Atg36 and peroxisome-vacuole 
contact site formation via as yet unidentified factors. Diagram is not to scale. Modified from 














1.7 Organelle contact sites 
 
A distinguishing feature of eukaryotic cells is their compartmentalisation into distinct, 
membrane-bound organelles. This creates a diverse range of microenvironments and 
increases the efficiency of sub-cellular reactions but also means that there are physical 
barriers which could create obstacles as molecules move around the cell. In the mid-20th 
century, electron microscopy studies observed that organelles were frequently found in close 
apposition to each other with defined focal points of contact (Bernhard and Rouiller, 1956; 
Copeland and Dalton, 1959; Gray, 1963). These studies gave the first indications that 
organelles could communicate through direct contact with each other, however, it was widely 
believed that diffusion, active transport and vesicular trafficking through the cytoplasm were 
the primary methods by which inter-organellar exchange of cellular materials occurred. 
However, over recent years it has become increasingly obvious that organelles are not 
isolated structures and that cross-membrane communication and organelle functionality are 
frequently facilitated by physical contact between organelles at membrane contact sites 
(MCS). Membrane contact sites can be defined as domains where membranes from two 
intracellular compartments are tethered in close proximity by protein or lipid interactions, 
resulting in the function of one or both organelles being affected (Prinz, 2014; Shai et al., 
2018; Prinz et al., 2020). Every organelle has now been shown to have at least one functional 
MCS with another organelle and most organelles have more than one (Valm et al., 2017; Shai 
et al., 2018).  
 
Membrane contact sites are extremely diverse. The distance between organelles can be fixed 
or variable and where it varies, the range of distance between two organelles can be very 
broad. In S. cerevisiae the distance between the ER and the plasma membrane (PM) at MCS 
can range from 16-60nm (West et al., 2011). The stability of MCS also varies widely, some 
contacts are extremely stable and persist for the lifetime of the cell while others are much 
more transient and last for less than 1 second (Lewis et al., 2016). Some organelles share 
multiple physically and functionally distinct MCS at the same time. For example distinct 
contact sites between the ER and PM have been shown to co-exist to facilitate the functionally 
different processes of what appears to be cholesterol exchange and store-operated calcium 
entry (Besprozvannaya et al., 2018).  
 
Membrane contact sites are not restricted to just two different organelles and there are 
several examples of three-way organelle contact sites. For example, the ER is present at 
contact sites between the plasma membrane and mitochondria as part of a multi-subunit 
complex termed MECA (mitochondrial ER cortical anchor) (Lackner et al., 2013). Additionally, 
in S. cerevisiae the ER protein Mdm1 has been proposed to associate with lipid droplets and 
the vacuole, creating a three-way junction between the organelles (Hariri et al., 2019). 
Another form of MCS are intraorganellar membrane contact sites. In the ER, Atlastin has been 
identified as a tether protein which creates junctions within the ER (Wang et al., 2016). 
 
1.7.1 Roles of contact sites 
 
Membrane contact sites have been shown to have a wide range of roles with the best 
characterised being non-vesicular transport of metabolites such as lipids and cell 
communication and signalling pathways. Intracellular lipid transport by non-vesicular lipid 
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exchange is facilitated by lipid transport proteins (LTPs). LTPs are often enriched at MCS and 
bind to MCS-associated proteins. Lipid exchange at MCS serves to alter lipid compositions of 
specific membranes or organelles and to regulate lipid-based signalling pathways such as 
phosphoinositide (PI) based signalling at the ER-PM membrane contact site (reviewed by 
Cockcroft and Raghu, 2018). MCSs can serve as signalling hubs in response to external stimuli 
such as stress or nutrition. Phosphatidylinositol is synthesised in the ER but the kinases that 
convert it to phosphoinositides such as PI(4)P or PI(4,5)P2 are present in other organelles such 
as the plasma membrane or Golgi (Agranoff et al., 1958; Walch-Solimena and Novick, 1999; 
Audhya and Emr, 2002). Hence, the formation of MCS between the ER and other organelles 
allows for differential amounts of PI to be produced or depleted dependent on the cell’s needs 
(Kim et al., 2011). These phosphoinositides then have downstream functions in a broad range 
of cellular processes such as cell signalling, regulation of ion channel activity, endocytosis and 
vesicular transport (reviewed by Balla et al., 2009 and Dickson and Hille, 2019). 
 
MCSs also allow for the efficient exchange of metabolites such as calcium ions between 
organelles. This increases reaction rates and prevents loss of metabolites to the surrounding 
areas of the cell. For example, there is an enrichment of ER Ca2+ channels at ER-Mitochondria 
MCS which results in a higher concentration of Ca2+ at these sites and hence increases the 
efficiency of metabolite transfer between the two organelles (Rizzuto et al., 1993; Csordás et 
al., 2010). 
 
1.8 Organelle positioning and tethering 
 
1.8.1 Mitochondrial tethering 
 
MCS are required for regulation of organelle inheritance and retention and this has been 
shown in S. cerevisiae with mitochondria, peroxisomes and lipid droplets. During asymmetric 
cell division, the correct positioning of mitochondria at the cell periphery is mediated by at 
least three known MCSs. Cortical mitochondrial anchorage occurs via the mitochondrial ER 
cortex anchor (MECA), a multi-subunit protein complex (Lackner et al., 2013). The core 
component of MECA is Num1, a cortical associated protein which binds to the mitochondrial 
outer membrane and the plasma membrane via two distinct lipid binding domains (Lackner 
et al., 2013; Ping et al., 2016). Although MECA is reported to be a tether between three 
organelle membranes, the molecular mechanisms for MECA association with the ER remain 
poorly understood. The plasma membrane has been further implicated in mitochondrial 
tethering via site-specific mitochondrial anchorage at the mother cell tip via Mfb1 (Pernice et 
al., 2016). In the bud, the mitochondrial Myo2 receptor-related protein Mmr1 mediates ER-
Mitochondria MCS to anchor mitochondria to the bud cell tip (Swayne et al., 2011). The 
various MCS between mitochondria, the PM and the ER ensure that functional organelles are 







1.8.2 Peroxisome contact sites  
 
Peroxisome – ER 
 
In mammalian cells, nearly 90% of peroxisomes contact the ER (Valm et al., 2017). The 
proteins which tether the ER and Peroxisomes at their MCS in mammalian cells were 
described by two independent groups. The ER resident proteins known as Vesicle associated 
membrane protein (VAMP)-associated proteins A and B (VAP-A and VAP-B) interact with the 
FFAT-like motifs of the peroxisomal membrane proteins ACBD4 and ACBD5 in mammalian 
cells (Loewen and Levine, 2003; Hua et al., 2017; Costello et al., 2017a; Costello et al., 2017b). 
Absence or disruption of these tethers results in decreased plasmalogen, cholesterol and fatty 
acid b-oxidation levels and implies that ER-peroxisome contact is important in lipid transport 
(Hua et al., 2017; Yagita et al., 2017). 
 
In yeast, several membrane contact sites between the ER and Peroxisome have so far been 
described. One such MCS plays a role in peroxisome retention and requires Inp1 and Pex3. 
This is fully described in Section 1.6.3.  Peroxisome-ER contact in S. cerevisiae also involves 
the Pex23 family proteins Pex29 and Pex30 which form a complex with ER-localised reticulon 
homology proteins Rtn1 and Yop1 and create an ER-Peroxisome CONtact site (EPCON). The 
ER domains enriched for Pex29 and Pex30 dynamically associated with peroxisomes during 
growth on glucose and stably associate during growth on oleate. It is suggested that the 
EPCON plays a role in de novo biogenesis of peroxisomes (David et al., 2013; Mast et al., 2016; 
Joshi et al., 2016; Joshi et al., 2018). Similar observations have recently been made in H. 
polymorpha where it was shown that the Pex23 family peroxins Pex24 and Pex32 function as 
tethers to mediate peroxisome-ER contact sites. Deletion of HpPex24 or HpPex32 results in 
disruption of peroxisome-ER contacts and impairs peroxisome biogenesis and normal 
peroxisome segregation between mother cells and buds (Wu et al., 2020). 
 
Peroxisome – Mitochondria 
 
Peroxisomes and mitochondria co-operate closely in b-oxidation of fatty acids and share 
proteins required for their respective division machineries, a relationship which implies the 
need for close contact between the two organelles (reviewed by Schrader et al., 2012). Sites 
of close proximity between peroxisomes and mitochondria have been observed in S. 
cerevisiae and mammalian cells with several different tether complexes proposed in S. 
cerevisiae (Fan et al., 2016; Shai et al., 2018).  
 
The peroxisomal membrane protein Pex34 and the mitochondrial outer membrane mitofusin 
protein Fzo1 are proposed to exist as distinct tether complexes. They are enriched at 
peroxisome-mitochondria MCS and their overexpression enhances the number of contact 
sites between the two organelles. However, the identities of their counterpart binding 
partners remains unclear. Associations between peroxisomes and mitochondria are assumed 
to allow efficient transport of metabolites to enhance metabolism as it is proposed that Pex34 
functions in the transfer of b-oxidation intermediates between the two organelles (Shai et al., 
2018). In mammalian cells it is suggested that peroxisome-mitochondria MCS allow for 
interorganellar exchange of steroid biosynthesis metabolites (Fan et al., 2016). Pex11 has also 
been identified as a potential peroxisome-mitochondria tether through direct interaction 
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with Mdm34, a component of the ERMES (ER-mitochondrial encounter structure) complex 
(Ušaj et al., 2015). Pex11 interacts directly with Fis1, a shared component of both peroxisomal 
and mitochondrial fission and as such the Pex11-Mdm34 MCS could have a role in peroxisome 
fission (Koch et al., 2010; Joshi et al., 2012).  
 
Peroxisome – Lipid droplets 
 
Growth of yeast on oleate induces peroxisome proliferation and has also been shown to 
increase the number and stability of peroxisome-lipid droplet contact sites (Binns et al., 2006). 
Contact between these two organelles is assumed to be mainly for lipid transfer. In addition 
to observations made in fungal cells, lipid droplets have also been observed to form contact 
sites with peroxisomes in mammalian cells through the peroxisomal membrane protein 
ABCD1 and the lipid droplet protein M1 Spastin (Chang et al., 2019).  
 
Peroxisome – Vacuole 
 
Membrane contact sites between the vacuole and peroxisome have been observed in the 
budding yeast S. cerevisiae using split-GFP technology (Shai et al., 2018; Kakimoto et al., 
2018). These MCS are further described in the yeast Hansenula polymorpha where Pex3 is 
implicated to play a crucial role in the formation of Peroxisome-Vacuole contact sites (Wu et 
al., 2019). 
 
1.8.3 Defining a tether 
 
After the identification of MCS by electron microscopy, further studies went on to find 
proteins which were present at the sites of contact between interorganellar membranes and 
were involved in physically bridging the opposing membranes (Kawamoto et al., 1986; Pan et 
al., 2000). It is now established that contact between organellar membranes is achieved 
through proteins or protein complexes known as ‘tethers’ due to their functional and 
structural capacity to physically tether organelles together. Some tethers actively participate 
in the specific function of the interorganellar MCS whilst others adapt the size and number of 
MCS in response to environmental stimuli  (Kornmann et al., 2011; Prinz, 2014). Other tethers 
serve as molecular bridges, physically attaching the membranes together (Csordás et al., 
2006).  
 
The list of interorganellar contact sites is expanding all the time and it is clear that the proteins 
which reside in these contact sites and are implicated in interorganellar tethering roles may 
contribute to any of several molecular functions.  The recent increase in the identification of 
contact site proteins has led to a formal consensus of criteria that a protein should adhere to 
in order to be formally classified as an MCS tether (Eisenberg-Bord et al., 2016; Scorrano et 
al., 2019). 
 
1) Defined location: A tether must reside exclusively in or be enriched in a contact site. 
 
2) Structural capacity: A tether or tether complex must have the ability to mediate binding to 
the opposing membranes. 
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3) Functional activity: A tether must exert a tethering force. This can be measured by 
observing the effect that loss of or overexpression of a tether has on the extent of a contact 





The molecular interaction between Inp1 and Pex3 was first described by the Hettema lab,  
(Munck et al., 2009) and the current model of Inp1/Pex3-mediated peroxisome retention was 
established in 2013 (Knoblach et al., 2013). This model was widely accepted by the cell biology 
community until fairly recently when the authors (Knoblach and Rachubinski, 2019), shed 
doubt on the mechanisms of their own model with the suggestion that additional components 
are required for peroxisome tethering to the cell cortex and that Inp1 may function as a tether 
between peroxisomes and other organelles. 
 
The original aim of this study was to functionally characterise Inp1 in molecular detail, 
however the data obtained led to an investigation into the role of Inp1 as a potential 
membrane contact site tether between peroxisomes and another organelle, the plasma 
membrane. This study now aims to present evidence that Inp1 is the first identified 
peroxisome-plasma membrane tether and proposes a new model for peroxisome retention 
during asymmetric cell division in yeast. 
 
Chapter 3 aims to confirm the preliminary characterisation of the Inp1-Pex3 interaction and 
further previously obtained data (Hutchinson, 2016). Both in vivo and in vitro techniques are 
employed to reveal the molecular mechanisms by which Inp1 interacts with peroxisomal 
Pex3. Chapter 4 aims to elucidate the role of the N-terminal domain of Inp1 and through in 
vitro liposome binding assays, investigates how, if not via ER-bound Pex3, Inp1 tethers 
peroxisomes to the mother cell cortex during asymmetric cell division. Chapter 5 serves to 
explore the identity of Inp1 as a membrane contact site tether protein between the plasma 
membrane and peroxisomes. The evidence presented illustrates that Inp1 adheres to the 
criteria which allow a protein to be formally classified as a tether (Eisenberg-Bord et al., 2016). 
Finally, Chapter 6 aims to discuss the data obtained throughout the study and concludes with 













Chapter 2 - Materials and Methods 
 
2.1 Chemicals and enzymes 
 
Most of the chemicals, primers and materials used throughout this study were supplied by 
MERCK (Formerly Sigma-Aldrich). Restriction enzymes and buffers were supplied by New 
England Biolabs (NEB). PCR buffers, dNTPs, DNA polymerases and Miniprep kits were supplied 
by Bioline UK. Gel extraction kits were supplied by Qiagen. 
Growth media components were supplied by Difco Laboratories and ForMedium. D-Glucose 
was provided by Fisher Scientific UK. 
Equipment used for DNA and protein work was supplied by BioRad. Buffers for protein work 
were provided by Geneflow. 
 




Table 2.1 - The yeast strains used in this study. Gene deletions or modifications were 
performed as described in (Longtine et al., 1998). 
 
Strain Genotype Source 
BY4741 WT MATA his3-1 leu2-0 met15-0 ura3-0 Euroscarf 
BY4742 WT MATα his3-1 leu2-0 lys2-0 ura3-0 Euroscarf 
inp1∆ MATA his3-1 leu2-0 met15-0 ura3-0 
inp1::KanMX4 
Euroscarf 
inp1/pex3∆ MATA his3-1 leu2-0 met15-0 ura3-0 
inp1::KanMX4 pex3::hphMX6 
Hettema Lab 
inp1/inp2∆ MATA his3-1 leu2-0 met15-0 ura3-0 
inp1::KanMX4 inp2::hphMX6 
Hettema Lab 
pex3∆ MATA his3-1 leu2-0 met15-0 ura3-0 
pex3::KanMX4 
Euroscarf 
pex19∆ MATα his3-1 leu2-0 lys2-0 ura3-0 pex19::KanMX4 Euroscarf 
atg36∆ MATA his3-1 leu2-0 met15-0 ura3-0 
atg36Δ::KanMX4 
Euroscarf 
mdh3/gpd1∆ MATA his3-1 leu2-0 met15-0 ura3-0 
gpd1Δ::KanMX4 mdh3Δ::SpHis5 
(Al-Saryi et al., 
2017) 
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mdh3/gpd1/pex3∆ MATA his3-1 leu2-0 met15-0 ura3-0 
gpd1Δ::KanMX4 mdh3Δ::SpHis5 pex3Δ::HphMX6 
(Al-Saryi et al., 
2017) 
sac1∆ MATA his3-1 leu2-0 met15-0 ura3-0 
sac1::KanMX4 
Euroscarf 
rtn1/rtn2/yop1∆ MATA his3-1 leu2-0 met15-0 ura3-0 
rtn1::KanMX4 rtn2::KanMX4 yop1::KanMX4 





MATA his3-1 leu2-0 met15-0 ura3-0 





MATA leu2-3,112 ura3-52 his3-Δ 200 trp1-Δ901 
lys2-801 suc2-Δ9 ist2::HISMX6 scs2::TRP1 
scs22::HISMX6 tcb1::KANMX6 tcb2::KANMX6 
tcb3::HISMX6 





MATA leu2-3,112 ura3-52 his3-Δ 200 trp1-Δ901 
lys2-801 suc2-Δ9 ist2::HISMX6 scs2::TRP1 






his3delta1 leu2delta0 lys2+/lys+ met15delta0 
ura3delta0 can1∆::STE2pr-sp HIS5 lyp1∆::STE3pr-




his3delta1 leu2delta0 lys2+/lys+ met15delta0 
ura3delta0 can1∆::STE2pr-sp HIS5 lyp1∆::STE3pr-
LEU2; Sec63-VC-His; Pex3-VN-Kan 






his3delta1 leu2delta0 lys2+/lys+ met15delta0 
ura3delta0 can1∆::STE2pr-sp HIS5 lyp1∆::STE3pr-
LEU2; Tom20-VC-His; Pex11-VN-Kan 






his3delta1 leu2delta0 lys2+/lys+ met15delta0 
ura3delta0 can1∆::STE2pr-sp HIS5 lyp1∆::STE3pr-
LEU2; Zrc1-VC-His; Pex25-VN-Kan 






Table 2.2 – The Escherichia coli strains used in this study. The strain, genotype, purpose and 
source of each E. coli strain are shown. 
E. coli strain Genotype Purpose Source 
DH5α  supE44 ΔlacU169 (Φ80 lacZ 
ΔM15) hsdR17 recA1 




plasmid DNA from 
S. cerevisiae 





BL21 DE3 hsdS gal (λcIts857 ind1 
Sam7 nin5 lacUV5-T7 gene 
1) 
Expression of GST, 








The plasmids used in this study are shown in Table 2.3. Plasmids were made by restriction 
digest and ligation followed by transformation into E. coli or by homologous recombination 
in S. cerevisiae. For E. coli expression, the parental vectors pET42a and pET30a were used 
(Rosenberg et al., 1987). For plasmids expressed in yeast, the parental vectors Ycplac33 and 
Ycplac111 were used which contain the multiple cloning site shown below (Gietz and Sugino, 
1988). Promoters, terminators, recombinant tags and open reading frames were introduced 
into the restriction sites. 
 
            EcoRI      SacI        KpnI               BamHI     XbaI        SalI         PstI         SphI      HindIII 
gaa ttc gag ctc ggt acc cgg gga tcc tct aga gtc gac ctg cag gca tgc aag ctt 
                                                      SmaI 
 
Table 2.3 - Plasmids used in this study. The description, parental plasmid, primer codes, 
restriction enzymes and vector backbone are shown. 
Plasmid Made from Primers (F + R) Enzymes Vector 
Plasmids used in 
truncation screen 
    
GAL1 Inp1-GFP GAL1 GFP VIP55 + VIP 167 BamH1/Sal
1 
ycplac111 
GAL1 Inp1 1-400 GFP GAL1 Inp1-GFP VIP49 + VIP556 EcoR1/Pst1 ycplac111 
GAL1 Inp1 1-370 GFP GAL1 Inp1-GFP VIP49 + VIP604 EcoR1/Pst1 ycplac111 
GAL1 Inp1 1-340 GFP GAL1 Inp1-GFP VIP49 + VIP603 EcoR1/Pst1 ycplac111 
GAL1 Inp1 1-315 GFP GAL1 Inp1-GFP VIP49 + VIP602 EcoR1/Pst1 ycplac111 
GAL1 Inp1 1-282 GFP GAL1 Inp1-GFP VIP49 + VIP 557 EcoR1/Pst1 ycplac111 
GAL1 Inp1 100-420 GFP GAL1 Inp1-GFP VIP648 + VIP643 Sac1/Pst1 ycplac111 
GAL1 Inp1 170-420 GFP GAL1 Inp1-GFP VIP649 + VIP643 Sac1/Pst1 ycplac111 
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GAL1 Inp1 240-420 GFP GAL1 Inp1-GFP VIP650+ VIP643 Sac1/Pst1 ycplac111 
GAL1 Inp1 295-420 GFP GAL1 Inp1-GFP VIP642 + VIP643 Sac1/Pst1 ycplac111 
GAL1 Inp1 300-420 GFP GAL1 Inp1-GFP VIP644 + VIP 643 Sac1/Pst1 ycplac111 
GAL1 Inp1 311-420 GFP GAL1 Inp1-GFP VIP645 + VIP643 Sac1/Pst1 ycplac111 
GAL1 Inp1 315-420 GFP GAL1 Inp1-GFP VIP625 + VIP 643 Sac1/Pst1 ycplac111 
GAL1 Inp1 281-400 GFP GAL1 Inp1-GFP VIP605 + VIP556 Sac1/Pst1 ycplac111 
GAL1 Inp1 311-370 GFP GAL1 Inp1-GFP VIP645 + VIP604 Sac1/Pst1 ycplac111 
GAL1 Inp1 315-400 GFP GAL1 Inp1-GFP VIP625 + VIP556 Sac1/Pst1 ycplac111 
GAL1 Inp1 315-370 GFP GAL1 Inp1-GFP VIP625 + VIP604 Sac1/Pst1 ycplac111 
Point mutation 
plasmids 
    
Inp1-GFP GFP VIP261 + VIP167 EcoR1 ycplac33 
Inp1 DD>AA-GFP Inp1-GFP VIP2617 + 
VIP2618 
 ycplac33 
Inp1 L>A-GFP Inp1-GFP VIP1722 + 
VIP1723 
 ycplac33 
Inp1 NY>AA-GFP Inp1-GFP VIP3664 + 
VIP3665 
 ycplac33 
Inp1 LL>AA-GFP Inp1-GFP VIP1724 + 
VIP1725 
 ycplac33 
Inp1 DEE>AAA-GFP Inp1-GFP VIP1778 + 
VIP1779 
 ycplac33 
Inp1 ∆motif-GFP Inp1-GFP VIP3663 + 
VIP3664 
 ycplac33 
Tpi-Inp1 Tpi-MCS VIP55 + VIP56 BamH1/Sal
1 
ycplac111 
Tpi-Inp1 LL>AA Tpi-MCS VIP1722 + 
VIP1723 
 ycplac111 





GFP-Pex19 L>A GFP-Pex19 VIP1780 + 
VIP1781 
 ycplac111 
GFP-Pex19 LL>AA GFP-Pex19 VIP1782 + 
VIP1783 
 ycplac111 





    
His-Pex3 (40-441) pET30a VIP235 + VIP237 BamH1/Sal
1 
pET30a 






























    
Inp1-GFP-Pex15 GFP-Pex15 VIP49 + VIP272 EcoR1/Sac1 ycplac111 
Inp1 ∆motif-GFP-Pex15 GFP-Pex15 VIP49 + VIP272 EcoR1/Sac1 ycplac111 
Inp1 1-280-GFP-Pex15 GFP-Pex15 VIP49 + VIP3755 EcoR1/Sac1 ycplac111 
Inp1 281-420-GFP-
Pex15 
GFP-Pex15 VIP3756 + 
VIP272 
EcoR1/Sac1 ycplac111 
Inp1 1-100-GFP-Pex15 GFP-Pex15 VIP49 + VIP2090 EcoR1/Sac1 ycplac111 
Inp1 101-280-GFP-
Pex15 
GFP-Pex15 VIP3764 + 
VIP3755 
EcoR1/Sac1 ycplac111 
GFP-Pex15 GFP-MCS VIP1119 + 
VIP1120 
BamH1 ycplac111 













TPI1 Inp1 1-100 mRFP-
Pex15 
mRFP-Pex15 VIP49 + VIP3972 EcoR1 ycplac111 
GAL1 Inp1 1-100-GFP Tpi Inp1 1-100-
GFP 
















2.3 Growth media 
 
All components of cell growth media were dissolved in Millipore water, mixed with a magnetic 
stirrer and autoclaved to sterilisation at 121°c. Where antibiotics or amino acid stocks were 
required, these were added to their final concentration when the autoclaved media had 
cooled to at least 50°c. The reagents required to make growth media are listed in Table 2.4. 
 
 
Table 2.4 - Growth media. Antibiotic and amino acid concentrations are final concentrations. 
 
Culture Media Description 
2TY 1.6% Bacto-tryptone, 1% yeast extract, 0.5% 
NaCl. Where required, ampicillin or kanamycin 
was added to autoclaved media to final 




2% Bacto-peptone, 2% D-Glucose, 1% yeast 
extract. 
Yeast minimal medium 1  
YM1 (For selection of all auxotrophic 
markers) 
0.17% yeast nitrogen base (without amino acids 
and ammonium sulphate), 0.5% ammonium 
sulphate, 2% D-Glucose, raffinose or galactose. 
Adjusted to pH 6.5 with NaOH. Relevant amino 
acid stocks added after autoclaving. 
Yeast minimal medium 2  
YM2 (For selection of Uracil auxotrophic 
marker) 
0.17% yeast nitrogen base (without amino acids 
and ammonium sulphate), 0.5% ammonium 
sulphate, 2% D-Glucose, raffinose or galactose, 
1% casamino acids. Adjusted to pH 6.5 with 
NaOH. 30ng/ml Leucine added after autoclaving. 
Amino acid and Uracil stocks Amino acid/Uracil stocks were added to YM1 and 
YM2 as required from 100x stocks to final 
concentrations of 20ng/ml (Uracil, Tryptophan, 
Methionine, Histidine-HCl) or 30ng/ml (Leucine, 
Lysine-HCl). Sometimes amino acids were added 
before autoclaving in the form of dropout 
supplements from ForMedium. 
Solid Media 2% (w/v) agar was added to liquid growth media 
prior to autoclaving. Once autoclaved and 
cooled, media was poured into sterile petri 
dishes (Sterilin) and left to set at room 







2.4 S. cerevisiae protocols 
 
2.4.1 Yeast growth and maintenance  
 
Yeast strains were grown at 30°C on either solid media or in liquid media on an oscillating 
shaker at 200 rpm. Amino acids and uracil were added to media for auxotrophic strains as 
required. Antibiotics were used to select for cassettes conferring resistance. For strains 
containing a plasmid with an inducible GAL1/10 promoter, cells were grown overnight in 
selective medium containing 2% raffinose then transferred to YM2 + 2% galactose for the 
time stated, for induction of gene expression. For long term storage, cells were grown up 
overnight and 15% v/v glycerol stocks were prepared in cryogenic vials (Nunc) and stored at -
80°C. 
 
2.4.2 One step transformation 
 
Yeast strains were transformed with plasmid DNA using the One Step method (Chen et al., 
1992). Cells were inoculated into 3ml of appropriate media (usually YPD) and grown overnight 
at 30°C on a shaker at 200 rpm. The next day, 200µl of the culture was harvested by 
centrifugation for 1 minute at 12,000 rpm in an Eppendorf table top centrifuge. The 
supernatant was removed and 1µl plasmid DNA (100ng-400ng), 5µl (50µg) of single stranded 
DNA (ssDNA) from Salmon sperm and 50µl one step buffer (0.2M LiAc pH 5.0, 40% (w/v) PEG 
4000 (polyethylene glycol), 0.1M DTT) were added to the cell pellet and mixed by vortexing. 
The tube was incubated at room temperature for 3-5 hours with occasional vortexing. The 
tube was then heat shocked at 42°C in a water bath for 30 minutes, vortexed again and the 
cell suspension was plated onto relevant selective solid media. Plates were incubated at 30°C 
for 2-3 days then stored at room temperature once colonies had appeared. 
 
2.4.3 High efficiency transformation 
 
High efficiency yeast transformations were performed to create knockout strains and 
plasmids. This was according to the Lithium Acetate protocol (Gietz and Woods, 2002) using 
the reagents listed in Table 2.5. Yeast strains were grown overnight in 3ml YPD liquid medium 
at 30°C with shaking at 200 rpm. The following morning, the optical density (O.D.600) of the 
culture was measured in a Jenway spectrophotometer at 600nm wavelength and the 
appropriate amount of overnight culture was added to 5ml YPD to give an OD of 0.1. Cells 
were grown at 30°C on an oscillating shaker at 200 rpm until they reached exponential phase 
(O.D.600=0.5). The cells were then centrifuged at 2500 rpm for 5 minutes at room temperature 
and the supernatant was discarded. The pellet was washed in 1ml sterile water, centrifuged 
as before then washed in 1ml 1xTE/LiAc solution. The supernatant was completely removed 
and the pellet was resuspended in 50µl 1xTE/LiAc. 
5µl digested vector (0.2-0.5µg), 5µl PCR product, 5µl (50µg) ssDNA and 300µl 40% PEG 4000 
was added to 50µl resuspended pellet in an Eppendorf tube. The reaction was left at room 
temperature for 30 minutes, incubated at 30°C for 30 minutes then heat shocked in a 42°C 
water bath for 15 minutes. The cells were harvested by centrifuging for 30 seconds at 8000 
rpm, the supernatant discarded and the pellet resuspended in 50µl 1xTE. The cells were then 
plated on selective agar media and incubated for 3 days at 30°C. 
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Table 2.5 – Components of the solutions required for high efficiency yeast transformation. 
Solutions were prepared from sterile stocks of the reagents listed. 
 
Solution Stock reagents used 
1xTE/Lithium Acetate 
solution 
1ml 10x TE (0.1M Tris-HCl and 0.01M EDTA) (pH 7.4) 




3.2ml 50% (w/v) PEG 4000 dissolved in Millipore water 
0.4ml 10x TE (0.1M Tris-HCl and 0.01M EDTA) (pH 7.4) 
0.4ml 1M Lithium Acetate (pH 7.5) 
1x TE  1ml 10xTE (0.1M Tris-HCl and 0.01M EDTA) (pH 7.4) 
9ml dH20 
 
2.4.4 Yeast genomic DNA isolation 
 
Transformed yeast cells were scraped from a selective plate and centrifuged in a 2ml screw 
cap tube with 1ml sterile water at 12,000 rpm for 1 minute. For each sample, 200µl of TENTS 
solution (20mM Tris/HCl pH 8.0, 1mM EDTA, 100mM NaCl, 2% Triton X-100, 1% SDS), 200µl 
glass beads and 200µl phenol/chloroform was added. Samples were placed in a bead beater 
for 45 seconds at full speed and then centrifuged at 12,000 rpm for 1 minute. A further 200µl 
TENTS solution was added and the mixture was vortexed. The sample was then centrifuged 
at 12,000 rpm for 5 minutes. 350µl supernatant was removed and transferred to a fresh 
Eppendorf tube. 200µl phenol/chloroform was added, the sample was vortexed and 
centrifuged as before. 300µl supernatant was removed and transferred to a fresh Eppendorf 
tube, the nucleic acids were then precipitated using 30µl 3M Sodium acetate and 750µl 100% 
ethanol. The sample was vortexed and stored at -20°C for an hour. 
The sample was then centrifuged at 12,000 rpm for 10 minutes. The supernatant was 
removed and the pellet washed in 250µl 70% ethanol before the sample was again 
centrifuged at 12,000 rpm for a further 10 minutes. The supernatant was removed, the pellet 
was resuspended in 200µl 1xTE pH 8.0 and 2µl RNAse was added. After 10 minutes incubation 
at room temperature, 20µl 3M Sodium acetate and 500µl 100% ethanol was added, the 
sample was vortexed and stored at -20°C for a further hour. Centrifugation was then carried 
out as before and the remaining pellet was washed in 70% ethanol, left to air dry then 
resuspended in a final volume of 50µl 1xTE pH 8.0. 
 
2.4.5 Epitope tagging or gene knockout in the genome 
 
Epitope tags or knockout cassettes with selective markers were amplified by PCR. Forward 
primers were designed to contain 50 nucleotides identical to the region immediately 
upstream of the open reading frame (ORF) (for gene deletion) or stop codon (for epitope 
tagging) and reverse primers were designed to contain 50 nucleotides downstream of the 
stop codon (Fig. 2.1). PCR fragments were transformed into yeast by high efficiency 
transformation (Section 2.4.3) and grown on appropriate selective medium. Correct clones 





























Figure 2.1 – Schematic representations of the methods used to modify genes in the yeast 
genome. (A) Method for epitope tagging at the C-terminus of open reading frames (ORF). (B) 
Method for gene deletion. PCR products were transformed into yeast strains by the high 
efficiency transformation protocol to obtain the desired genetically modified strains. TADH1 
indicates ADH1 terminator.  
GFP/HA/TAP TADH1 Selectable Marker
Forward Primer
GFP/HA/TAP TADH1 Selectable Marker
ORF Terminator



















2.4.6 Mating assays 
 
Cells of each mating type were grown to logarithmic phase on YPD. Cells were then mixed, 
pelleted, and spotted onto a pre-warmed YPD plate and incubated at 30°C for the times 
indicated. Cells were harvested from the plate by scraping, resuspended into selective growth 
medium and analysed by fluorescence microscopy. 
 
2.4.7 Fluorescence microscopy 
 
Cells were analysed with a microscope (Axiovert 200M; Carl Zeiss, Inc.) equipped with Exfo X-
cite 120 excitation light source, band-pass filters (Carl Zeiss, Inc. and Chroma), a Plan-Fluar 
100x/1.45 NA or Plan-Apochromat 63x 1.4 NA objective lens (Carl Zeiss, Inc.) and a digital 
camera (Orca ER; Hamamatsu Phototonics). Image acquisition was performed using Volocity 
software (PerkinElmer). Fluorescence images were routinely collected as 0.5 µm z-stacks and 
several layers were merged into one plane in Openlab (PerkinElmer) (except where it is 
indicated that single focal planes are shown). Images were then processed further in 
Photoshop (Adobe) by adjusting brightness and contrast levels where appropriate. Brightfield 
images were processed where necessary to illustrate the circumference of cells by increasing 
the contrast of the image in the blue RGB channel on Photoshop. For linescan analyses, lines 
were drawn through a region of interest on ImageJ/FIJI to generate intensity profiles across 
the line for each channel. In order to categorise peroxisomes as ‘peripheral’ (For example in 
Fig. 5.3), the individual z-stack layers of relevant images were carefully analysed in order to 
determine the location of individual peroxisomes in relation to the periphery of the cell. 
Experimental and control cells were scored in a consistent way. 
 
2.5 E. coli protocols 
 
2.5.1 E. coli growth and maintenance 
 
E. coli was inoculated into 4ml liquid 2TY medium and incubated at 37°C overnight on an 
oscillating shaker at 200 rpm or spread onto 2TY agar plates and grown at 37°C. In order to 
select for transformants, the media was supplemented accordingly with 75µg/ml ampicillin 
or 50µg/ml kanamycin. 
 
2.5.2 Production of chemically competent E. coli cells 
 
E. coli DH5α cells were thawed from -80°C, streaked onto a 2TY plate and incubated overnight 
at 37°C. The following day a single colony was inoculated into 4ml of 2TY and grown overnight 
at 37°C on an oscillating shaker at 200 rpm. The next morning, a secondary culture of 200ml 
2TY in a 1 litre flask was inoculated to give an O.D.600 of 0.1. Cells were grown at 37°C on an 
oscillating shaker at 200 rpm until they reached exponential phase (O.D.600=0.5) then placed 
on ice for 10 minutes.  
The culture was divided between 4, 50ml sterile falcon tubes and centrifuged for 10 minutes 
at 3000 rpm at 4°C (Sigma4-16K). The supernatant was discarded, and the pellets were 
resuspended in 35ml of RF1 (See Table 2.6). 2 tubes were combined to make 2 70ml tubes, 
left on ice for 20 minutes then centrifuged as before. The supernatant was discarded and 8ml 
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of RF2 (See Table 2.6) was used to resuspend each pellet before combining the two to give 
16ml. 200µl aliquots were taken and put into pre-cooled Eppendorf tubes before flash 
freezing in liquid N2 and storing at -80°C.   
 
Table 2.6 – The components of the solutions RF1 and RF2. Required for the production of 
chemically competent (RbCl) E. coli DH5α cells. 
 
RF1 (pH 5.8) RF2 (pH 6.8) 
100mM RbCl 10mM MOPS 
50mM MnCl2 10mM RbCl 
30mM Potassium acetate 75mM CaCl2 
10mM CaCl2 15% (v/v) Glycerol 
15% (v/v) Glycerol  
 
2.5.3 Production of electrocompetent E. coli cells 
 
E. coli DH5α cells were thawed from -80°C, streaked onto a 2TY plate and incubated overnight 
at 37°C. The following day a single colony was inoculated into 4ml of 2TY and grown overnight 
at 37°C on an oscillating shaker at 200 rpm. The next morning, the appropriate amount of 
overnight culture was added to 1L 2TY to give a secondary culture with an O.D.600 of 0.1. Cells 
were then grown at 37°C on an oscillating shaker at 200 rpm. When exponential phase was 
reached (O.D.600=0.5) the culture was divided between two 500ml, sterile centrifuge buckets 
and centrifuged at 3000 rpm for 15 minutes at 4°C (Sigma 4-16K). The supernatant was 
removed and each pellet was resuspended in 250ml of ice cold 10% (v/v) glycerol. The cells 
were centrifuged twice more as before with the pellets being resuspended first in 125ml ice 
cold 10% (v/v) glycerol and then in 50ml ice cold 10% (v/v) glycerol after which both cultures 
were transferred to 50ml falcon tubes. After a final centrifugation (as before) the supernatant 
was removed and both pellets were resuspended in 0.35ml of ice cold 10% (v/v) glycerol and 
then combined to give a 0.7ml suspension. 40µl aliquots were taken and put into pre-cooled 
Eppendorf tubes before flash freezing in liquid N2 and storing at -80°C.    
 
2.5.4 Transformation of chemically competent E. coli 
 
50µl chemically competent DH5α or BL21 DE3 cells per transformation were removed from 
storage at -80°C and thawed on ice. 1µl plasmid DNA or 10µl ligation mixture was added to 
50µl cells in an Eppendorf tube and the tube was left on ice for 20 minutes. The cells were 
heat shocked in a 42°C water bath for 2 minutes then transferred back onto ice for 5 minutes. 
900µl 2TY was added to each transformation and the tube was incubated at 37°C for 45 
minutes. The tube was then centrifuged at 13,000 rpm for 1 minute and 850µl supernatant 
was removed leaving approximately 50µl 2TY media and cells. The cells were resuspended 
gently then plated onto the relevant selective agar media and incubated overnight at 37°C 
before being stored at 4°C. 
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2.5.5 Transformation of electrocompetent E. coli 
 
40µl electrocompetent cells per transformation were removed from storage at -80°C and 
thawed on ice. 10µl of 10x diluted gDNA was added to the electrocompetent cells and the 
reaction mixture was transferred to a 2mm electroporation cuvette (Fisher) on ice. The 
cuvette was loaded into the Biorad MicroPulser and the cells were electroporated with one 
pulse on the setting EC2 (V=2.5kV). 600µl 2TY was immediately added and the cells were 
transferred to a fresh 1.5ml Eppendorf tube and incubated at 37°C for 45 minutes. The tube 
was then centrifuged for 1 minute at 5000 rpm, the supernatant was removed and the cell 
pellet was plated onto relevant selective agar media and incubated overnight at 37°C before 
being stored at 4°C. 
 
2.6 DNA procedures 
 
2.6.1 Polymerase Chain Reaction (PCR) 
 
PCR was used to amplify specific regions of DNA or whole plasmids for Site Directed 
Mutagenesis (SDM). ACCUZYME™ or VELOCITY™ DNA polymerase were used to amplify DNA 
when proof-reading activity was required. MyTaq™ DNA polymerase was used for colony PCR.  
Biovision Pfu was used for SDM PCR. 25µl reactions were made up in PCR tubes. The reagents 
used are detailed in Table 2.7. 
 
Table 2.7 – PCR reaction mixture compositions. PCR reactions were prepared with the 
detailed reagents on ice with the DNA polymerase added last. For colony PCR, DNA templates 











2.5µl 10x ACCUZYME™ 
reaction buffer 
5µl 5x MyTaq™ 
reaction buffer 
5µl 5x Hi-Fi buffer 2.5µl 10x Pfu 
buffer 
2.5µl forward primer 
(5µM) 






2.5µl reverse primer 
(5µM)) 






1.5µl 2.5mM dNTP’s 
(0.15mM) 





0.75µl 50mM MgCl2 
(1.5mM) 
- - - 
1µl 1/50 diluted 
plasmid DNA (5-10ng) 
or 1µl gDNA 
DNA template 
acquired by 
inoculating with an 
individual bacterial 
colony 
1µl 1/50 diluted 
plasmid DNA (5-
10ng) or 1µl gDNA 




0.5µl ACCUZYME™ DNA 
polymerase (1.25 unit) 
0.25µl MYTAQ™ DNA 
polymerase (1.25 unit) 






13.75µl dH20 14.75µl dH20 12.25µl dH20 14.5µl dH20 
 
PCR reactions were run in a thermocycler with the lid preheated to 100°C to prevent 
condensation in the PCR tubes. The PCR conditions used are detailed in Table 2.8. 
 
Table 2.8 – PCR conditions. PCR conditions were set up as detailed. The annealing 
temperature was calculated depending on the AT/GC content of the individual primers used. 
Steps 2-4 were repeated for 30 cycles in each PCR reaction. 
 
 ACCUZYME™ 








1 - Initial DNA 
denaturing 
95°C 3 min 95°C 3 min 95°C 3 min 95°C 3 min 
2 – DNA 
denaturing 
95°C 30 sec 95°C 30 sec 95°C 30 sec 95°C 30 sec 
3 – Annealing of 
primers 
50-65°C 30 sec 50-65°C 30 sec 50-65°C 30 sec 50-65°C 1 min 
4 – Elongation 72°C 2min/kb 72°C 30sec/kb  72°C 15sec/kb 68°C 2min/kb 
5 – Final 
extension 
72°C 10 min 72°C 10 min 72°C 10 min 68°C 20 min 
 
Annealing temperature was dependent upon the nucleotide composition of each individual 
primer. These were calculated using the following equation: Annealing temperature (°C) = 
Melting temperature (°C) - 5°C where Melting temperature = 4(#G + #C) + 2(#A + #T). The 
primers used in this study are listed in Table 2.9. 
 
Table 2.9 – Primers used in this study. F = Forward and R = Reverse. Sequences are 5’ to 3’. 
 
No Description Sequence 5'-3' 
49 M13 in ycplac F GTTTTCCCAGTCACGACG 
167 Inp1-GFP R AGCACCCGCCCCTGCTCCAAGGTCGCCAAGACCAG 
644 GAL1 Inp1 300- F CAAGGAGAAAAAACTATAGAGCTCAAAATGAACGATGATGATGATGATAA 
643 Inp1-GFP R AGCACCCGCCCCTGCTCCCTGCAGAAGGTCGCCAAGACCAGATATG 
625 Inp1 315-420-GFP F CAAGGAGAAAAAACTATAGAGCTCAAAATGTTGCTGGATGAAGAATACG 
556 Inp1 -400-GFP R AGCACCCGCCCCTGCTCCCTGCAGCGGGGGAGAGTCGATAAAAGG 
604 Inp1 -370-GFP R AGCACCCGCCCCTGCTCCCTGCAGAGGAGCGGTTCGTCTGATAGC 
603 Inp1 -340-GFP R AGCACCCGCCCCTGCTCCCTGCAGATTTAGATTAGAGCAAGTGTTCG 
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602 Inp1 -325-GFP R AGCACCCGCCCCTGCTCCCTGCAGCAAGTAATTAAGGTCGTCATC 
557 Inp1 -282-GFP R AGCACCCGCCCCTGCTCCCTGCAGAGGCGGCAGTTTGAATTTATC 
648 GAL1 Inp1 100- F CAAGGAGAAAAAACTATAGAGCTCAAAATGAATGATATTCCGAATAGCAG 
649 GAL1 Inp1 170- F CAAGGAGAAAAAACTATAGAGCTCAAAATGCCCTTTCAAAAATCTAGTAA 
650 GAL1 Inp1 240- F CAAGGAGAAAAAACTATAGAGCTCAAAATGTCAGAGTTGGAAAATAGTG 
642 GAL1 Inp1 295- F CAAGGAGAAAAAACTATAGAGCTCAAAATGAATAATGATGATGATAACGA 
645 GAL1 Inp1 311- F CAAGGAGAAAAAACTATAGAGCTCAAAATGGACCTTAATTACTTGCTGG 
605 GAL1 Inp1 281- F CAAGGAGAAAAAACTATAGAGCTCAAAATGCCTACTTCGGACATAGAGC 
261 600bp upstream 
INP1 
GTAAAACGACGGCCAGTGAATTCATTGCTGACCATTTGGTTGG 
2617 Inp1 DD>AA SDM F GATGATAATTATGATGATGCCGCCCTTAATTACTTGCTGGATG 
2618 Inp1 DD>AA SDM R CATCCAGCAAGTAATTAAGGGCGGCATCATCATAATTATCATC 
1722 Inp1 L>A SDM F GATAATTATGATGATGACGACGCTAATTACTTGCTGGATGAAG 
1723 Inp1 L>A SDM R CTTCATCCAGCAAGTAATTAGCGTCGTCATCATCATAATTATC 
3664 Inp1 NY>AA SDM F GATAATTATGATGATGACGACCTTGCTGCTTTGCTGGATGAAGAATAC 
3665 Inp1 NY>AA SDM F GTATTCTTCATCCAGCAAAGCAGCAAGGTCGTCATCATCATAATTATC 
1724 Inp1 LL>AA SDM F GATGACGACCTTAATTACGCTGCAGATGAAGAATACGAACAAGG 
1725 Inp1 LL>AA SDM R CCTTGTTCGTATTCTTCATCTGCAGCGTAATTAAGGTCGTCATC 
1778 Inp1 DEE>AAA SDM F CGACCTTAATTACTTGCTGGCTGCAGCATACGAACAAGGATGTACAG 
1779 Inp1 DEE>AAA SDM R CTGTACATCCTTGTTCGTATGCTGCAGCCAGCAAGTAATTAAGGTCG 
3662 Inp1 ∆motif SDM F GATAATTATGATGATGACGACGATGAAGAATACGAACAAGGATGTACAG 
3663 Inp1 ∆motif SDM R CTGTACATCCTTGTTCGTATTCTTCATCGTCGTCATCATCATAATTATC 
1722 Inp1 L>A SDM F GATAATTATGATGATGACGACGCTAATTACTTGCTGGATGAAG 
1819 500bp upstream of 
PEX19 
GTAAAACGACGGCCAGTGAATTCTACACGTTTGGATGATAAAATCCGGC 
1792 Pex19 R GTTCTTCTCCTTTACTCATGAGCTCTACTTCGTGTTGTATGTTTGGC 
1780 Pex19 L>A SDM F CGAGTACGATAATTTTGATGATGCGGATGACCTTTTAGATGAAGATCC 
1781 Pex19 L>A SDM R GGATCTTCATCTAAAAGGTCATCCGCATCATCAAAATTATCGTACTCG 
1782 Pex19 LL>AA SDM F GATGATTTGGATGACGCTGCAGATGAAGATCCCAC 
1783 Pex19 LL>AA SDM R GTGGGATCTTCATCTGCAGCGTCATCCAAATCATC 
235 His Pex3 (40-441) F GAGCTCGGTACCCGGGGATCCAAGAGATGGTTGTATAAACAGC 
237 His Pex3 (40-441) R AAGCTTGCATGCCTGCAGGTCGACTTATCTAGAAGGCTTGAAGGAAAACG
AGC 
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2485 MBP-Inp1 F ACTGCATATGGTTTTATCAAGGGGAG 
2488 MBP-Inp1 R TGACGGATCCTCAAAGGTCGCCAAGACCAG 
2486 MBP-Inp1 1-280 R ACTGGGATCCCTACAGTTTGAATTTATCGCTC 
2487 MBP-Inp1 281-420 F ACTGCATATGCCGCCTACTTCGGACATAGAGC 
55 GST-Inp1 F GAGGGATCCGGTATGGTTTTATCAAGGGGAG 
56 GST-Inp1 R GAGGTCGACTCAAAGGTCGCCAAGACCAG 
2090 Inp1 1-100 GFP R AGCACCCGCCCCTGCTCCCTGCAGCTGCAGATTATGAATGGGAACGAATG 




3755 Inp1 -280 GFP R GTTCTTCTCCTTTACTCATTGCACCCGCCCCTGCTCCCAGTTTGAATTTATCG
CTC 
1119 GFP-Pex15 F TGGATGAACTATACAAAGGATCCATGGCTGCAAGTGAGATAATG 
1120 GFP-Pex15 R ATCGATAAGCTTGCATGCCTGCAGTCATATACTCGCTAGAAG 
3741 Inp1 R GCATGCCTGCAGGTCGACAAGGTCGCCAAGACCAGATATGG 
3909 INP1 promoter-
Num1 (2563-2692) F 
CTCAGGAAATTAAACAAAGTGGTATGAACGAACCAAGCATAATACCC 
3911 Num1 PH (2563-
2692)-GFP R 
CTTCTCCTTTACTCATTGCACCCGCCCCTGCTCCCTCTAAACTTATCCCTTGC 
3972 Inp1 1-100-mRFP R GACGTCCTCGGAGGAGGCCATTGCACCCGCCCCTGCTCCATTATGAATGG
GAACGAATG 
 
2.6.2 Restriction digest 
 
Each restriction digest was carried out in a volume of 20µl and contained 2µl 10x NEB 
CutSmart™ Buffer, 0.5µl each restriction enzyme required and 0.5-2µg plasmid DNA. The 
volume was made up to 20µl with dH20. Restriction digests were prepared on ice and 
incubated at 37°C for a minimum of 2 hours but usually overnight. 
 
2.6.3 Agarose gel electrophoresis 
 
DNA samples were analysed by agarose gel electrophoresis. 1% (w/v) agarose gels were 
prepared by dissolving high grade agarose powder in 1x TBE buffer solution (0.1M Tris-Base, 
0.1M Boric acid, 10mM EDTA, pH 8) and Ethidium bromide (final concentration 0.5µg/ml). 
Samples were loaded alongside Bioline Hyperladder I DNA ladder to determine DNA fragment 
size and 6x loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol FF, 30% (v/v) 
glycerol) was added to samples to give a 1x final concentration. 
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Agarose gels were run at a constant voltage of 90V for 35 minutes in 1xTBE buffer solution. 




2.6.4 DNA gel extraction 
 
DNA was run on an agarose gel as detailed in Section 2.6.3 and visualised on a long 
wavelength UV transilluminator. The relevant DNA bands were excised from the gel using a 
sterile scalpel and gel extractions were performed using the QIAquick gel extraction kit 




Each ligation reaction was made in a final volume of 20µl. A 3:1 insert:vector molar ratio was 
used with 50ng digested, gel extracted vector added to the relevant amount of digested, gel 
extracted insert. 2µl 10x ligase buffer and 0.5µl T4 DNA ligase (Promega) was added and the 
reactions were made up to 20µl with dH20. Ligation reactions were incubated for at least 2 
hours at room temperature but were preferentially left overnight for optimal ligation and 
transformed into chemically competent E. coli cells the following day. 
 
2.6.6 Site directed mutagenesis 
 
Site directed mutagenesis was carried out with Pfu DNA polymerase as described in Section 
2.6.1. The PCR product was digested with DpnI for 1 hour at 37°C then analysed on a gel by 
agarose gel electrophoresis. 1µl of PCR was transformed into electrocompetent E. coli cells 
and individual colonies were grown in selective overnight cultures of 2TY for miniprep 
purification of plasmids. Several plasmid clones were sent for sequencing to check for the 
presence of desired mutations. 
 
2.6.7 Plasmid Miniprep 
 
Plasmids were isolated from 4ml selective overnight cultures of E. coli using the Bioline 
miniprep kit according to the manufacturer’s instructions. Plasmid DNA was eluted into a 
1.5ml Eppendorf and the concentration of the sample was subsequently measured using a 
Nanodrop. 
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2.6.8 Homologous Recombination based cloning 
 
Homologous recombination in S. cerevisiae was used for gene cloning to introduce open 
reading frames or tags into a vector (Fig. 2.2). Target open reading frames were first amplified 
by PCR. The primers used were designed to ensure that the PCR product was flanked by at 
least 18 nucleotides which were homologous to the insertion sites in the vector. The vector 
was digested using restriction enzymes at the insertion site and the PCR fragment and 
linearised vector were transformed to yeast by high efficiency yeast transformation (Section 
2.4.3). Upon homologous recombination, gap repair occurs which circularises the vector, 
incorporating the PCR product. Yeast cells containing recombinant plasmids were then 
identified by growth on selective yeast medium. 
 
Figure 2.2 – Homologous recombination in S. cerevisiae was one method used to construct 
plasmids. A) Primers (represented by the orange and blue arrows) were designed to create a 
PCR product of the desired DNA insert (blue) flanked by approximately 18 nucleotides 
homologous to sequences in the vector (orange). B) The vector was digested with the 
appropriate restriction enzymes and was transformed into S. cerevisiae together with the PCR 
product. Homologous recombination then took place, producing a recombinant vector. 
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2.6.9 DNA sequencing 
 
Plasmids were sequenced by Source Bioscience using their Sanger sequencing service. The 
data was analysed using SnapGene and the online multiple sequence alignment tool ClustalW. 
 




Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was performed as 
described by (Sambrook and Russell, 2006). 8-12% gels were prepared using the reagents 
shown in Table 2.10. Protein loading dye was added to protein samples at 1X final 
concentration before loading onto the gel. Gels were then run at constant voltage (90-120V) 
until the dye front ran off the bottom of the gel. 
 
Protein running buffer (10X): 30.28g Tris Base, 144.13g Glycine, 1% (w/v) SDS, dH20 up to 1L. 
Protein loading dye (4X): 250mM Tris pH 6.8, 9.2% (w/v) SDS, 40% (w/v) Glycerol, 0.2% (w/v) 
Bromophenol brilliant blue, 100mM DTT. 
 
Table 2.10 – SDS-PAGE gel reagents. Volumes of each reagent used to make a 12% gel are 
shown. 
Reagents Resolving gel (12%) Stacking gel (4%) 
Protogel (Acrylamide, Bis-
acrylamide mix) 30% stock 
4ml 0.67ml 
Resolving buffer 4X stock 2.5ml - 
Stacking buffer 4X stock - 1.25ml 
APS 10% (w/v) stock 100µl 50µl 
TEMED 1000X stock 10µl 5µl 
dH20 3.39ml 3.025ml 
Total volume 10ml 5ml 
 
2.7.2 Protein induction 
 
Primary E. coli cultures were inoculated in 4ml 2TY containing the appropriate antibiotic and 
incubated overnight at 37°C on a shaker at 200 rpm. Secondary cultures were inoculated the 
following day in larger volumes of 2TY + antibiotic (usually 1 litre) to give a starting O.D.600 of 
0.1. Cells were grown to O.D.600 0.6-0.8 before protein induction was performed through the 
addition of Isopropyl-β-D-galactopyranoside (IPTG) to a final concentration of 1mM. Cells 
were grown for a further 3-4 hours at 37°C on a shaker at 200 rpm before cells were harvested 
through centrifugation at 8000 rpm for 15 minutes. Bacterial pellets were then stored at -




2.7.3 Protein purification 
 
Bacterial cell pellets were resuspended in 1ml ice cold 1xPBS, 1mM phenylmethylsulfonyl 
fluoride (PMSF) and EDTA-free protease inhibitor cocktail (Roche). Cells were subjected to 1x 
30sec, 2x 15sec sonication at an amplitude of 12 µm and samples were kept on ice 
throughout. 1% Triton X-100 was added to the lysates (except when lysate contained Pex3) 
and incubated at 4°C for 30 minutes with end over end turning. Lysates were subsequently 
centrifuged at 20,000 g for 5 minutes at 4°C and the supernatant retained. To purify tagged 
proteins, Glutathione Sepharose 4B (GE Healthcare), Amylose (New England Biolabs) or Ni-
Sepfast (BioToolomics) beads were prewashed in 1xPBS and added to relevant fusion protein 
lysates before incubation at 4°C with end over end mixing for 30 minutes. The beads were 
then washed twice with 1xPBS + 0.05% Igepal CA-630 (Sigma-Aldrich). 
 
2.7.4 Protein binding assays 
 
In vitro binding assays 
 
GST-Inp1, MBP-Inp1 and His-Pex3 proteins were expressed in E. coli BL21 DE3 and purified on 
Glutathione Sepharose 4B, Amylose or Ni-Sepfast beads prewashed in 1xPBS as described 
above (Section 2.7.2/2.7.3). The beads were washed twice with 1xPBS + 0.05% Igepal CA-630 
(Sigma-Aldrich) before relevant secondary E. coli lysates were added. Samples were then 
incubated for 2 hours at 4°C with end over end mixing. The beads were washed 4 times with 
1xPBS + 0.05% Igepal CA-630. The second wash included 500 mM KCl as this was found to be 
sufficient to remove any non-specific binding to bead only controls without affecting binding, 
as previously described (Munck et al., 2009). Bound material was eluted with SDS-PAGE 
sample loading buffer, resolved by SDS-PAGE and analysed by Coomassie staining. 
 
In vitro competition assay 
 
MBP-Inp1, GST-Pex19 and His-Pex3 proteins were expressed in E. coli BL21 DE3. Cells were 
grown, induced and lysates prepared as above (Section 2.7.2/2.7.3). Total lysates containing 
GST-Pex19 were incubated with washed glutathione Sepharose 4B beads at 4°C for 30 
minutes. Total lysates containing His-Pex3 and MBP-Inp1 proteins were mixed together and 
incubated at 4°C for 30 minutes. The glutathione Sepharose beads were washed twice with 
1xPBS + 0.05% Igepal CA-630 before the His-Pex3/MBP-Inp1 lysate mixtures were added. 
Samples were then incubated for 2 hours at 4°C with end over end mixing. The total unbound 
fraction was removed from the glutathione Sepharose beads and added immediately to 
Amylose resin beads. These samples were then incubated for a further 1 hour at 4°C with end 
over end mixing. All beads were washed 4 times with 1xPBS + 0.05% Igepal CA-630, with the 
second wash containing 500 mM KCl (as described above). Bound fractions were eluted from 
the glutathione Sepharose beads using SDS-PAGE sample loading buffer. Bound fractions 
were eluted from Amylose beads with maltose buffer (20 mM Tris-HCl pH7.4, 200 mM NaCl, 
1 mM EDTA, 10 mM maltose). All samples were resolved by SDS-PAGE and analysed by 
Coomassie staining. For detection of His-Pex3-MBP-Inp1 complexes, immunoblot analysis was 
carried out with the monoclonal anti-polyhistidine peroxidase antibody. 
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2.7.5 TCA protein extraction 
 
Yeast cultures were grown overnight in selective medium and 10 O.D.600 units of cells were 
harvested at 12,000 rpm for 1 minute. The supernatant was removed and the pellet was 
resuspended in 500µl TCA lysis buffer (0.2M NaOH, 0.2% β-Mercaptoethanol) before being 
incubated on ice for 10 minutes. Subsequently, 71µl of 40% (w/v) TCA (Trichloroacetic acid) 
solution was added and the mixture was again left on ice for 10 minutes. The sample was then 
centrifuged at 13,000 rpm for 5 minutes at 4°C and the supernatant was aspirated leaving 
behind the precipitated protein pellet. The pellet was neutralised by adding 10µl of 1M Tris-
HCl pH 9.4 before 90µl of 1X SDS protein loading buffer was added. Samples were boiled for 
10 minutes at 95°C before loading onto SDS-PAGE gel (1-2 O.D.600 equivalent). 
 
2.7.6 Western blot analysis 
 
Protein samples were separated by SDS-PAGE and transferred onto a nitrocellulose 
membrane using a Biorad Mini Trans-Blot Electrophoretic transfer cell. Samples were 
transferred at a constant 200mA current for 2 hours in transfer buffer (25mM Tris pH 8.3, 
150mM Glycine, 40% (v/v) methanol). Protein transfer was checked using Ponceau S solution 
(0.1% (w/v) Ponceau S in 5% (v/v) acetic acid). Blots were blocked overnight at 4°C in blocking 
buffer comprised of 2% (w/v) fat-free Marvel milk in TBS–Tween 20 (50 mM Tris-HCl, pH 7.5, 
150 mM NaCl, and 0.1% (v/v) Tween 20). Membranes were incubated with primary and 
secondary antibodies for 1 hour at room temperature in blocking buffer with wash steps of 
at least 30 minutes between incubations using TBS-Tween20 (without milk). Antibodies were 
used at the given dilutions: anti-GFP (1:3000), anti-His (1:10000), anti-PGK1 (1:3000). 
Secondary antibody was HRP-linked anti-mouse polyclonal (1:10000). Blots were developed 
using Enhanced Chemi-Luminescence (ECL) substrates and tagged proteins were detected 
and imaged using a Syngene GBox imaging system and Genesys software. 
 
2.7.7 Liposome binding assays 
 
For Folch liposomes, 22 μl of a 25 mg/ml solution of Folch fraction-1 (Sigma-Aldrich) was dried 
under nitrogen, then resuspended in 200 μl liposome buffer (20 mM HEPES pH 7.2, 100 mM 
KCl, 2 mM MgCl2, 1 mM DTT) at 60°C for 30 minutes with gentle agitation. For preparation of 
synthetic liposome solutions, 40µl of 25 mg/ml PC solution, 4.6µl of 25 mg/ml PE solution and 
307 µl of 1 mg/ml PI(4,5)P2 or PI(4)P solution or 12.3 µl 25 mg/ml PS solution (Avanti Polar 
Lipids, dissolved in chloroform) were dried under nitrogen then resuspended in 400 µl 
liposome buffer. Purified protein was pre-spun at 350,000 g for 15 minutes (Beckman Ultra 
centrifuge, TL100 rotor) then immediately added to 10 µl of liposome solution and made up 
to final volume 50 µl with maltose buffer. The mixture was incubated at room temperature 
for 30 minutes before pelleting the liposomes at 280,000 g for 15 minutes. After 
centrifugation, supernatants were removed and pellets were resuspended in 50 µl liposome 
buffer. 10 µl Strataclean resin (Stratagene) was added to each sample to concentrate the 
protein. This was pelleted by spinning at 8000 g in a table top microcentrifuge for 2 minutes. 
Supernatants were removed and the pellet of each sample was resuspended in 15 µl SDS-
PAGE loading buffer. Samples were then analysed by SDS-PAGE and Coomassie staining. 
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Chapter 3 – Inp1 and Pex19 compete for binding 
to Pex3 
 
3.1  Introduction 
 
S. cerevisiae cells divide asymmetrically and the balance between organelle tethering and 
motility determines the intracellular distribution of organelles. Faithful segregation of 
peroxisomes between the mother cell and growing bud requires a careful balance between 
the opposing processes of cortical anchoring in the mother cell and Myosin-dependent 
transport towards the bud. These processes rely on Inp1 and Inp2, proteins which perform 
antagonistic functions and ensure proper peroxisome segregation along the mother-bud axis 
(Hoepfner et al., 2001; Fagarasanu et al., 2005; Fagarasanu et al., 2010).  
 
Peroxisomes in Δinp1 cells have increased mobility and aren’t retained in fixed cortical 
positions in mother cells or larger buds as they are in wild type cells. By anchoring 
peroxisomes at the cortex of the mother cell, it is ensured that a sub-population of 
peroxisomes are retained in the mother. The exact mechanisms by which Inp1 functions in 
peroxisome retention at the cell cortex remain poorly understood. The existing model 
postulates that Inp1 acts as a ‘molecular hinge’ that simultaneously binds to both peroxisomal 
and cortical ER-localised Pex3 (Knoblach et al., 2013). However, further research by the same 
group has since shed doubt on the simplicity of this model with the suggestion that additional 
components are required for tethering of peroxisomes to the cell cortex and that contact 
between peroxisomes and the ER may occur independent of Inp1 (Knoblach and Rachubinski, 
2019). 
 
The molecular interaction between Inp1 and Pex3 was first described by the Hettema lab,  
(Munck et al., 2009) and has since been further studied by John Hutchinson (Hutchinson, 
2016). This subsequent work has led to the identification of a conserved, leucine-based motif 
present in the C-terminal region of Inp1. Furthermore, it has been noted that this motif bears 
a striking similarity with the established Pex3 binding site present in human Pex19, leading to 
the idea that Inp1 and Pex19 could compete for binding to Pex3 with their analogous, leucine-
based motifs (Sato et al., 2010; Schmidt et al., 2010; Schmidt et al., 2012). In Chapter 3, the 
preliminary characterisation of the Inp1-Pex3 interaction is confirmed and furthered in order 
to elucidate the molecular mechanisms by which Inp1 interacts with peroxisomal Pex3. 
 
3.2 Confirmation that a C-terminal motif in Inp1 is required for binding to Pex3 
 
3.2.1 A C-terminal region of Inp1 is required for its peroxisomal localisation 
 
Previous studies by the Hettema lab have uncovered that the C-terminal region of Inp1 is 
required for its interaction with peroxisomal Pex3. This was first elucidated by a genome wide 
yeast two-hybrid screen using the cytosolic domain of Pex3 as bait (amino acids 40-441) 
(Motley et al., 2012). This screen identified interactions between Pex3 and 10 different Inp1 
protein fragments encoded by 14 independent Inp1 DNA clones. The smallest fragment of 
 42 
Inp1 that interacted with Pex3 comprised amino acids 300-378 and this region was common 
to all hits (Fig. 3.1A).  
 
In order to confirm earlier work that this minimal region of Inp1 is sufficient to associate with 
peroxisomes, a library of galactose-inducible Inp1-GFP truncations were co-expressed in 
Δinp1 or Δinp1/Δpex3 cells with a peroxisomal matrix marker consisting of a fluorescent 
protein appended with a peroxisomal targeting signal type I (HcRed-PTS1) (Fig. 3.1B, C). 
Analysis by fluorescence microscopy revealed that, as expected, full length Inp1-GFP was 
present in punctate structures which co-localised with HcRed-PTS1 when expressed in inp1Δ 
cells and was cytosolic in Δinp1/Δpex3 cells where peroxisomes are absent. This localisation 
pattern was observed for truncations of Inp1-GFP up to and including amino acids 300-420. 
However, when Inp1 was further truncated (amino acids 315-420) it was no longer associated 
with peroxisomes. Further fine mapping revealed that the minimal region that still associated 






















Figure 3.1  – Summary of the yeast two-hybrid and in vivo Inp1-GFP truncation screens. A) 
The upper panel is a line diagram showing the truncations of Inp1 identified by a genome 
wide yeast two-hybrid screen with the cytosolic domain of Pex3 (40-441) as bait (performed 
by Motley et al., 2012). The lower panel shows the truncations of Inp1-GFP which localise to 
peroxisomes (black lines) or do not localise to peroxisomes (red lines). The vertical black lines 
indicate the minimal region required for Inp1-GFP localisation to peroxisomes. Truncations 
shown in the lower panel are as follows (from top to bottom) amino acids 1-420, 1-400, 1-
370, 1-315, 1-282, 100-420, 170-420, 240-420, 295-420, 300-420, 311-420, 315-420, 281-400, 
311-370, 315-420, 315-400, 315-370. B) Truncations of Inp1-GFP under the control of the 
GAL1/10 inducible promoter were expressed in Δinp1 or Δinp1/Δpex3 cells and analysed by 
fluorescence microscopy. C) Truncations of Inp1-GFP under the control of the control of the 
GAL1/10 inducible promoter were co-expressed in Δinp1 cells with the peroxisomal matrix 
marker HcRed-PTS1 and analysed by fluorescence microscopy. Bars, 5 μm.  
3.2.2 The C-terminus of Inp1 binds to Pex3 in vitro 
 
Previously, it has been shown that Inp1 interacts directly with Pex3 (Munck et al., 2009). To 
further investigate the regions of Inp1 required for this interaction, an in vitro binding assay 
was performed (Fig. 3.2). Previous studies have interpreted secondary structure analysis of 
Inp1 to predict that the protein can be roughly divided into “two globular domains”, an N-
terminal domain comprised of amino acids 1-280 and a C-terminal domain comprised of 
amino acids 281-420 (Knoblach et al., 2013). We used these same domains to carry out 
experiments in this study (Fig. 3.2). Maltose binding protein (MBP) fusions of the N- or C-
terminal domains of Inp1 were expressed in E. coli and bound to amylose beads. 
Subsequently, total E. coli lysates expressing the cytosolic domain of Pex3 (40-441) with a 6x-
His tag (His-Pex3) or a His tag only, were added to and incubated with the samples. The His-
Pex3 lysate was also incubated with the MBP alone, bound to amylose beads. After extensive 
washing with 1x phosphate buffer saline (PBS) including a PBS + 0.5M KCl wash, bound protein 
was eluted from the amylose beads with 1x protein loading buffer. The binding of His-Pex3 to 
the MBP-Inp1 truncations was subsequently analysed by SDS-PAGE, Coomassie staining of the 
gel and western blotting. Anti-His tag antibody was used to confirm the presence His-Pex3 
bound to MBP-Inp1 C. 
 
A direct interaction was found between His-Pex3 and the C-terminal domain of Inp1 (MBP-
Inp1 281-420). His-Pex3 did not bind to the N-terminal domain of Inp1 (MBP-Inp1 1-280) nor 
MBP alone, thus suggesting that the direct interaction between Pex3 and the Inp1 is 
dependent on the C-terminal domain of Inp1. This is in agreement with the in vivo data 





























Figure 3.2 – The C-terminus of Inp1 binds directly to Pex3 in vitro. The schematic diagram 
illustrates how Inp1 was considered as two domains as in (Knoblach et al., 2013). The N-
terminal domain comprises amino acids 1-280, the C-terminal domain comprises amino acids 
281-420. E. coli expressed MBP-Inp1 N (blue asterisk, amino acids 1-280), MBP-Inp1 C (green 
asterisk, amino acids 281-420) or MBP only (orange asterisk) were bound to amylose beads 
and incubated with a total lysate of E. coli expressing either 6xHis-Pex3 (40-441) or 6xHis-tag 
only. After extensive wash steps, bound protein fractions were analysed with SDS-PAGE 
followed by Coomassie staining (upper gel) and western blotting (lower panel). A lane was 
included with enriched His-Pex3 as a control. M, molecular weight marker. TL, total lysate. 
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Previously, it has been reported that both the N- and C-terminal domains of Inp1 bind directly 
to Pex3 in vitro (Knoblach et al., 2013). Specific binding of the N-terminal domain of Inp1 to 
Pex3 was not able to be repeated under our assay conditions. The first explanation for this 
could be due to the inclusion of a high salt wash (PBS + 0.5M KCl) during the extensive wash 
steps. A wash with PBS + 0.5M KCl was found to be sufficient to remove non-specific binding 
to bead only controls without affecting binding, as previously described (Munck et al., 2009). 
A second explanation could be the omission of detergent, specifically Triton X-100, from any 
E. coli lysates containing His-Pex3. It has been shown that the cytosolic domain of Pex3 can 
be purified from E. coli in the absence of detergent and that it aggregates in the presence of 
Triton X-100 (Pinto et al., 2009). The binding assay performed by Knoblach et al. does include 
the incubation of Triton X-100 with Pex3 lysates and does not include a high salt wash. 
Detergent-dependent aggregation of Pex3, non-specific binding or a combination of the two 
could form a plausible explanation as to why Pex3 binding to MBP-Inp1 1-280 is reported in 
their assay but not observed here. 
 
3.2.3 Confirmation of the identity of the LXXLL motif in Pex19 and Inp1 
 
Bioinformatic analysis of the amino acid sequences of Inp1 orthologues in other budding yeast 
species highlighted a highly conserved leucine-based motif flanked by negatively charged 
residues (Fig. 3.3). This motif corresponds to amino acids 312-316 and so is present within the 
minimal region of Inp1 that was confirmed as necessary for localisation to peroxisomes in vivo 


























































Figure 3.3 - Bioinformatic analysis of Inp1 revealed a conserved LXXLL motif. A) ClustalW 
was used to create a multiple sequence alignment of the conserved motif region of Inp1 
orthologues of species closely related to S. cerevisiae (S. cer). S. paradoxus (S. par), S. mikatae 
(S. mik), S. bayanus (S. bay), S. kluyveri (S. klu), Candida glabrata, (C. gla), Kluyveromyces waltii 
(K. wal). The residues numbered in red highlight the conserved leucine motif with amino acid 
numbers corresponding to those in ScInp1. B) A consensus sequence of the motif region of 
interest shown in A. The height of letters within the stack indicates the relative frequency of 
each amino acid at that position. C) A schematic diagram showing an overview of the 
hypothetical Inp1 domain structure. Green, N-terminal domain 1-280. Blue, C-terminal 
domain 281-420. Red, conserved leucine motif. Y2H box, the smallest region of Inp1 found to 
















It was noted that the identified motif (which will be referred to as LXXLL) bears a striking 
similarity to the designated Pex3 binding motif of Pex19 (Fig. 3.4A). The interaction between 
Pex3 and Pex19 has been well characterised (Sato et al., 2010; Schmidt et al., 2010; Agrawal 
et al., 2017), and a “leucine triad” motif in human Pex19 has been identified as being critical 
for Pex3 binding and peroxisome biogenesis. Substitution of the leucine residues in the LXXLL 
motif of human Pex19 have been shown to result in decreased affinity for Pex3 (Sato et al., 
2010; Schmidt et al., 2012). We tested the functional importance of the leucine triad in the S. 
cerevisiae orthologue of Pex19 (ScPex19) using an alanine scan. The Pex19 mutants were co-
expressed under the control of the PEX19 promoter in Δpex19 cells with the peroxisomal 
matrix marker HcRed-PTS1. Cells devoid of functional Pex19 are blocked in peroxisome 
formation and consequently mislocalise peroxisomal matrix proteins to the cytosol (Götte et 
al., 1998). Substitutions of the leucine residues for alanines resulted in the cytosolic 
localisation of HcRed-PTS1 (Fig. 3.4B). This indicates a loss of functional Pex19 although the 
ScPex19 mutants were well expressed (Fig. 3.4C). This confirms that as in human Pex19, the 

























Figure 3.4 – ScPex19 also contains an LXXLL motif required for function. A) ClustalW was 
used to create a multiple sequence alignment of ScPex19 amino acids 6-23, human Pex19 
amino acids 12-29 and ScInp1 amino acids 306-323. Residues numbered in red highlight the 
conserved leucine motif with amino acid numbers corresponding to those in ScPex19. B) 
Wildtype ScPex19 (WT) or ScPex19 leucine motif mutants were expressed with the PEX19 
promoter in Δpex19 cells co-expressing HcRed-PTS1. Bar, 5 μm. C) Immunoblot analysis of 






























In order to determine if the LXXLL motif of Inp1 is also important for its function, the LXXLL 
motif of Inp1 was subsequently targeted for mutagenesis. A loss of functional Inp1 is easily 
assayed in S. cerevisiae by observing the distribution of peroxisomes in budding cells. In cells 
lacking functional Inp1, peroxisomes are not retained at the mother cell cortex and so there 
is an abnormal distribution of peroxisomes between mother cells and their buds with almost 
all peroxisomes present in the bud. Additionally, in peroxisome retention mutants (devoid of 
functional Inp1), cells have a phenotype of reduced numbers of enlarged peroxisomes 
(Fagarasanu et al., 2005) (Fig. 3.5A). First, the LXXLL motif was deleted in Inp1-GFP (Inp1 
L312_L316-GFP) and this Δmotif mutant was co-expressed under the control of the 
endogenous INP1 promoter in Δinp1 cells with HcRed-PTS1 (Fig. 3.5B, C). Inp1 Δmotif-GFP 
was stably expressed but no longer localised to peroxisomes and failed to rescue the Δinp1 
peroxisome retention defect phenotype. 
Figure 3.5 – Deletion of the LXXLL motif of Inp1 results in a loss of peroxisomal localisation 
and function. A) HcRed-PTS1 was expressed in Δinp1 cells in the presence or absence of Inp1 
and analysed by fluorescence microscopy. The schematic diagrams represent the peroxisomal 
phenotypes observed when INP1 is absent or present in budding S. cerevisiae cells. B) Inp1-
GFP and a leucine motif deletion mutant (Δmotif) were expressed under control of the INP1 
promoter with HcRed-PTS1 and analysed by fluorescence microscopy. Bars, 5 μm. C) 























The LXXLL motif sits in a highly acidic region of Inp1. From amino acids 285-326 there are 20 
acidic residues (D/E) and none with a positive charge. In order to further characterise the 
functionality of the LXXLL motif, an alanine scan of the motif and its adjacent acidic residues 
(amino acids 310-319) was carried out in Inp1-GFP (Fig. 3.6). Most mutants behaved as wild 
type Inp1 with peroxisomal localisation and complementation of the Δinp1 phenotype. 
However, substitution of the three leucine residues L312, L315 and L316 resulted in a loss of 
peroxisomal localisation of Inp1-GFP and a peroxisome retention defect indicative of a lack of 
functional Inp1, as was observed for the Inp1-Δmotif mutant (Fig. 3.6A, B). This is the first 
detailed alanine scan analysis which includes the acidic residues within a Pex3 binding motif 
and from this experiment, it was established that it is the leucine residues that are important 
for the peroxisomal localisation and function of Inp1. Inp1 mutants with reduced peroxisomal 
localisation were no longer concentrated in punctate structures and difficult to visualise with 
fluorescence microscopy due to them being expressed from their endogenous promoter. 
Western blot analysis showed that all of the mutants were stably expressed (Fig. 3.6C).  
 
Figure 3.6 – An alanine scan of the LXXLL motif region found that it is the leucine residues 
which are required for the peroxisomal localisation and function of Inp1. A) Alanine scan of 
Inp1-GFP region amino acids 310-319. Mutants were expressed under control of the INP1 
promoter in Δinp1 cells co-expressing HcRed-PTS1. Bar, 5 μm. B) Quantitative analysis of 
peroxisome retention in alanine scan mutants. Budding cells were scored for the presence or 
absence of peroxisomes in the mother cell. At least 100 budding cells were quantified for each 
mutant. The motif region targeted for mutagenesis, amino acids 310-319, is shown. C) 




























































































3.2.4 The LXXLL motif of Inp1 is involved in direct binding to Pex3 
 
The Inp1 Δmotif-GFP and Inp1 LL315,316AA-GFP (LL>AA) mutants had the strongest effect on 
peroxisomal localisation and function of Inp1-GFP and so these mutants were tested for their 
binding to the cytosolic domain of Pex3 (40-441) in an in vitro binding assay. Glutathione S-
transferase tag (GST) fusions of wild type Inp1, Inp1 Δmotif or Inp1 LL>AA were expressed in 
E. coli and bound to glutathione Sepharose beads. Subsequently, total E. coli lysates 
expressing the cytosolic domain of Pex3 (40-441) with a 6x-His tag (His-Pex3) or a His tag only, 
were incubated with the beads. The His-Pex3 lysate was also incubated with the GST tag 
alone. After extensive wash steps, bound fractions were analysed by SDS-PAGE followed by 
Coomassie staining. 
 
As reported previously, (Munck et al., 2009), His-Pex3 directly interacts with GST-Inp1. 
Conversely, both GST-Inp1 motif mutants were strongly compromised in direct binding to His-
Pex3. Mutation of the two leucine residues (LL>AA) massively reduces the interaction 
between Inp1 and His-Pex3 whilst deletion of the motif appears to completely prevent His-
Pex3 from binding to Inp1. From the in vivo and in vitro data obtained, it can be concluded 
that Inp1 contains an LXXLL motif that is required for its function as it is involved in direct 
binding to Pex3 and localisation to peroxisomes. During the course of this work, an 
independent study reported a random Inp1 mutant in this motif (LXXLP) which also blocked 
recruitment of Inp1 to peroxisomes and interfered with Inp1 function (Knoblach and 
Rachubinski, 2019). This further supports the conclusion that the LXXLL motif plays an 





























Figure 3.7 – Mutation of the LXXLL motif of Inp1 disrupts its direct binding to Pex3. E. coli 
expressed GST-Inp1, GST-Inp1 Δmotif, GST-Inp1 LL>AA and GST were bound to glutathione 
Sepharose beads and incubated with a total lysate of E. coli expressing either His-Pex3 (40-
441) or His-tag only. After extensive washing with 1x PBS including a PBS + 0.5M KCl wash, 
bound protein was eluted from the glutathione Sepharose beads with 1x protein loading 
buffer and analysed by SDS-PAGE and Coomassie staining of the gel. A lane was included with 
enriched His-Pex3 as a control. M, molecular weight marker. TL, total lysate. Red arrows 
indicate His-Pex3. Asterisks indicate multiple GST-Inp1 fragments. 
 
3.3 Inp1 competes with Pex19 for binding to Pex3 
 
3.3.1 Overexpression of Inp1 results in a loss of peroxisomal structures 
 
Initially, overexpression of Inp1 results in an increase in the number of peroxisomes which 
are retained at the mother cell periphery. Peroxisomes are prevented from being normally 
transported to the bud which results in buds being devoid of peroxisomes and an observable 
over-retention of peroxisomes in the mother cell (Fagarasanu et al., 2005). However, it has 
also been observed that constitutive overexpression of Inp1 under control of the TPI1 
promoter, leads to mislocalisation of a peroxisomal matrix marker to the cytosol (Munck, 
2008) (Fig. S3 of Knoblach et al., 2013). Mislocalisation of a peroxisomal matrix protein can 
be the result of a block in matrix protein import or peroxisomal membrane biogenesis, 
excessive peroxisome degradation (pexophagy) or mis-segregation of peroxisomes. 
 
To confirm the overexpression phenotype, Inp1 was constitutively overexpressed under the 































































mislocalised to the cytosol and the peroxisomal membrane marker Pex11-GFP no longer 
displayed a punctate pattern but appeared as a tubular network. These phenotypes resemble 
those seen in Δpex3 and Δpex19 cells where matrix proteins and Pex11 mislocalise to the 
cytosol and mitochondria, respectively, due to the absence of peroxisomal membrane 
structures (Motley et al., 2015). This suggests that typical peroxisomal structures are absent 
upon overexpression of Inp1. The same phenotypes were also observed when the experiment 
was repeated in Δatg36 cells, a mutant which is deficient in pexophagy. This confirmed that 
the phenotypes observed are not a result of excessive peroxisomal degradation. 
  
In order to investigate the role of the LXXLL motif in this overexpression phenotype of Inp1, 
the experiment was repeated with the double leucine mutant Inp1 LL>AA. Overexpression of 
Inp1 LL>AA did not affect localisation of GFP-PTS1 nor Pex11-GFP. This implies that the loss 
of typical peroxisomal membranes upon overexpression of Inp1 is dependent upon its LXXLL 
motif. 
 
Figure 3.8 – Overexpression of Inp1 results in a loss of peroxisomal membrane structures. 
Fluorescence microscopy images of WT cells overexpressing Inp1 or Inp1 LL>AA under control 
of the TPI1 promoter with either GFP-PTS1 or the peroxisomal membrane marker Pex11-GFP. 
An empty plasmid was used as a control. Δpex19 cells were transformed with GFP-PTS1 or 
Pex11-GFP to show the location of these proteins in the absence of typical peroxisomal 
structures. Inp1 was also overexpressed in Δatg36 cells co-expressing GFP-PTS1 to show that 
the loss of peroxisomal structures is not due to increased pexophagy. Bar, 5 µm. 
Δpex19WT





Inp1 O/E Empty plasmid
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The loss of peroxisomal structures upon Inp1 overexpression was further tested using an 
assay developed in the Hettema lab. Previously, it has been reported that the last step in the 
lysine biosynthesis pathway, the conversion of saccharopine to lysine by Lys1, occurs in 
peroxisomes (Al-Saryi et al., 2017). This reaction requires regeneration of NAD+ from NADH 
which also occurs intraperoxisomally and is mediated by peroxisomal malate dehydrogenase 
(Mdh3) and glyercol-3-phosphate dehydrogenase (Gpd1). As such, Δmdh3/Δgpd1 mutants 
are unable to synthesise lysine and so show strong growth defects when grown on lysine 
deficient medium. This growth deficiency can be overcome when Lys1 is mislocalised from 
peroxisomes to the cytosol for example, in mutants where peroxisomes are absent due to a 
peroxisome biogenesis defect such as in Δmdh3/Δgpd1/Δpex3 cells (Al-Saryi et al., 2017). This 
simple growth assay can be exploited to screen for mutants with peroxisome biogenesis 
defects.  
 
Overexpression of Inp1 in Δmdh3/Δgpd1 cells restored their growth on lysine deficient 
medium. This implies that upon overexpression of Inp1, Lys1 is mislocalised to the cytosol due 
to a loss of peroxisomal structures and confirms the phenotypes observed in Fig. 3.8. 
Conversely, overexpression of the motif mutant Inp1 LL>AA did not restore growth of 
Δmdh3/Δgpd1 cells on lysine deficient medium, indicating that peroxisomes remained intact. 
This again supports the idea that the loss of peroxisomal membranes upon Inp1 





















Figure 3.9 – Growth of Δmdh3/Δgpd1 cells on lysine deficient medium can be used as an 
assay to show that overexpression of Inp1 results in loss of peroxisomal structures. The 
strains indicated were grown on solid complete synthetic glucose medium in the absence of 
L-lysine for 2 days at 30°C. Growth of cells overexpressing Inp1 indicates that there is a loss 
of peroxisomal structures. 
 
Δmdh3/Δgpd1 + Gpd1-GFP
Δmdh3/Δgpd1 + empty plasmid
Δmdh3/Δgpd1 + O/E Inp1
Δmdh3/Δgpd1 + O/E Inp1 LL>AA
Δmdh3/Δgpd1 + O/E GFP-PTS1
Δmdh3/Δgpd1/Δpex3 + empty plasmid
glucose, lys-
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3.3.2 Overexpression of Inp1 blocks de novo biogenesis of peroxisomes 
 
Since both Inp1 and Pex19 have an LXXLL motif required for their respective functions and 
both bind to Pex3 to perform these functions, it is a logical prediction that they compete for 
binding to Pex3. The crystal structure of the soluble domain of human Pex3 has been resolved 
and so predictions can be made about the structure of ScPex3 due to the high levels of 
conservation between the two proteins (Schmidt et al., 2010).  Mutation of a conserved 
Tryptophan (W104) in human Pex3 results in a loss of interaction with Pex19 and hence a 
block in peroxisome formation (Sato et al., 2008). Mutagenesis of the homologous residue 
W128 to Alanine in ScPex3 has also been shown to block peroxisomal formation and prevent 
co-localization between Pex3 and Inp1 foci (Knoblach et al., 2013). This data supports the idea 
that both Inp1 and Pex19 interact with a similar region of Pex3.  
 
The loss of peroxisomal structures upon overexpression of Inp1 also supports this theory. As 
mentioned previously, the absence of peroxisomes in cells overexpressing Inp1 could initially 
be a result of peroxisome over-retention, with buds failing to inherit peroxisomes and so 
peroxisome-containing cells slowly being diluted out of the population (Fagarasanu et al., 
2005; Fig. S1B of Munck et al., 2009). Under these circumstances, cells are able to reform 
peroxisomes de novo, a process reliant on the direct interaction between Pex3 and Pex19 
(Hoepfner et al., 2005; Motley and Hettema, 2007). In cells overexpressing Inp1, it appears 
that this de novo synthesis pathway of peroxisome formation is blocked as even after several 
hours of growth, no peroxisomes are present. To directly test this, an assay for de novo 
peroxisomes formation was carried out based on the mating of Δpex3 and Δpex19 cells 
(Motley and Hettema, 2007). 
 
Both Δpex3 and Δpex19 cells are devoid of typical peroxisomal membrane structures 
(Hettema et al., 2000). In Δpex19 cells, Pex3 accumulates in the ER and so upon mating, the 
soluble Pex19 from the Δpex3 mating partner should diffuse into the Δpex19 cell and initiate 
the exit of Pex3 from the ER. This will then lead to the de novo formation of peroxisomes 
within 4-6 hours of mating. Haploid Δpex3 cells labelled with GFP-PTS1 were mated with 
Δpex19 cells constitutively overexpressing Inp1 under control of the TPI1 promoter or Δpex19 
cells containing an empty plasmid and hence with endogenous levels of Inp1. Within 6 hours 
of mating, peroxisomes were formed de novo in the control cells, but GFP-PTS1 remained 
cytosolic in mated cells in which Inp1 was overexpressed as peroxisomes failed to form. The 
experiment was then repeated with constitutive overexpression of Inp1 LL>AA in the Δpex19 
mating cells. Within 6 hours, peroxisomes were formed de novo as in the control (Fig. 3.10).  
 
Taken together, the data presented in Sections 3.2.1 and 3.2.2 show that constitutive 
overexpression of Inp1 prevents the de novo synthesis of peroxisomes and that this is 
dependent on the LXXLL motif. This strongly supports the idea that the overexpression of Inp1 
prevents Pex19 from interacting with Pex3, hence blocking peroxisome biogenesis, and that 













































Figure 3.10 – Overexpression of Inp1 blocks de novo formation of peroxisomes. Δpex3 
(MATa) cells expressing GFP-PTS1 were mated with Δpex19 (MATα) cells expressing an empty 
plasmid of overexpressing either Inp1 or Inp1 LL>AA (under control of the TPI1 promoter). 
Cells were imaged after 2.5 or 6 hours to check for de novo formation of peroxisomes. The 
graph represents quantitative analysis of the mating assay. Mating cell pairs were scored for 
the presence or absence of peroxisomes after 6 hours. At least 100 mating cell pairs were 
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3.3.3 Inp1 prevents Pex3 from binding to Pex19 in vitro  
 
In order to further investigate the theory that Inp1 and Pex19 can bind to the same binding 
site on Pex3, in vitro binding assays were performed (Fig. 3.11 and 3.12). First, a total lysate 
of E. coli cells expressing His-Pex3 was preincubated with a total lysate of E. coli cells 
expressing MBP-Inp1 in order to allow Pex3 to bind to Inp1. This unpurified mixture was then 
poured over E. coli expressed GST-Pex19 fusions, immobilised on glutathione Sepharose 
beads. After further incubation, the beads were extensively washed with 1x PBS including a 
PBS + 0.5M KCl wash and protein was eluted from the glutathione Sepharose beads with 1x 
protein loading buffer. The binding of His-Pex3 to GST-Pex19 was subsequently analysed by 
SDS-PAGE and Coomassie staining of the gel. 
 
Where MBP-Inp1 had been preincubated with His-Pex3, His-Pex3 was prevented from binding 
to the immobilised GST-Pex19.  When the E. coli lysate containing the MBP tag only was 
preincubated with His-Pex3, no competition was observed. This demonstrates that Pex19 
cannot bind to Pex3 in vitro in the presence of Inp1 (Fig. 3.11).  
 
The competition assay was then repeated with MBP fusions of the N- or C-terminal domains 
of Inp1 (amino acids 1-280 and 281-420, respectively, as described in Fig. 3.2) (Fig. 3.12). His-
Pex3 was found to bind directly to GST-Pex19, except where it had been preincubated with 
the C-terminus of Inp1. This suggests that a complex had formed between Pex3 and the C-
terminus of Inp1 (281-420) during the preincubation and supports earlier experiments 
described in Fig 3.2, that the C-terminus of Inp1 binds directly to Pex3. The N-terminus of Inp1 
(1-280) did not disrupt binding of GST-Pex19 to His-Pex3 indicating that the N-terminus of 
Inp1 does not compete with Pex19 for Pex3 binding. This is probably because, as seen 
previously (Fig. 3.2), under these experimental conditions, the N-terminus of Inp1 does not 
directly bind to Pex3. To confirm this, the unbound fractions of the competition assay were 
further analysed. After incubation with GST-Pex19 immobilised on glutathione Sepharose 
beads, the unbound fractions were removed and incubated with amylose beads to which the 
MBP-fusions bind. The proteins were subsequently eluted from the amylose beads with 
10mM maltose buffer. Due to breakdown bands of MBP-Inp1, the bound His-Pex3 is not easily 
distinguishable by Coomassie staining and so a western blot with Anti-His tag antibody was 
done. This confirmed the presence of His-Pex3 bound to MBP-Inp1 C and also showed that 
MBP-Inp1 N does not compete with GST-Pex19 as no His-Pex3 was bound in that fraction.  
 
These results show that the C-terminus of Inp1 competes with Pex19 for binding to Pex3 and 
reinforce that the C-terminus of Inp1 binds directly to Pex3. This supports a hypothesis that 








































Figure 3.11 – Inp1 prevents Pex3 from binding to Pex19 in vitro. E. coli total lysates 
expressing His-Pex3 (40-441) or His tag only were mixed with buffer only or with E. coli total 
lysates containing either MBP-Inp1 or MBP. These mixtures were then incubated with GST-
Pex19 (blue asterisk) or GST (green asterisk) immobilised on glutathione Sepharose beads. 
After extensive washing, including a PBS + 0.5M KCl wash, bound fractions were analysed by 
SDS-PAGE and Coomassie staining of the gel. A lane was included with enriched His-Pex3 as a 




















































































Figure 3.12 – The C-terminus of Inp1 prevents Pex3 from binding to Pex19.  E. coli total 
lysates containing His-Pex3 (40-441) or His-tag only were mixed with E. coli total lysates 
containing MBP-Inp1 N (1-280), MBP-Inp1 C (281-420) or MBP. These lysates were then 
incubated with GST-Pex19 or GST and the mixture was immobilised on glutathione Sepharose 
beads. After this incubation, the unbound fraction was removed and incubated with amylose 
beads. The glutathione Sepharose beads and amylose beads were washed extensively. 
Protein was eluted from the glutathione Sepharose beads with protein loading buffer and 
bound fractions were analysed by SDS-PAGE and Coomassie staining of the gel (See upper 
gel). A lane was included with enriched His-Pex3 as a control. MBP-Inp1 C prevents binding of 
His-Pex3 to GST-Pex19. Protein was eluted from the amylose beads with 10mM maltose 
buffer and bound fractions were analysed by SDS-PAGE and Coomassie staining (See lower 
gel) and Western blotting with anti-His (bottom panel). M, molecular weight marker. Red 
arrow indicates His-Pex3. Protein visible of the gel on the right is ¼ total protein incubated 


















































































































































































3.3.4 In vivo competition between Inp1 and Pex19 can be investigated by swapping their 
LXXLL motifs 
 
As discussed in Section 3.2.2, overexpression of Inp1 blocks de novo biogenesis of 
peroxisomes dependent on its LXXLL motif. This is assumed to be due high levels of Inp1 
outcompeting endogenous levels of Pex19 by interacting with all available Pex3. During this 
study,  in vivo and in vitro evidence has been obtained which supports this idea and so the 
converse experiment was carried out where Pex19 was overexpressed to assess if it has the 
ability to outcompete Inp1 (Fig 3.13). 
 
Constitutive overexpression of Pex19 under the TPI1 promoter in Δpex19 cells does not have 
any obvious effect on the distribution of peroxisomes compared to Pex19 expressed under 
its endogenous promoter. Peroxisomes are retained in the mother cell and transported into 
the bud as in wild type cells. This implies that, despite the overabundance of Pex19, Inp1 is 
still able to bind to Pex3 and function in the retention of peroxisomes. The main difference in 
the putative Pex3 binding sites of Inp1 and Pex19 is that the central, non-leucine residues of 
the LXXLL motifs are NY in Inp1 and DD in Pex19. To further study the potential for Pex19 to 
outcompete Inp1, the LXXLL motif of Pex19 was mutated to resemble the LXXLL motif of Inp1. 
 
Amino acids D13 and D14 of Pex19 were mutated to N and Y, respectively, and the mutant 
was overexpressed under the TPI1 promoter in Δpex19 cells co-expressing HcRed-PTS1. 
Firstly, the protein was confirmed to be functional due to the complementation of the Δpex19 
phenotype illustrated by the presence of peroxisomes. Overexpression of wild type Pex19 did 
not affect peroxisome retention but interestingly, overexpression of the LNYLL mutant 
resulted in a partial peroxisome inheritance defect. Over half of budding cells resembled 
Δinp1 cells with peroxisomes only present in the bud and a failure to retain peroxisomes in 
the mother cell, despite the presence of endogenous Inp1. These results show that when 
overexpressed, Pex19 DD13,14NY has the ability to outcompete endogenous Inp1 for 





















Figure 3.13 – Pex19 can out-compete endogenous Inp1 for Pex3 binding when its LXXLL 
motif is replaced with that of Inp1. A) Wild type Pex19 under its endogenous promoter (WT 
Pex19) and Pex19 or Pex19 DD13,14NY under the TPI1 overexpression promoter (Pex19 O/E 
and Pex19 LNYLL O/E, respectively) were co-expressed with HcRed-PTS1 in Δpex19 cells. Cells 
were analysed by fluorescence microscopy. Bar, 5 µm. B) Quantitative analysis of peroxisome 
retention in the strains shown in A. Budding cells were scored for the presence or absence of 
peroxisomes in the mother cell. At least 100 budding cells were quantified for each strain. C) 
Schematic diagram illustrating the mutations made to the Pex3 binding motif of Pex19 with 
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In this chapter, the role of Inp1 has been confirmed and further characterised with evidence 
that it is a leucine-based motif which is required for its interaction with peroxisomal Pex3 and 
subsequently for its correct function in peroxisome retention and positioning. A minimal 
region of Inp1 containing only amino acids 311-370 has previously been shown by our lab 
(Hutchinson, 2016), to be crucial for peroxisomal localisation and this was corroborated by 
yeast 2-hybrid data in which a minimal region of Inp1 corresponding to amino acids 300-378 
was found to interact with Pex3. 
 
In this study, the importance of a conserved, leucine-based motif in the interaction between 
Inp1 and Pex3 was confirmed and it was found that it is specifically the leucine resides which 
affects the peroxisomal localisation of Inp1 and its ability to bind to Pex3 in vitro (Fig. 3.5, 3.6, 
3.7) This is supported by an independent study carried out during the course of this work 
which reported a random Inp1 mutant in this motif (LXXLP) that also interfered with Inp1 
function by blocking recruitment of Inp1 to peroxisomes (Knoblach and Rachubinski, 2019). 
Taken together, this evidence is strongly suggestive that the leucine residues of the LXXLL 
motif of Inp1 are required for its interaction with peroxisomal Pex3 and hence for its function 
in peroxisomal retention. 
 
The comparison between the LXXLL Pex3 binding motifs of Pex19 and Inp1 was confirmed 
with evidence that disruption of the leucine resides in the motifs of both proteins is sufficient 
to disrupt their respective Pex3 interaction-dependent functions (Fig. 3.4, 3.5, 3.6). Previous 
observations have shown that overexpression of Inp1 results in a loss of peroxisomal 
structures and led to a hypothesis that Inp1 and Pex19 compete for binding to Pex3 based on 
their analogous LXXLL motifs. Additional in vivo evidence was compiled to support this theory, 
showing that overexpression of Inp1 does indeed lead to a loss of peroxisomal structures and 
that this is not as a result of increased pexophagy (Fig. 3.8).  
 
As shown in Section 3.2.4, when overexpressed, Inp1 outcompetes endogenous Pex19 for 
binding to Pex3 but interestingly, overexpression of wild type Pex19 does not outcompete 
endogenous Inp1, unless its Pex3 binding motif is replaced with that of Inp1 (Fig. 3.13). A 
reasonable explanation for this could be that the central two residues of the LXXLL motif (NY 
or DD) affect the affinity with which Inp1 or Pex19 bind to Pex3. The Asparagine and Tyrosine 
in Inp1’s binding motif may strengthen the interaction with Pex3 compared to the two 
Aspartate residues present in Pex19 which may facilitate a more transient interaction. This is 
logical when the role of each protein is considered. Inp1 functions as a tether, securely 
anchoring proteins to the cell cortex for prolonged periods during cell division. Conversely, 
Pex19 is a cytosolic chaperone which makes temporary interactions with Pex3 as it delivers 
peroxisomal membrane proteins to the peroxisomal membrane. Additionally, according to 
datasets on the Saccharomyces Genome Database, endogenous levels of Inp1 are Pex3 are 
fairly similar, with levels of Pex19 protein suggested to be 2-5 times higher. It would be 
reasonable to assume that Inp1 binds to Pex3 with higher affinity to ensure it can compete 
with Pex19 despite its protein levels being lower. The varying amounts of endogenous 
proteins in combination with different Pex3 binding site affinities could maintain competition 
at the desired levels. This would result in a careful cellular balance of both peroxisome 
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retention and PMP import and ensure that Pex3 is able to maintain different peroxisomal 
processes through 1 binding site. 
 
The potential for competition between Inp1 and Pex19 was also confirmed in vitro (Fig. 3.11, 
3.12) Interestingly, it was only the C-terminal domain of Inp1 (281-420) which prevented 
Pex19 from binding to Pex3 and this was supported by the data presented in Fig. 3.2 which 
illustrated that specific binding could be shown between Pex3 and the C-terminal domain 
(281-420) of Inp1 but not the N-terminal domain (1-280). The existing model states that Inp1 
acts as a ‘molecular hinge’ between peroxisomal and cortical ER-localised Pex3 and this comes 
from the reported observation that both the N- and C-terminal domains of Inp1 
independently bind directly to Pex3 in vitro (Knoblach et al., 2013). As highlighted in Section 
3.2.2, specific binding of the N-terminal domain of Inp1 to Pex3 was not able to be repeated 
under the assay conditions used in this study. Detergent-dependent aggregation of Pex3, non-
specific binding or a combination of the two could form a plausible explanation as to why 
Pex3 binding to MBP-Inp1 1-280 is reported by Knoblach et al., 2013, but is not seen during 
this study in the in vitro binding nor the competition assays. 
 
This chapter has partially characterised the molecular nature by which Inp1 interacts with 
peroxisomal Pex3 and has established that this is a motif with much similarity to that of Pex19. 
The next chapter serves to elucidate how the N-terminal domain of Inp1, if not via ER-bound 


























Chapter 4 – Inp1 has an N-terminal lipid-binding 





The data reported in Chapter 3 shows that Inp1 has a leucine-based motif in the C-terminal 
part of the protein that is required for localisation to peroxisomes via an interaction with the 
cytosolic domain of peroxisomal Pex3. Contrary to previously published observations 
(Knoblach et al., 2013), direct in vitro interactions between the N-terminal domain of Inp1 
and Pex3 were not observed under the assay conditions of this study. As such, the data 
obtained in Chapter 3 are not supportive of the current model of peroxisome retention which 
postulates that Inp1 acts as a ‘molecular hinge’ between peroxisomes and the ER by 
interacting in trans with both ER-associated and peroxisome-associated Pex3 via N and C-
terminal Pex3 binding domains (Knoblach et al., 2013). 
 
Interestingly, further research by the same group has recently shed doubt on the simplicity 
of this model with the suggestion that the ER-peroxisome tether is likely to involve additional 
cortical factors. That study also concludes that peroxisomes are likely to be tethered to 
organelles other than the ER and that the role of Inp1 as a tether probably expands beyond 
its function in tethering peroxisomes to the ER but it may also tether peroxisomes to other 
organelles (Knoblach and Rachubinski, 2019). It was shown in Chapter 3 that the C-terminal 
part of Inp1 is required for its interaction with peroxisomal Pex3 but it is not sufficient to 
retain peroxisomes at the mother cell periphery. The data presented in this chapter serves to 
discover which part of Inp1 anchors peroxisomes at the mother cell periphery and to elucidate 
how Inp1, if not via ER-bound Pex3, interacts with the mother cell cortex.  
 
4.2 The N-terminus of Inp1 is necessary and sufficient for interaction with the cell 
cortex 
 
As discussed in Chapter 3, the ability of Inp1 to localise to peroxisomes is dependent upon its 
C-terminal LXXLL Pex3 binding motif. The truncation screen of Inp1 described in Section 3.2.1 
uncovered that the C-terminus of Inp1 is required for its localisation to peroxisomes. 
Additionally, this screen uncovered several N-terminal truncations of Inp1 that co-localised 
with peroxisomal markers but, when expressed in Δinp1 cells, failed to rescue peroxisome 
retention (Hutchinson, 2016). This indicates that it is the N-terminal region of Inp1 which is 
required for the association of peroxisomes with the mother cell cortex.  
 
In order to identify the region of Inp1 that is necessary for peroxisome association with the 
cell cortex, independent of its binding to Pex3, truncations of Inp1 were fused to GFP-Pex15, 
a tail anchored peroxisomal membrane protein with a cytosolic facing globular domain 
(Elgersma et al., 1997). This created fusion proteins where Inp1 was exposed to the cytosol 
and anchored to the peroxisomal membrane by Pex15, with a GFP spacer moiety between 
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the two proteins. These fusion proteins were then co-expressed under control of the INP1 
promoter in Δinp1 cells with HcRed-PTS1 (Fig. 4.1).  
 
First, the functionality of the chimeric protein was confirmed, as Inp1-GFP-Pex15 was able to 
complement the Δinp1 phenotype and restore peroxisome retention in mother cells (Fig 4.1). 
Additionally, Inp1 L312_L316del (Δmotif)-GFP-Pex15 was also able to rescue peroxisome 
retention. This shows that the ability of Inp1 to anchor peroxisomes to the cell periphery is 







































































Figure 4.1 – Inp1 can restore peroxisome retention independent of its LXXLL binding motif. 
Inp1 or Inp1 L312_L316del (Δmotif) were fused to GFP-Pex15 and expressed under control of 
the INP1 promoter in Δinp1 cells co-expressing HcRed-PTS1. Cells were analysed by 
fluorescence microscopy. The schematic diagram illustrates the predicted topology of the 
Inp1-Pex15 fusion proteins with Inp1 exposed to the cytosol and anchored to the peroxisomal 
membrane by Pex15 with a GFP moiety acting as a spacer between the two proteins. Bar, 
5μm. 
Various truncations of Inp1 were then fused to Pex15 in order to identify a minimal region 
required for peroxisome retention to the cell periphery. The N-terminal 100 amino acids (1-
100) of Inp1 were found to be the smallest, stable truncation of Inp1 which was sufficient to 
rescue peroxisome retention in Δinp1 cells (Fig. 4.2). In order to verify the role of the N-
terminal 100 amino acids, Inp1 100-420-GFP was expressed in Δinp1 cells and it was 
confirmed that this truncation does not rescue peroxisome retention (Fig. 4.3). It can 
therefore be concluded that the N-terminal 100 amino acids of Inp1 are both necessary and, 
when associated with the peroxisomal membrane, sufficient for retention of peroxisomes to 














































Figure 4.2 – The N-terminal 100 amino acids of Inp1 are sufficient for tethering of 
peroxisomes to the cell periphery. Truncations of Inp1 were fused to GFP-Pex15 and 
expressed under control of the INP1 promoter in Δinp1 cells co-expressing HcRed-PTS1. Cells 
were analysed by fluorescence microscopy. The table summarises which Inp1-GFP-Pex15 
fusion proteins were sufficient to rescue peroxisome retention. Cells were assessed for rescue 
of the Δinp1 phenotype (obvious presence of peroxisomes in the mother cell) and at least 100 





Inp1-GFP-Pex15 fusion protein Able to restore peroxisome 
retention in Δinp1 cells?
GFP-Pex15 No
Full length Inp1 Yes




































Figure 4.3 – The N-terminal 100 amino acids of Inp1 are necessary for peroxisome retention. 
The Inp1-GFP truncation 100-420 was expressed under control of the INP1 promoter in Δinp1 
cells with the constitutively expressed HcRed-PTS1. Cells were examined by fluorescence 
microscopy. Bar, 5μm. The graph shows quantitative analysis of the assay. Mating cell pairs 
were scored for the presence of peroxisomes in the mother cell. At least 100 budding cells 
were quantified for each strain. Three independent experiments were carried out. Error bars 


































4.3 The N-terminus of Inp1 contains a lipid binding domain 
 
4.3.1 The N-terminus of Inp1 localises to the plasma membrane 
 
As shown and discussed in Chapter 3, the N-terminus of Inp1 (amino acids 1-282) does not 
bind to Pex3 under the in vitro binding assay conditions used in this study. However, the 
experiments presented in Figures 4.2 and 4.3 show that the first 100 amino acids are 
necessary for peroxisome retention and that when fused artificially to peroxisomes, this N-
terminal domain is sufficient to tether peroxisomes to the mother cell cortex.  The subsequent 
experiments set out to characterise the anchoring function of this domain of Inp1 and to 
investigate what, if not Pex3, the N-terminal domain of Inp1 could be interacting with at the 
cell periphery. 
 
In order to determine the sub-cellular localisation of the N-terminal domain of Inp1, the first 
100 amino acids were fused to GFP and expressed under control of the inducible GAL1/10 
promoter in wild type cells. The protein was found to be cytosolic and localised to the nucleus 
but, surprisingly, the protein also showed plasma membrane localisation (Fig. 4.4). Nuclear 
localisation such as this has previously been observed with GFP fusions of proteins which 
contain plasma membrane-associated lipid binding domains, although the reason for this has 
not been established (Yu et al., 2004). This led to the hypothesis that the N-terminal domain 
of Inp1 has the capacity to bind to lipids and that this could facilitate an interaction between 

















Figure 4.4 – Inp1 1-100 localises to the plasma membrane. An inducible truncation of 1-100 
Inp1-GFP was expressed under control of the GAL1/10 promoter in WT cells. GFP-Sso1 
expressed under control of the TPI1 promoter in WT cells is shown to exemplify characteristic 





4.3.2 Inp1 is a lipid binding protein and is able to bind to PI(4,5)P2 
 
In order to test the capability of Inp1 to bind to the plasma membrane, in vitro lipid binding 
assays were carried out. In these assays, purified protein is incubated with liposomes and the 
mixture is subjected to ultra-centrifugation (280,000 g). Liposomes sediment in a pellet whilst 
non-bound protein will remain in the soluble supernatant fraction. Purified protein which is 
able to bind to the liposomes will co-sediment with the liposomes in the pellet fraction. 
 
E. coli expressed MBP-Inp1 was bound to amylose beads, extensively washed and eluted from 
the beads with 10mM maltose buffer in order to obtain purified protein. Protein-free 
liposomes were prepared from Type I, Folch I fraction of total bovine brain lipid extract which 
is mainly comprised of phosphatidylinositol (PI) and phosphatidylserine (PS) (Sigma Aldrich). 
The purified protein was subjected to a preliminary ultra-centrifugation (350,000 g) to 
remove any aggregated protein and subsequently incubated with the Folch liposomes before 
ultra-centrifugation (280,000 g). Protein loading buffer was added to both the soluble fraction 
and the pellet and the total protein present in each fraction was analysed by SDS-PAGE and 
Coomassie staining of the gel (Fig. 4.5).  
 
MBP was used as a control and was judged not to sediment in the presence or absence of 
Folch liposomes (8% and 5% total protein present in the pellet, respectively). MBP-Inp1 was 
clearly present in the pellet in the presence of Folch liposomes (36% total full length protein) 
and in the absence of liposomes was present in the pellet at a similar level to the MBP only 
control (7% total full length protein). This confirms that MBP-Inp1 does not aggregate upon 
ultra-centrifugation and identifies Inp1 as a lipid binding protein, as it is able to bind to the 




































Figure 4.5  – MBP-Inp1 binds to Folch extract liposomes in vitro. Purified MBP-Inp1 or MBP 
only were incubated with Folch fraction I liposomes made from total bovine brain extract and 
subjected to ultra-centrifugation. Supernatant (S) and pellet (P) fractions were then analysed 
by SDS-PAGE and Coomassie staining. Asterisks indicate multiple MBP-Inp1 fragments. The 
percentage of protein present in each pellet was quantified. Each supernatant + pellet band 
were combined and considered to represent 100% of the protein used in the experiment 
(where there are multiple breakdown bands for MBP-Inp1, the top band representing full 
length MBP-Inp1 was used). The percentage of protein in each pellet in the presence (+) or 
absence (-) of the Folch liposomes is shown. The assay was performed in 3 independent 





































In order to further characterise the Inp1-lipid interaction observed in Fig. 4.5, liposomes were 
synthesised which were comprised of 70% phosphatidylcholine (PC), 8% 
phosphatidylethanolamine (PE) with 22% phosphatidylinositol 4-phosphate (PI(4)P) or 
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2). The ultra-centrifugation assays were 
repeated with these synthetic liposomes as described previously. Protein loading buffer was 
added to both the soluble fractions and the pellets and the total protein present in each 
fraction was analysed by SDS-PAGE and Coomassie staining of the gels (Fig. 4.6). 
 
The MBP only control was judged not to co-sediment in the presence or absence of either of 
the synthetic liposomes. With PC/PE liposomes supplemented with PI(4)P, MBP-Inp1 was 
present in the pellet in comparative levels to the MBP control (9% and 10% total full length 
protein, respectively) and so it was concluded that Inp1 does not bind to PI(4)P (Fig. 4.6). 
However, much higher levels of MBP-Inp1 were observed in the pellet in the presence of 
PC/PE liposomes supplemented with PI(4,5)P2 (35% total full length protein) (Fig. 4.7). MBP-
Inp1 showed co-sedimentation with the PC/PE liposomes supplemented with PI(4,5)P2 but 
not with PI(4)P, strongly indicating Inp1 has the ability to bind to PI(4,5)P2 (Fig. 4.6). This result 
is significant as PI(4,5)P2 is predominantly localised to and synthesised at the inner leaflet of 



















































Figure 4.6 – MBP-Inp1 does not bind to PC/PE liposomes containing PI(4)P. Purified MBP-
Inp1 or MBP only was incubated with liposomes made up of PC, PE and PI(4)P and subjected 
to ultra-centrifugation. Total protein input, supernatant (S) and pellet (P) fractions were 
analysed by SDS-PAGE and Coomassie staining. The percentage of protein present in each 
supernatant and pellet was quantified. Each supernatant + pellet band were combined and 
considered to represent 100% of the protein used in the experiment. Where there are 
multiple breakdown bands for MBP-Inp1, the top band representing full length MBP-Inp1 was 
used, the red arrow indicates full length MBP-Inp1. The percentage of protein in each 
supernatant (S) or pellet (P) in the presence (+) or absence (-) of the PI(4)P liposomes is shown. 
























































































































Figure 4.7 – MBP-Inp1 binds to PC/PE liposomes containing PI(4,5)P2. Purified MBP-Inp1 or 
MBP only was incubated with liposomes made up of PC, PE and PI(4,5)P2 and subjected to 
ultra-centrifugation. Total protein input, supernatant (S) and pellet (P) fractions were 
analysed by SDS-PAGE and Coomassie staining. Black arrow indicates a breakdown product 
truncation of MBP-Inp1 which is still able to bind to lipids containing PI(4,5)P2. The percentage 
of protein present in each supernatant and pellet was quantified. Each supernatant + pellet 
band were combined and considered to represent 100% of the protein used in the 
experiment. Where there are multiple breakdown bands for MBP-Inp1, the top band 
representing full length MBP-Inp1 was used, the red arrow indicates full length MBP-Inp1. 
The percentage of protein in each supernatant (S) or pellet (P) in the presence (+) or absence 
(-) of the PI(4,5)P2 liposomes is shown. The assay was performed in 6 independent 
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Protein-lipid interactions at membranes can be due to non-specific, electrostatic interactions, 
(Lemmon, 2008), and it is plausible that such non-specific interactions between positively 
charged residues in Inp1 and negatively charged phospholipids, such as PI(4,5)P2, could have 
been taking place in the liposome co-sedimentation assays. Although no interaction was seen 
between MBP-Inp1 and PI(4)P supplemented liposomes, to fully exclude that Inp1 was simply 
binding non-specifically to negatively charged PI(4,5)P2, the co-sedimentation assay was 
repeated with PC/PE liposomes supplemented with another negatively charged phospholipid, 
phosphatidylserine (PS) (Fig. 4.8). Additionally, a PC/PE only control was included this time to 
completely exclude that MBP-Inp1 was binding to those phospholipids in the synthetic 
liposomes. Again, MBP-Inp1 co-sedimented with PI(4,5)P2 containing liposomes 
comparatively more than with the PC/PE only control and the liposomes supplemented with 
PS.  
 
As electrostatic interactions between proteins and membrane surfaces are salt sensitive, 
carrying out co-sedimentation assays at different salt concentrations can also indicate 
whether a protein is binding to the lipids in a non-specific, charge dependent manner 
(Saarikangas et al., 2009). Loss of interaction at a higher salt concentration indicates that the 
interaction between a protein and lipid is mainly mediated through non-specific electrostatic 
interactions. In the co-sedimentation assays carried out throughout this chapter, binding 
between liposomes and purified protein took place in a buffer with a final salt concentration 
of 180mM (20mM KCl and 160mM NaCl). Further co-sedimentation assays were subsequently 
carried out in buffers with gradually increasing concentrations of NaCl (200mM-350mM, data 
not shown), in order to assess whether binding between MBP-Inp1 and liposomes was 
maintained in the presence of higher concentrations of salt ions, or not. 
 
The buffer with the highest concentration of added salt (370mM, 20mM KCl with the addition 
of 350mM NaCl) was sufficient to maintain MBP-Inp1 binding to PI(4,5)P2 liposomes, albeit 
with a small reduction from 53% to 40% (Fig. 4.9). The maintenance of an interaction between 
MBP-Inp1 and PI(4,5)P2 liposomes in high salt conditions implies that the efficient binding of 
Inp1 to PI(4,5)P2  depends mainly on specific interactions but the small reduction observed 
could be indicative that electrostatic interactions also contribute. Conversely, the small 
amount of binding observed between PS liposomes and MBP-Inp1 at 180mM NaCl was 
depleted to a level indistinguishable from background binding under the same high salt 
conditions (370mM). This implies that any interactions between MBP-Inp1 and PS are mainly 
mediated through non-specific, electrostatic interactions.  
 
Taken together, these results suggest that MBP-Inp1 has additional mechanisms in binding 
PI(4,5)P2 beyond electrostatic interactions and indicates that there is specificity in the binding 
of Inp1 to the plasma membrane-associated phosphoinositide. Co-sedimentation assays 
performed in 370mM high salt conditions are shown in this thesis as at this concentration of 
salt, interactions between MBP-Inp1 and PS liposomes are lost whilst interactions with 
PI(4,5)P2 liposomes are maintained. However, a full range of controls has yet to be tested in 
order to conclusively rule whether the binding between MBP-Inp1 and the liposomes is 






































Figure 4.8 – MBP-Inp1 binds to PC/PE liposomes supplemented with PI(4,5)P2 but not those 
supplemented with PS. Purified MBP-Inp1 or MBP only were incubated with liposomes made 
up of PC/PE +/- either 22% PI(4,5)P2 or PS and subjected to ultra-centrifugation. Total protein 
input, supernatant (S) and pellet (P) fractions were analysed by SDS-PAGE and Coomassie 
staining. The quantitative analysis summarises the data obtained for MBP-Inp1 and MBP with 
various liposomes. The percentage of protein present in each pellet was quantified, each 
supernatant + pellet band were combined and considered to represent 100% of the protein 
used in the experiment. Where there are multiple breakdown bands for MBP-Inp1, the top 
band representing full length MBP-Inp1 was used (as indicated in Figures 4.7 and 4.8). The 
percentage of protein in each pellet in the presence of various liposomes is shown. Liposome 
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Figure 4.9 – MBP-Inp1 co-sediments with PC/PE liposomes supplemented with PI(4,5)P2 
even in high salt conditions. (A) Purified MBP-Inp1 was incubated with liposomes made up 
of PC/PE +/- 22% PI(4,5)P2 or PS in the presence of either 180mM salt (20mM KCl + 160mM 
NaCl) or 370mM salt (20mM KCl + 350mM NaCl) and subjected to ultra-centrifugation. Total 
protein input, supernatant (S) and pellet (P) fractions were analysed by SDS-PAGE and 
Coomassie staining. (B, C) The percentage of protein present in each pellet was quantified, 
each supernatant + pellet band were combined and considered to represent 100% of the 
protein used in the experiment. Where there are multiple breakdown bands for MBP-Inp1, 
the top band representing full length MBP-Inp1 was used (as indicated in Figures 4.7 and 4.8). 
The percentage of protein in each pellet under the different NaCl conditions is shown. High 
salt = 370mM. Liposome binding assays were all performed in at least 3 independent 
experiments, error bars represent SEM. 
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4.3.3 The N-terminal part of Inp1 binds to PI(4,5)P2 
 
As seen in this study and as observed previously in independent studies, samples of purified 
MBP-Inp1 or GST-Inp1 contain truncated fragments (Munck et al., 2009; Knoblach et al., 
2013). The presence of truncated fragments was informative in the co-sedimentation assays 
as some truncations were able to bind to liposomes (See black arrow in Fig. 4.7). As the MBP-
fusion proteins were N-terminally tagged and since the molecular weight of MBP is 42.5kDa, 
it could be deduced that the N-terminal domain of Inp1 is able to bind to lipids. To test this 
further, N- and C-terminal truncations of Inp1 were expressed in E. coli and subsequently 
assayed for their ability to interact with PI(4,5)P2 (Fig. 4.10, 4.11).  
 
The N-terminal domain MBP-Inp1 1-280 binds PI(4,5)P2 liposomes in contrast to the C-
terminal domain MBP-Inp1 281-420. This confirms that the N-terminal part of Inp1 has a role 
in lipid binding. As Inp1 1-100-GFP was shown to localise to the plasma membrane (Section 
4.3.1), MBP-Inp1 1-100 was then assayed for its ability to bind to PI(4,5)P2 and also co-
sedimented with PI(4,5)P2 supplemented liposomes. It can be concluded that Inp1 is a lipid 
binding protein which binds preferentially to PI(4,5)P2 but not PI(4)P or PS phospholipids. 
Additionally, the N-terminal 100 amino acids of Inp1 are sufficient for binding to PI(4,5)P2 






















Figure 4.10 – The N-terminal truncations of MBP-Inp1 1-280 and 1-100 bind to PI(4,5)P2 
liposomes but MBP-Inp1 281-420 does not. Purified truncations of MBP-Inp1 1-280 and 281-
420 (upper gel) and MBP-Inp1 1-100 (lower gel) were incubated with liposomes made up of 
PC, PE +/- PI(4,5)P2 and subjected to ultracentrifugation. Supernatant (S) and pellet (P) 


















































































































Figure 4.11 – Inp1 is a lipid binding protein, able to bind PI(4,5)P2 via its N-terminal domain. 
Purified truncations of MBP-Inp1 (FL), 1-280, 281-420, 1-100 and MBP only were incubated 
with liposomes made up of PC, PE +/- PI(4,5)P2 and subjected to ultracentrifugation. 
Supernatant (S) and pellet (P) fractions were then analysed by SDS-PAGE and Coomassie 
staining. The percentage of protein present in each pellet was quantified, each supernatant + 
pellet band were combined and considered to represent 100% of the protein used in the 
experiment. Where there are multiple breakdown bands for MBP-Inp1, the top band 
representing full length MBP-Inp1 was used (as indicated in Figures 4.7 and 4.8). For MBP-
Inp1 1-100, the top band representing full length MBP-Inp1 1-100 was used. The percentage 
of protein in each pellet in the presence of various liposomes is shown. Liposome binding 












































4.3.4 Reduction in cellular PI(4,5)P2 levels results in a reduction of Inp1 1-100 localisation to 
the plasma membrane 
 
The data presented in this chapter indicates that the N-terminal 100 amino acids of Inp1 
localise to the plasma membrane in vivo and are capable of binding in vitro to liposomes 
containing PI(4,5)P2. PI(4,5)P2 is predominantly localised to and synthesised at the inner 
leaflet of the yeast plasma membrane (Yu et al., 2004; Vernay et al., 2012) and so the 
following experiment was carried out in order to determine how cellular PI(4,5)P2 levels would 
affect the plasma membrane localisation of Inp1 1-100-GFP.  
 
Sac1 is a phosphatidylinositol phosphate phosphatase, required for hydrolysis of PI(4)P. In 
∆sac1 cells, PI(4)P accumulates to levels 20-fold higher than normal and PI(4,5)P2 levels 
decrease by 75-80% (Hughes et al., 2000; Foti et al., 2001). Previously, it has been shown that 
other PI(4,5)P2 binding GFP-fusion proteins are less plasma membrane localised in ∆sac1 cells 
(Yu et al., 2004). Likewise, when Inp1 1-100-GFP was expressed in ∆sac1 cells, a visible 
reduction was observed in its plasma membrane localisation (Fig. 4.12). Line scans were taken 
across the plasma membrane which plotted relative fluorescent intensity versus distance. For 
WT cells, the line scans showed defined peaks of plasma membrane enrichment, but these 
peaks were not observed in ∆sac1 cells. This confirmed the loss of Inp1 1-100-GFP enrichment 
at the plasma membrane in ∆sac1 cells compared to WT cells and strongly supports the idea 























































Figure 4.12 – Inp1 1-100-GFP localisation to the plasma membrane is reduced in Δsac1 cells. 
An inducible truncation of Inp1 1-100-GFP was expressed in wild type and Δsac1 cells and 
examined by fluorescence microscopy. The graphs show relative fluorescence intensities of 
Inp1 1-100-GFP across the plasma membrane. Red lines indicate where the measurements 
were taken from. Single focal planes are shown. Defined peaks corresponding to enrichment 
at the plasma membrane were observed in WT cells (blue arrows) but were not observed in 





























































The existing model of peroxisome retention portrays Inp1 as a modular protein which anchors 
peroxisomes to the cell periphery via an N- and C-terminal domain (Knoblach et al., 2013). In 
Chapter 3, it was shown that Inp1 interacts directly with peroxisomal Pex3 via a conserved 
motif in its C-terminal domain. In Chapter 4, the role of the N-terminal domain of Inp1 in 
peroxisome retention has been characterised. By artificially attaching truncations of Inp1 to 
the peroxisomal membrane via Pex15, peroxisome retention could be studied independently 
of Inp1’s interaction with peroxisomal Pex3. Through these assays, the N-terminal 100 amino 
acids of Inp1 were identified as being necessary and capable of peroxisome retention at the 
cell periphery. As such, it has been shown that Inp1 interacts with the cell periphery via its N-
terminal domain and this can be genetically separated from its direct interaction with 
peroxisomal Pex3 via its C-terminal domain. In that respect, the current model portraying 
Inp1 as a modular protein seems to be correct. However, the data acquired in this study does 
not support the idea that the N-terminal domain of Inp1 interacts with Pex3 and identifies 
the N-terminus of Inp1 as a lipid binding domain that binds to PI(4,5)P2 and associates with 
the plasma membrane.  
 
When expressed as a GFP-fusion protein in wild type cells, the N-terminal 100 amino acids of 
Inp1 exhibit plasma membrane localisation (Fig. 4.4). Interestingly, they also show nuclear 
localisation, an observation which has been reported for other proteins upon expression of 
their plasma membrane binding domains and as yet is not understood (Yu et al., 2004). This 
additional observation supports the idea that Inp1 1-100-GFP has the capability to bind to the 
plasma membrane as not only does it localise there but the pattern of localisation closely 
resembles that of other, well characterised plasma membrane binding domains.  
 
The hypothesis that the N-terminal 100 amino acids of Inp1 are capable of binding to the 
plasma membrane was supported by the in vitro liposome co-sedimentation assays carried 
out in this chapter. These showed that Inp1 is a lipid binding protein which binds to liposomes 
containing PI(4,5)P2, a phosphoinositide which is primarily synthesised and located at the 
inner leaflet of the yeast plasma membrane (Yu et al., 2004; Vernay et al., 2012). A low 
amount of MBP-Inp1 did appear to co-sediment with liposomes supplemented with PS (Fig. 
4.8, 4.9). However, as PS is mainly concentrated and highly abundant in the plasma 
membrane, this would not affect the final conclusion that Inp1 binds to plasma membrane 
lipids. Importantly, this weak interaction with PS was salt sensitive, implying that the 
interaction is based on non-specific, electrostatic charges. The co-sedimentation assays also 
showed that MBP-Inp1 interacts with PI(4,5)P2 even under high salt conditions, albeit less 
efficiently than at 180mM salt (Fig. 4.9). The slight reduction in MBP-Inp1 co-sedimentation 
suggests again that electrostatic interactions do contribute in the binding of Inp1 to the 
liposomes, but that there is some specificity in Inp1 binding to PI(4,5)P2 containing liposomes 
and the interaction is not solely based on charge.  
 
The in vitro lipid co-sedimentation assays also showed that it is the N-terminal domain of Inp1 
that is able to bind to lipids and indeed that amino acids 1-100 possess the ability to bind to 
PI(4,5)P2 (Fig. 4.10, 4.11). The in vitro work was then supported with in vivo data as a reduction 
of cellular PI(4,5)P2 in ∆sac1 cells was shown to result in a reduction of Inp1 1-100-GFP 
localisation to the plasma membrane (Fig. 4.12). Additionally, in ∆sac1 cells, PI(4)P levels are 
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increased 10-20 fold with PI(4)P accumulating at the ER and vacuole (Tahirovic et al., 2005). 
Nonetheless, Inp1 1-100-GFP was not seen accumulating at ER or vacuolar membranes which 
gives additional support to the observations made in the liposome binding assays MBP-Inp1 
binds to PI(4,5)P2 and not PI(4)P. Taken together, the work presented in this chapter provides 
convincing evidence that the N-terminus of Inp1 is a lipid binding protein which binds to the 
plasma membrane. 
 
Attempts were made during this study to further pinpoint regions in the first 100 amino acids 
required for peroxisomal tethering. It was found that when the first 52 amino acids of Inp1 
are deleted in the endogenously expressed Inp1-GFP (Inp1 52-420-GFP), peroxisome 
retention is restored in Δinp1 cells. As 100-420-GFP does not restore peroxisome retention in 
Δinp1 cells (Fig. 4.3) this points to the fact that retention relies on amino acids in the 52-100 
region. However, when experiments were attempted with these smaller tethers, the proteins 
were found to be unstable. Due to this, it was most appropriate to use amino acids 1-100 as 
a minimal tether as this truncation was stable and behaved as such that confident 
observations and conclusions could be made. 
 
It is perhaps too simplistic to simply try and shave off more and more amino acids from the 
primary sequence of Inp1 in order to find a minimal tether. The tethering ability of the N-
terminal domain of Inp1 most likely relies on a secondary or tertiary folded structure such as 
a PH domain. An archetypal PH-domain is a structural module which interacts with 
phosphoinositides and the majority of PH-like domains are also protein binding (Yu et al., 
2004). During the course of this study, an additional, complementary study was also accepted 
for publication which investigates the functional role of Inp1 in H. polymorpha (Krikken et al., 
2020). Additionally, Krikken et al. analyse the sequence of a middle domain (100-216) of 
HpInp1 and predict that it may fold as a divergent Ran-binding domain from the PH-like 
domain superfamily (Krikken et al., 2020). This sequence roughly aligns with ScInp1 amino 
acids 80-260 and so by using the truncations 1-100 and 101-280, I may have missed the 
presence of an orthologous domain in ScInp1. This is something which is further discussed in 
Section 6.1. 
 
To summarise the results obtained in Chapter 4, Inp1 appears to be a modular protein with 
an N-terminal lipid binding domain and a C-terminal Pex3 binding region. This illustrates that 
Inp1 has the capacity to act as a molecular tether between the plasma and peroxisomal 
membranes by directly binding to PI(4,5)P2 at the plasma membrane and to Pex3 on the 
peroxisomal membrane. In order to be considered a contact site tether, a protein must 
adhere to a pre-determined set of criteria (Eisenberg-Bord et al., 2016). The following Chapter 









Chapter 5 – Inp1 meets the criteria to be classed 




In recent years, it has become increasingly obvious that organelles make physical contact with 
each other at membrane contact sites (MCS). Membrane contact sites can be defined as 
cellular domains where membranes from opposing organelles are tethered in close proximity 
by protein or lipid interactions, resulting in the function of one or both organelles being 
affected (Prinz, 2014; Shai et al., 2018; Prinz et al., 2020). Research of MCS’s is increasing 
rapidly and every organelle has now been shown to have at least one functional MCS with 
another organelle. Most organelles are now known to have multiple MCS’s and these 
encompass a range of functions such as exchange of cellular materials, arrangement of the 
cell, organelle inheritance and fission (Valm et al., 2017; Shai et al., 2018). The 
characterisation of MCS’s has also led to the identification of proteins that tether and regulate 
contact sites. However, as more contact sites are identified, there remains a range of MCS 
tethering factors which are as yet unknown. 
 
As has been postulated for other organelles, yeast peroxisomes have been found to interact 
with many cellular structures including the plasma membrane, ER, vacuole, mitochondria and 
lipid bodies (Eisenberg-Bord et al., 2016; Knoblach & Rachubinski, 2019; Wu et al., 2019). 
Although components of some of these interorganellar peroxisomal contact sites have been 
identified, others are still completely uncharacterised (Shai et al., 2018). Inp1 and Pex3 are 
implicated as peroxisome-ER contact site proteins, although a more recent study suggests 
that additional components are required for peroxisome tethering to the cell cortex 
(Knoblach et al., 2013; Knoblach & Rachubinski, 2019). Additionally, the data obtained during 
this study, as presented in Chapters 3 and 4, are suggestive of an alternative model of Inp1 
function involving the plasma membrane rather than the cortical ER. Although contact sites 
between peroxisomes and the plasma membrane have been observed, (Shai et al., 2018), any 
factors or tether proteins required to mediate these membrane contact sites have not yet 
been identified.  
 
Contact sites between the plasma membrane and other organelles such as the ER have been 
more widely studied and in yeast cells, the plasma membrane and cortical ER (cER) are in very 
close proximity with up to 45% of the plasma membrane in contact with the cER network 
(Pichler et al., 2001; West et al., 2011). These areas of close contact between the two 
membranes create distinct, sub-cellular microenvironments and have been shown to have 
membrane contact sites with a third organelle, the mitochondria (Lackner et al., 2013). 
Cortical mitochondrial anchorage occurs via the mitochondria ER cortex anchor (MECA), a 
multi-subunit protein complex (Lackner et al., 2013). The core component of MECA is Num1, 
a cortical associated protein which binds to the mitochondrial outer membrane and the 
plasma membrane via two distinct lipid binding domains (Lackner et al., 2013). Although 
MECA is reported to be a tether between three organelle membranes, the molecular 
mechanisms for MECA association with the ER remain poorly understood. 
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The plasma membrane has been further implicated in mitochondrial tethering via site-specific 
mitochondrial anchorage at the mother cell tip via Mfb1 (Manford et al., 2012; Pernice et al., 
2016). As the plasma membrane has been shown to be required for cortical retention and 
correct spatial distribution of mitochondria, this raises the possibility that organelle retention 
via the plasma membrane could also occur in the cases of other cortically associated 
organelles such as peroxisomes.  
 
The data presented in Chapters 3 and 4 characterises Inp1 as a modular protein with an N-
terminal lipid binding domain and a C-terminal peroxisomal Pex3 binding region. The N-
terminal 100 amino acids of Inp1 localise to the plasma membrane, bind to liposomes 
containing the plasma membrane localised phosphoinositide PI(4,5)P2 and can act as a 
minimal tether which, when artificially attached to peroxisomes, restores retention of 
peroxisomes to the cell periphery in Δinp1 cells. As research into membrane contact sites 
grows, the research community has proposed a ‘gold standard’ of 3 criteria which an MCS 
tether protein must fulfil. Chapter 5 serves to explore whether Inp1 adheres to these pre-
requisites and therefore whether Inp1 can be formally characterised as a plasma membrane-
peroxisome contact site tether (Eisenberg-Bord et al., 2016).  
 
5.2 Inp1 is in the correct sub-cellular location to be a PM-PER tether 
 
5.2.1 Peroxisome retention at the mother cell periphery is not disrupted in cortical ER mutants. 
 
The current model of peroxisome retention classifies Inp1 as a peroxisome-ER tether protein 
due to the apparent ability of Inp1 to simultaneously interact with both peroxisomal and 
cortical ER-associated Pex3 (Knoblach et al., 2013a). Though the role of the cortical ER (cER) 
in peroxisome retention has been reported, the role of the plasma membrane remains 
unexplored. In order to investigate the contribution of the cER to peroxisome retention, 
peroxisome distribution was analysed by expressing the peroxisomal matrix marker HcRed-
PTS1 in two mutants where the cER is disrupted. Δrtn1/Δrtn2/Δyop1 cells do not form cortical 
ER tubules but instead produce ER sheets which leaves large parts of the plasma membrane 
free of ER (Voeltz et al., 2006). A second ER mutant, Δscs2/Δscs22/Δist2/Δtcb1/Δtcb2/Δtcb3 
was also studied. In this second strain, which will be referred to as (ΔER-PM tether), the 
proteins required for tethering the cortical ER to the plasma membrane  are absent and so 
the cER is separated from the plasma membrane and accumulates in the cytoplasm, almost 
completely collapsed away from the cell cortex (Manford et al., 2012). 
 
In both strains, the severe disruption of the cER does not appear to affect peroxisome 
partitioning with peroxisomes retained in mother cells as in wild type (Fig. 5.1). This implies 
that despite the absence of typical ER structures at the cell cortex, peroxisomes are still able 
to be retained at the cell periphery. Deletion of INP1 in these strains results in a typical Δinp1 













































Figure 5.1 – Disruption of the cER does not affect peroxisome distribution. The peroxisomal 
matrix marker HcRed-PTS1 was constitutively expressed in wild type (WT), 
Δrtn1/Δrtn2/Δyop1, ΔER-PM tether, Δinp1, Δrtn1/Δrtn2/Δyop1/Δinp1 and ΔER-PM 
tether/Δinp1 cells. Cells were examined by epifluorescence microscopy. The peroxisome 
distribution between mother and daughter cells we analysed in the strains described. Each 
budding cell was scored for what percentage of its total cellular peroxisomes were present in 
the mother cell. Per. = peroxisomes. Over 100 budding cells were analysed for each strain. 
























































5.2.2 Peroxisomes are still present at the cell periphery in the absence of the cortical ER 
 
In order to further visualise peroxisome localisation when the normal cellular distribution of 
the cortical ER is disrupted, the ER marker Sec63-mRFP, the plasma membrane marker GFP-
Sso1 and the peroxisomal matrix marker blue fluorescent protein-PTS1 (BFP-PTS1) were co-
expressed in Δrtn1/Δrtn2/Δyop1 cells. As shown in Figure 5.1, peroxisomes in this mutant 
were normally distributed and present at the mother cell periphery. Analysis of these mutants 
found that peroxisomes were often seen at the exposed ends of ER sheets and 46% of budding 
cells contained at least one peroxisome at the cell periphery in areas devoid of ER (n=170) 
(Fig. 5.2).  
 
In order to further visualise the spatial relationship between peroxisomes, the ER and the 
plasma membrane, line-scan analyses of the images were used to obtain plots of the relative 
fluorescent intensities versus distance. These confirmed that peroxisomes were present even 
in regions with little to no Sec63-mRFP signal and showed an overlap in the signal of 
peroxisomal foci and the plasma membrane, indicative of PM-PER contact sites. 
 
Figure 5.2  – Peroxisomes are present at the cell periphery in Δrtn1/Δrtn2/Δyop1 cells, even 
in the absence of cortical ER. Sec63-mRFP, BFP-PTS1 and GFP-Sso1 were co-expressed in 
Δrtn1/Δrtn2/Δyop1 cells and imaged using epifluorescence microscopy. Single focal planes 
are shown from the centre of the Z-stack. The white arrow highlights a peroxisome present 
at the end of an ER sheet. The boxed areas are magnified. The graph shows relative 
fluorescence intensities of the markers for the ER (red), the peroxisomal matrix (blue) and the 
plasma membrane (green) along a line drawn through the centre of the peroxisomal focus 
indicated by the yellow line on the magnification panel. Bar, 5μm except where indicated as 
2.5μm. 

























Peroxisome localisation at the periphery of cER mutants was further visualised in the ΔER-PM 
tether strain by co-expressing the ER marker Sec63-GFP with HcRed-PTS1 (Fig. 5.3). Despite a 
lack of cER, around half of cells (50.3%, n=150) appeared to contain at least 1 peroxisome at 
the cell periphery in areas devoid of detectable ER signal. When INP1 was also deleted from 
the ΔER-PM tether strain, peroxisomes were no longer localised at the periphery but were 
still observed in close proximity to internal cellular ER structures in buds. It is important to 
acknowledge that the Axiovert microscopy images obtained during this study may have 
limitations and so it cannot be stated with 100% confidence that when a peroxisome appears 
in an area devoid of ER, that there are no traces of ER structure present. However, the images 
obtained do suggest that peroxisomes are able to localise to the periphery even in the 
absence of typical cortical ER structures and illustrate that contact between peroxisomes and 


































































Figure 5.3 – Peroxisomes are present at the cell periphery in ΔER-PM tether cells, even in 
the absence of cortical ER. A) Sec63-GFP and HcRed-PTS1 were co-expressed in ΔER-PM 
tether cells and examined by fluorescence microscopy. The white arrow highlights an example 
of a peroxisome which is at the cell periphery in the absence of visible ER. A single focal plane 
is shown from the centre of the z-stack. Border of cell is outlined in blue in the second merge 
image. B) Budding Δrtn1/Δrtn2/Δyop1 or ΔER-PM tether cells were scored for the presence 
of at least one peroxisome present at the cell periphery but not associated with visible ER. 
Over 100 budding cells were quantified for each strain. Three independent experiments were 
carried out. Error bars represent SEM. C) Sec63-GFP and HcRed-PTS1 were co-expressed in 
ΔER-PM tether/Δinp1 cells and examined by fluorescence microscopy. The boxed area is 
magnified and exemplifies peroxisomes associated with a central ER structure in the absence 
of INP1. A single focal plane is shown from the centre of the z-stack. Bars, 5μm. 
 
 



















































5.2.3 Inp1 is present in close proximity to the plasma membrane and peroxisomes 
 
The first requirement that a protein must meet in order to be considered a bona fide 
membrane contact site tether is that it must reside in a defined location at the contact site 
(Eisenberg-Bord et al., 2016). In order to begin elucidating the potential for Inp1 to be a 
plasma membrane-peroxisome tether protein, the sub-cellular localisation of Inp1 was 
explored in relation to peroxisomes, the plasma membrane and the ER. First, Inp1-mCherry, 
Sec63-GFP and BFP-PTS1 were co-expressed in Δrtn1/Δrtn2/Δyop1/Δinp1 cells (Fig. 5.4). 
Where peripheral peroxisomes could be seen localised to the exposed ends of ER sheets, (Fig. 
5.4A), or in areas free of ER, Inp1 foci was always observed to be partially co-localised with 
peroxisomal matrix foci on the side of peroxisomes proximal to the cell periphery. 
Peroxisomes were often seen ‘sandwiched’ between the ER and the cell periphery and in 
these instances, peroxisomal matrix foci were consistently located between Inp1 foci and the 
ER. Inp1 was again proximal to the cell periphery and distal from ER sheets. Line-scan analyses 
were carried out which confirmed that the profiles of Inp1-mCherry were slightly juxtaposed 
to those of peroxisomal matrix foci but the peak intensities of Inp1-mCherry and the ER were 
spatially resolved indicating no physical contact (Fig. 5.4C).  
 
Where Inp1-mCherry was co-expressed with BFP-PTS1 and the plasma membrane marker 
GFP-Sso1, Inp1-mCherry again partially overlapped with peroxisomal matrix foci, proximal to 
the cell periphery and co-localised with GFP-Sso1 at the plasma membrane (Fig. 5.5). Taken 
together, these observations show that Inp1 foci are present in locations closely apposed to 
the peroxisomal and plasma membranes but can be spatially resolved from the ER and are 
even seen at the cell periphery in areas devoid of cortical ER. As these images were obtained 
using an Axiovert microscope, it is likely that the fluorescent signals in the images appear 
bigger than the protein that they represent. As such, it is likely that where fluorescent signals 
of proteins appear to be spatially distinct, the proteins are perhaps even further apart in 
reality. It can therefore be concluded that Inp1 is present in the correct sub-cellular locations 


























































Figure 5.4 – Inp1 foci can be seen proximal to the cell periphery but distal from ER sheets. 
(A, B) Sec63-GFP, Inp1-mCherry and BFP-PTS1 were co-expressed in 
Δrtn1/Δrtn2/Δyop1/Δinp1 cells and imaged using epifluorescence microscopy. In A, a single 
focal plane is shown. In B, three single, consecutive Z-stack layers of the same image are 
shown. The boxed areas are numbered and magnified in C. (C) The graphs show relative 
fluorescence intensities of the ER (green), the peroxisomal matrix (blue) and Inp1 (red) along 
a line drawn through the centre of peroxisomal foci, indicated by the white lines on the 
magnified images. Bars, 5μm except where indicated as 2.5μm. 




























































































Figure 5.5  – Inp1 foci are seen juxtaposed to peroxisomal matrix markers but co-localise 
with the plasma membrane. GFP-Sso1, Inp1-mCherry and BFP-PTS1 were co-expressed in 
Δrtn1/Δrtn2/Δyop1/Δinp1 cells and imaged using epifluorescence microscopy. A single focal 
plane is shown. Image B is a magnification of Image A. The graph shows relative fluorescence 
intensities of the plasma membrane (green), the peroxisomal matrix (blue) and Inp1 (red) 
along a line drawn (yellow) through the centre of the peroxisomal foci. Bars, 5 µm (A) and 2.5 






































5.3 Inp1 has the functional capacity to be considered a PM-PER tether 
 
5.3.1 The PH domain of Num1 can act as an artificial tether to restore peroxisome retention 
 
The second minimal requirement that a protein must fulfil in order to be considered a tether 
is that it must have functional activity and therefore exert a tethering force. The molecular 
function of a tether protein is to physically hold membranes of distinct cellular components 
at close distance. As such, depletion of a tether protein should result in loss of physical 
proximity of the two membranes. In the field of contact site research, it is regarded that the 
functional capacity of a protein as a contact site tether can be assayed by expression of an 
artificial tether. Expression of synthetic components designed to tether the respective 
membranes should, in theory, compensate for loss of a tether protein (Eisenberg-Bord et al., 
2016).  
 
One such example of a synthetic tether being used to establish an endogenous tethering role 
is in previously published work regarding Num1, a mitochondrial-plasma membrane tether 
(Ping et al., 2016). Num1 binds to the mitochondrial outer membrane and the plasma 
membrane via two distinct and characterised lipid-binding domains.  In Δnum1 cells 
mitochondrial tethering is defective and this phenotype can be compensated for by 
expression of a truncated, artificial tether comprised just of the two, lipid membrane-binding 
domains of Num1, spaced by a GFP moiety (Lackner et al., 2013; Ping et al., 2016).  
 
A similar experiment was carried out as part of this study in Figure 4.2, where a minimal region 
of Inp1, comprised of the N-terminal 100 amino acids, was artificially attached to the 
peroxisomal membrane via Pex15. This minimal tether was found to be sufficient to restore 
peroxisome retention in Δinp1 cells (Fig. 4.2). The functional capacity of Inp1 to be a PM-PER 
tether was further tested by investigating whether the Δinp1 phenotype could be rescued by 
a completely artificial tether. For this, the plasma membrane-binding PH domain of Num1 
(amino acids 2563-2692) was used, which has been shown to be a highly selective PI(4,5)P2 
binding domain (Yu et al., 2004; Tang et al., 2009). The Num1 PH domain was fused to Pex15 
in the same way as the Inp1 1-100 minimal tether, with a GFP spacer moiety, and expressed 
under control of the INP1 promoter in Δinp1 cells (Fig. 5.6). This completely artificial tether 
was sufficient to restore peroxisome retention to the mother cell cortex in Δinp1 cells, closely 
resembling the Inp1 1-100-GFP-Pex15 minimal tether. As stated above, the loss of a tether 
should be rescued by expression of synthetic components that are able to tether the 
respective membranes. As peroxisome localisation to the cell periphery was restored through 
expression of a tether comprising a plasma membrane-binding domain and a peroxisomal 
membrane-associated domain, this strongly suggests that Inp1 has the functional capacity to 














































Figure 5.6 – The PH domain of Num1 can function as an artificial peroxisome tether and 
rescue peroxisome retention in Δinp1 cells. The N-terminus of Inp1 (amino acids 1-100) or 
the PH domain of Num1 (amino acids 2563-2692) were fused to GFP-Pex15 and expressed 
under control of the INP1 promoter in Δinp1 cells with the constitutively expressed HcRed-
PTS1. Cells were examined by fluorescence microscopy. The diagram illustrates the predicted 
topology of the Num1-Pex15 fusion protein with the PH domain of Num1 exposed to the 
cytosol and anchored to the peroxisomal membrane by Pex15 with a GFP moiety acting as a 















5.3.2 Overexpression of a minimal Inp1 tether results in an increase in PM-PER contact sites 
 
Another method of assaying the functional ability of a tether protein is by measuring its effect 
on the extent of a contact site. Depletion of a tether protein may result in a loss of proximity 
between distinct membranes, but a complementary approach is to observe what happens 
when the tether is overexpressed. If overexpression of a tether protein results in an increase 
in the size or amount of contact sites between distinct membranes, this is a good indicator 
that the protein contributes to interorganellar tethering (Eisenberg-Bord et al., 2016). 
 
In order to carry out this assay, a series of yeast strains were obtained from the laboratory of 
Maya Schuldiner (Weizmann Insitute of Science, Rehovet, Israel) which use a bimolecular 
fluorescence complementation assay to allow for visualisation of contact sites (Shai et al., 
2018). Each strain contains split Venus reporters for peroxisomes and one other organelle 
(ER, mitochondria, plasma membrane or vacuoles). The perimeter of the peroxisomes and 
the other given organelle in each strain are each coated with half of a Venus fluorescence 
protein and at contact sites between the two organelles, the two halves of the Venus 
fluorescent protein interact and form a full fluorophore. This allows for the visualisation of 
the number or size of contact sites between organelles. 
 
In order to measure its functional capacity, Inp1 could not simply be overexpressed in these 
strains as overexpression of Inp1 leads to a loss of peroxisomal structures (Fig. 3.8). As such, 
an alternative approach was taken and the minimal Inp1 peroxisomal tether, which has been 
established in this study, was overexpressed (Inp1 1-100-mRFP-Pex15). The minimal tether 
was first overexpressed in wild type cells which resulted in over-retention of peroxisomes in 
mother cells, as initial overexpression of wild type Inp1 does (Fig. S1B of Munck et al., 2009), 
but importantly overexpression of the minimal tether did not affect overall peroxisome 
number or peroxisome biogenesis (Fig. 5.7). 
 
This minimal tether was then overexpressed in the series of split Venus reporter strains. The 
number of fluorescent puncta representing peroxisomal contact sites with ER, mitochondria 
and vacuoles were unaffected by this overexpression. On the other hand, the number of 
plasma membrane-peroxisome contact site reporter puncta in the cell population increased 
with overexpression of the minimal tether. Both the frequency of cells with PM-PER reporter 


















Figure 5.7 – Overexpression of the minimal tether results in over-retention of peroxisomes 
but does not affect peroxisome biogenesis. The N-terminus of Inp1 (amino acids 1-100) was 
fused to mRFP-Pex15 and overexpressed under control of the TPI1 promoter in wild type cells 
with the constitutively expressed peroxisomal matrix marker GFP-PTS1. Cells were examined 
by fluorescence microscopy. Whole cell projections are shown. Bar, 5μm. The experiment was 
then quantitatively analysed by scoring budding cells for the presence of peroxisomes in the 














































































Figure 5.8 – Overexpression of the Inp1 minimal tether results in an increase in plasma 
membrane-peroxisome contact sites. The Inp1 1-100 truncation was fused to mRFP-Pex15 
and this minimal tether was overexpressed under the control of the TPI1 promoter in 
different peroxisome contact site split reporter strains. PM-PER, plasma membrane-
peroxisome. ER-PER, endoplasmic reticulum-peroxisome. Mito-PER, mitochondria-
peroxisome. Vac-PER, vacuole-peroxisome. Strains are described in Table 2.1, Section 2.2.1. 
Cells were examined by fluorescence microscopy for the presence of Venus puncta indicative 
of inter-organelle contact sites. Images labelled 1, 2 and 3 indicate various examples of the 
effect that overexpression of the minimal tether had on the PM-PER split reporter. Whole cell 
projections are shown. Bar, 5μm.  The effect of overexpression of the minimal tether Inp1 1-
100 mRFP-Pex15 on PM-PER split reporter was quantified. Over 100 cells were analysed for 
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5.3.3 The Inp1 minimal tether localises to the correct sub-cellular location to be a plasma 
membrane-peroxisome tether  
 
As discussed in Section 5.2.3, one characteristic of a membrane contact site tether protein is 
its sub-cellular localisation to the contact site and full length Inp1-mCherry was shown to be 
closely apposed to the peroxisomal and plasma membranes (Fig. 5.3). The minimal Inp1 
tether of amino acids 1-100, artificially attached to peroxisomes via Pex15, has been shown 
to be capable of restoring peroxisome localisation to the cell periphery and increasing the 
number of peroxisome-plasma membrane contact sites and so the sub-cellular location of 
this minimal tether was subsequently investigated. 
 
To visualise the sub-cellular localisation of the minimal tether, it was first co-expressed in the 
cortical ER mutant rtn1/rtn2/yop1/inp1Δ with Sec63-GFP (Fig. 5.9A). The minimal tether was 
always seen to be present on the peripheral side of the ER, proximal to the plasma membrane. 
Quantitative analysis found that in around 49% of cells, the minimal tether was present in 
areas devoid of cortical ER (n=150 cells). This is comparable with the 46% of 
rtn1/rtn2/yop1/inp1Δ cells which had peripheral peroxisomes in the absence of cortical ER 
when expressing wild type Inp1.  In order to further visualise the spatial relationship between 
the minimal Inp1 tether, peroxisomes and the ER, the minimal tether was co-expressed in 
rtn1/rtn2/yop1/inp1Δ cells with Sec63-GFP and BFP-PTS1 (Fig. 5.9B, C). Again, peroxisomes 
appeared ‘sandwiched’ between cortical ER and the cell periphery with the Inp1 minimal 
tether foci consistently juxtaposed to the peroxisomal matrix foci, closer to the cell periphery, 
and spatially resolved from the ER. Line scan analyses of the images confirmed that the 
minimal tether signal overlapped with that of the peroxisomal foci but that, as with full length 
Inp1, the peaks of the minimal tether and Sec63-GFP were spatially resolved. It can therefore 
be concluded that the N-terminal domain of Inp1, when retaining peroxisomes as a minimal 










































Figure 5.9 – The minimal tether Inp1 1-100-mRFP-Pex15 localises to the correct sub-cellular 
location to be considered a PM-PER tether. (A) Inp1 1-100-mRFP-Pex15 was overexpressed 
under control of the TPI1 promoter in rtn1/rtn2/yop1/inp1Δ cells with Sec63-GFP and 
analysed using epifluorescence microscopy. Budding rtn1/rtn2/yop1/inp1Δ cells were scored 
for the presence of peroxisomes at the periphery but not associated with visible ER. Over 100 
budding cells were quantified for each strain. Three independent experiments were carried 
out. Error bars represent SEM. (B, C) Images are taken from the same experiment. Inp1 1-100-
mRFP-Pex15 was overexpressed under the control of the TPI1 promoter in 
rtn1/rtn2/yop1/inp1Δ cells with Sec63-GFP and BFP-PTS1 and analysed using epifluorescence 
microscopy. The boxed areas are magnified (Merge crop). The graphs show relative 
fluorescence intensities of Inp1 (red), the peroxisomal matrix (blue) and the ER (green) along 
a line drawn through the centre of the Inp1 foci (Indicated by yellow lines). In A, B and C, 


















































































5.4 Inp1 has the structural capacity to be considered a PM-PER tether 
 
5.4.1 Inp1 has two distinct membrane interacting domains and so meets the structural 
requirements to be a PM-PER tether 
 
The third minimal requirement that a protein must fulfil in order to be considered a contact 
site tether is it must have the structural capacity to mediate binding to the opposing 
membrane of the organelles forming the contact site (Eisenberg-Bord et al., 2016). Structure 
function analysis must show that a protein has at least two domains, each with the ability to 
bind to a distinct membrane. The data obtained in this study has shown that Inp1 can interact 
with the plasma membrane via an N-terminal lipid-binding domain which binds to PI(4,5)P2 
and a C-terminal Pex3 binding domain by which Inp1 associates with the peroxisomal 
membrane. Taken together, the in vivo and in vitro data supports the idea that Inp1 has the 
structural capacity to be a plasma membrane-peroxisome tether. 
 
A way of further analysing the structural capacity of a potential tether is by observing what 
happens when the putative membrane-binding domains of a tether protein are mutated. 
Many tether proteins are present at organellar interfaces as foci yet redistribute to different 
areas of the cell upon the functional loss of one membrane-binding domain. The same can 
also be observed with Inp1 (Fig. 5.10). Whilst wild type Inp1 can be found in foci at the 
interface of the peroxisomal and plasma membranes (See Figs. 5.4 and 5.5), upon deletion of 
the LNYLL peroxisomal Pex3 binding motif in the C-terminal domain, Inp1 foci that co-localise 
with peroxisomes are lost and the protein is present diffusely in the cytosol. When the N-
terminal plasma membrane-binding domain (amino acids 1-100) is deleted, Inp1 still forms 
peroxisome-localised foci, but is unable to retain peroxisomes at the mother cell cortex. 
These Inp1 foci are therefore present only in the bud and are no longer in close proximity to 
the plasma membrane at the mother cell periphery. When either of the newly characterised 
Inp1 domains are mutated, Inp1 is redistributed to different sub-cellular locations. This, along 
with the data obtained in Chapters 3 and 4, confirms a structural capacity of Inp1 to act as a 










































Figure 5.10 – Mutation of Inp1’s functional domains results in a sub-cellular redistribution 
of the protein. Inp1-GFP, a leucine motif deletion (L312_L316del) (motifΔ) and Inp1 100-420-
GFP were expressed under the endogenous INP1 promoter in Δinp1 cells with HcRed-PTS1 
and analysed by epifluorescence microscopy. The schematic diagrams represent a simplified 
domain structure of Inp1 with the N-terminal plasma membrane binding domain (amino acids 
1-100) marked in green and the LNYLL Pex3 binding site (amino acids 312-316) shown in red. 










































5.4.2 The minimal tethers do not fully restore peroxisome positioning at the mother cell 
cortex 
 
Previously in this study, it has been shown that minimal and artificial tethers comprised of the 
first 100 amino acids of Inp1 or the PH domain of Num1 are able to restore peroxisome 
localisation to the mother cell periphery in Δinp1 cells when anchored into the peroxisomal 
membrane via Pex15 (Fig. 5.6). However, although peroxisome retention was restored, it was 
also observed that peroxisome distribution in these cells did not resemble that of wild type 
cells. A characteristic ‘budneck clustering’ phenotype was observed for both tethers where 
peroxisomes appeared to cluster at the mother cell side of the budneck. Extreme examples 
are shown in Fig. 5.11B. This clustering phenotype has been observed previously (Knoblach 
and Rachubinski, 2019). To further understand why peroxisomes cluster in the bud neck, 
Myo2-dependent peroxisome transport was blocked by deletion of the peroxisomal Myo2 
receptor gene INP2. Accumulation in the bud neck was no longer observed in Δinp1/Δinp2 
cells expressing the minimal or artificial tethers, indicating that the clustering is a 

































































Figure 5.11 – Peroxisomes cluster at the bud neck in an INP2 dependent manner when 
retention is restored by a minimal or artificial tether. (A) HcRed-PTS1 was expressed in 
Δinp1/Δinp2 with Inp1, Inp2 or a control plasmid in order to demonstrate the effect of 
restored expression of Inp1, Inp2 and a control plasmid on peroxisome localisation in 
Δinp1/Δinp2 cells. (B) Inp1 1-100 GFP-Pex15 or Num1 PH-GFP-Pex15 were expressed under 
control of the INP1 promoter in Δinp1 or Δinp1/Δinp2 cells as indicated, with the 
constitutively expressed HcRed-PTS1. Cells showing strong phenotypic examples of bud neck 
clustering are shown. The white arrows indicate accumulation of peroxisomes on the mother 
cell side of the bud neck. Bars, 5 µm. (C) Quantification of the bud neck accumulation 
phenotype observed upon expression of Inp1-GFP or Inp1 1-100 GFP-Pex15 in Δinp1 or 
Δinp1/Δinp2 cells as indicated. Over 100 cells were analysed for each strain. Cells were 
deemed to have bud neck clustering when more than half of the peroxisomes in the cell were 
present at the bud neck area in the mother. Three independent experiments were carried 
out. Error bars represent SEM. 
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The data acquired in this chapter demonstrates that Inp1 meets the requirements to be 
categorized as a membrane-contact site tether protein (Eisenberg-Bord et al., 2016). Inp1 can 
be recognised as a component of the plasma membrane-peroxisome (PM-PER) tether as, 1) 
it is present in the correct sub-cellular location, closely apposed to the peroxisome and plasma 
membranes (Fig. 5.4, 5.5). 2) Inp1 has the structural capacity to form a PM-PER tether by 
binding the peroxisomal membrane via a C-terminal Pex3 binding motif and by binding the 
plasma membrane via an N-terminal domain that binds PI(4,5)P2. 3) Inp1 has the functional 
capacity to form a PM-PER tether. The first 100 amino acids of Inp1 or the plasma membrane-
binding PH domain of Num1 can act as artificial tethers when attached to peroxisomes, which 
are sufficient to relocate peroxisomes to the cell periphery in Δinp1 cells (Fig. 5.5). 
Additionally, overexpression of the Inp1 minimal tether (Inp1 1-100 GFP-Pex15) increases the 
number of PM-PER contact sites (Fig. 5.7) and when expressed in cortical ER mutants, the 
minimal tether localises to the side of peroxisomal foci proximal to the plasma membrane, 
spatially resolved from the ER (Fig. 5.8). The observations presented throughout this thesis 
qualify Inp1 as the first characterised PM-PER tether and support a new model for peroxisome 
retention (Fig. 5.11). 
 
It has previously been reported that peroxisomes are retained at the mother cell cortex by 
Inp1 acting as a ‘molecular hinge’ and binding to both peroxisomal and ER bound Pex3 
(Knoblach and Rachubinski, 2013). However, the results obtained throughout this study do 
not support this model. As well as a lack of evidence that the N-terminus of Inp1 binds to 
Pex3, it was shown that peroxisomes still localise to the periphery of the cell in mutants with 
severely disrupted cortical ER structures (Fig. 5.1, 5.2, 5.3). This shows that the role of the 
cortical ER in peroxisome tethering is not as essential as the existing model suggests. During 
the course of this work, another study by the same authors shed doubt on the simplicity of 
the existing Pex3-Inp1-Pex3 retention model with the suggestion that additional components 
are required for peroxisome tethering to the cell cortex. The authors (Knoblach and 
Rachubinski, 2019), suggest that Inp1 may function as a tether between peroxisomes and 
other organelles. In agreement with this postulate, I show that Inp1 is a tether protein at 
membrane contact sites between peroxisomes and the plasma membrane.  
 
Although the proposed mechanisms for the existing Pex3-Inp1-Pex3 retention model do not 
correlate with the findings of this study, it cannot be ruled out that there are additional 
interactions domains elsewhere in Inp1. Whilst the artificial tethers Inp1 1-100 GFP-Pex15 
and Num1 PH GFP-Pex15 restore peroxisome retention to the mother cell cortex in Dinp1 
cells, peroxisome positioning is not restored to that of wildtype cells with peroxisomes 
frequently seen ‘clustering’ at the bud neck (Fig. 5.10).  
 
One explanation for the clustering phenotype could be that in budding yeast, PI(4,5)P2 is not 
uniformly present around the plasma membrane and is enriched at areas of polarised growth 
and the bud neck (Garrenton et al., 2010). The artificial tethers are comprised of the PI(4,5)P2 
binding domain of Inp1 or the PH-domain of Num1 and so their expression may result in an 
enrichment of peroxisome tethering to sites where PI(4,5)P2 is more concentrated, such as 
the bud neck. 
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Additionally, the phenotype could be due to a lack of regulation of the artificial tethers. During 
observation with fluorescence microscopy, the artificial tethers were seen to be visibly 
brighter than wild type Inp1-GFP, despite being expressed under control of the same INP1 
promoter. This is probably due to the fact that any potential regulatory machinery which 
exists for Inp1 would not recognise these artificial, chimeric tether proteins. As such, the 
tether proteins are not regulated or degraded as wild type Inp1 and so are present at higher 
levels than an endogenous Inp1 tether would be. In wild type yeast, it has been reported that 
peroxisomes with Inp1 foci attached can sometimes be observed moving along the cell cortex 
but being retained at the mother-bud neck interface. It seems that peroxisomes which are 
cortically attached via Inp1 are unable to enter the bud (Knoblach et al., 2013). The phenotype 
observed with the artificial tethers may be explained in the same way. There is a high cellular 
amount of plasma membrane-peroxisome tethers which are not broken down and so remain 
attached to peroxisomes. The phenotype has been shown to be dependent on Inp2 and so 
the peroxisomes are probably being dragged along the plasma membrane via Inp2-
dependent transport towards the bud neck. These peroxisomes are unable to enter the bud 
due to still being cortically attached in the mother cell, hence they cluster at the mother cell 






















Figure 5.12 – Peroxisome clustering observed at the bud neck could be due to a lack of 
regulation of artificial tethers. Peroxisomes are normally transported along actin cables to 
the bud via Myo2 and the peroxisome-specific adaptor Inp2. Artificial tethers used in this 
study such as Inp1 1-100-GFP-Pex15 are likely not regulated as wild type Inp1 would be and 
so remain attached to peroxisomes, tethering them at the cell cortex. As peroxisomes are 
transported along actin cables to the bud, they may remain attached at the periphery by a 
tether which is not broken down or regulated properly and so gather at the bud neck, unable 
to enter the bud, resulting in the observed bud neck clustering phenotype. 
 
The Inp2-dependent, ‘bud neck clustering’ seen upon expression of the artificial peroxisomal 
tethers could also suggest that the native Inp1 tether possesses additional functionality. It is 
known that Num1 has a dual role as a mitochondrial tether protein and as a cortical anchor 
for dynein attachment sites required for nuclear migration (Heil-Chapdelaine et al., 2000; 
Farkasovsky and Küntzel, 2001). Inp1 could also have an additional role in cortical recruitment 
of additional factors such as dynein, resultant in opposition to Myo2 traffic. The absence of 
amino acids 101-420 in the artificial tethers could mean that although the tethers can interact 
with lipids at the plasma membrane, the Inp1 domains required for dynein recruitment 
activity are absent. Therefore, the artificial tethers cannot oppose Myo2-based movement of 
peroxisomes which results in peroxisomes being ‘dragged’ along the cortex to the bud neck. 
 
Further to the idea that the native Inp1 tether possesses further functionality, it can be 
hypothesised that additional contacts at the cell cortex are required in order to fix 
peroxisomes in the correct position. This study does not exclude that Inp1 could tether 





Diagram is not to scale
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peroxisomes via dual interaction at the cell cortex. This could be mediated by as yet 
unidentified factors which also reside at the mother cell cortex. Alternatively, this could be 
via other organelles such as the cortical ER, analogous to how mitochondria are positioned by 
dual interaction with the plasma membrane and the cER via MECA (Lackner et al., 2013). The 
existence of another three-way tether involving the cER and plasma membrane would 
suggest there are conserved mechanisms by which organelles make contact with each other. 
Inp1’s role as a peroxisome tether is clear as an absence of functional Inp1 results in a 
complete lack of peroxisome retention in the mother cell. However, accurate peroxisome 
distribution at the cell periphery could also involve contact with organelles or cortical factors 




































Chapter 6 - Discussion 
 
Initially, the primary aim of this study was to functionally characterise Inp1 in molecular detail 
and to investigate how Inp1 and Pex19 compete with their highly similar binding motifs for 
interaction with peroxisomal Pex3.  However, the data that was subsequently obtained also 
indicated a role for Inp1 as tether protein at peroxisome-plasma membrane contact sites. The 
evidence presented has resulted in the proposal of a new model for peroxisome retention 
during asymmetric cell division with Inp1 identified as a component of the peroxisome-
plasma membrane tether. The final sections of Chapters 3, 4 and 5 discuss and interpret the 
specific experimental data presented in each respective chapter. In this final chapter, a 
broader discussion will take place of the newly identified function of Inp1 as a peroxisome-
plasma membrane tether and the new proposed model of peroxisome retention. 
 
6.1 The functional domains of Inp1 
 
Previous studies have interpreted the secondary structure of Inp1 to predict that it is a protein 
that can be roughly divided into two globular domains, an N-terminal domain comprised of 
amino acids 1-280 and a C-terminal domain comprised of amino acids 281-420 (Knoblach et 
al., 2013). In this study, these truncations were also used for initial functional analysis of Inp1. 
In Chapter 3, it was shown that Inp1 interacts directly with peroxisomal Pex3 via a conserved 
motif in its C-terminal domain. In Chapter 4, the N-terminal domain of Inp1 was found to be 
a lipid binding domain that binds to PI(4,5)P2 and associates with the plasma membrane. As 
such, it has been shown that Inp1 interacts with the cell periphery via its N-terminus and this 
can be genetically separated from its direct interaction with peroxisomal Pex3 via its C-
terminal domain. 
 
Further analysis uncovered that the N-terminal 100 amino acids of Inp1 can be functionally 
separated as a domain which is capable of lipid binding and, when artificially attached to 
peroxisomes, is capable of tethering peroxisomes to the cell periphery. As discussed in 
Section 4.4, attempts were made during this study to further pinpoint regions in the first 100 
amino acids required for peroxisomal tethering. However, when experiments were 
attempted with smaller tethers, the proteins were found to be unstable and as such, 
confident interpretations could not be made. This led to a conclusion that it is perhaps too 
simplistic to keep removing amino acids from a primary sequence of Inp1 in order to find a 
minimal tether. In order to function as a tether, the N-terminal domain of Inp1 most likely 
relies on a secondary or tertiary folded structure.  
 
During the course of this study, an additional, complementary study has also been accepted 
for publication which investigates the functional role of Inp1 in H. polymorpha (Krikken et al., 
2020). The authors divide HpInp1 into 3 functional domains, an N-terminal domain (amino 
acids 1-99), a middle homology domain (MHD) (100-216) and a C-terminal domain (217-405). 
As in this study, they also conclude that the N-terminal domain (1-99) of HpInp1 is required 
for association with the plasma membrane whilst the C-terminal domain of HpInp1 is required 
for peroxisome binding. 
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The authors observe that the N-terminal domain (1-99) of HpInp1 accumulates at the cell 
cortex, with higher concentrations of signal observed initially at the bud tip and then in the 
bud neck (Krikken et al., 2020). These observations were also made during this study, (Fig. 
4.4, 4.12), and additionally, peroxisomes were seen to cluster at the bud neck when tethered 
to the periphery artificially by a plasma membrane-binding domain (Fig. 5.10). These 
observations could be explained by the fact that in budding yeast, PI(4,5)P2 is not uniformly 
present around the plasma membrane and is enriched at areas of polarised growth and the 
bud neck (Garrenton et al., 2010). This pattern of enriched localisation to the bud neck has 
also been seen upon expression of the PI(4,5)P2 binding pleckstrin homology (PH)-domain of 
Num1 (Tang et al., 2009). 
 
Krikken et al. note that there is a high percentage of positive residues in the first 100 amino 
acids of HpInp1 and this is also true of ScInp1. The function of HpInp1 is affected upon 
substitution of these positive residues to negative ones and so it would be interesting to assay 
the effect that mutating these equivalent amino acids in ScInp1 has on its respective function. 
The positive residues could be required for binding to the plasma membrane, as is true for 
septins which associate specifically with PI(4,5)P2 in the plasma membrane at the bud neck 
through positive residues in conserved, N-terminal polybasic regions (Casamayor and Snyder, 
2003). The data shown in Fig. 4.8 and 4.9 is also supportive that charge plays some role in the 
interaction between Inp1 and PI(4,5)P2. MBP-Inp1 shows clear binding to PI(4,5)P2 liposomes 
under high salt conditions, but this is slightly reduced compared to lower salt conditions. This 
could be indicative that efficient binding of Inp1 to PI(4,5)P2  liposomes depends mainly on 
specific interactions but that electrostatic interactions also contribute to binding. 
 
Krikken et al. analyse the sequence of the MHD (100-216) of HpInp1 and predict that it may 
fold as a divergent Ran-binding domain from the PH-like domain superfamily (Krikken et al., 
2020). The MHD of HpInp1 is found to contribute to peroxisome-plasma membrane contact 
in combination with the positive residues of the N-terminal domain and due to its predicted 
structural features, the authors suggest it could bind to an α-helix or proline-rich sequence 
but likely does not bind to the plasma membrane via anionic lipids. Whilst Krikken et al find 
that HpInp1 101-405 is able to partially rescue peroxisome retention, the same was not found 
for the equivalent truncation of ScInp1 in this study (100-420) (Fig. 4.3).  However, 
retrospective analysis of the data in this thesis allows for speculation that there could also be 
an orthologous ‘MHD’ in ScInp1. 
 
This study made use of truncations of Inp1 which provided major insights into the 
functionality of the protein. However, the design of these truncations may have resulted in a 
failure to identify additional functional domains. Structural analysis of HpInp1 100-216 shows 
that the MHD contains 7 b-sheets followed by an α-helix (Krikken et al., 2020). The authors 
align this sequence with that of other Inp1 orthologues including ScInp1 and show apparent 
conservation of this secondary structure (Fig. S1, Krikken et al., 2020). Retrospective analysis 
of the data obtained in this thesis and the work by Krikken et al, reveals a putative orthologous 
domain in ScInp1 in the region of amino acids 80-260. Through use of the truncations 1-100 
and 101-280 during this study, identification of this domain may have been missed. Further 
work will be needed to fully characterise this putative PH-family domain of ScInp1 but it 
seems likely that this domain is involved in ScInp1’s tethering function and could have the 
capabilities to bind to other proteins or cortical factors. 
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Figure 6.1 – Schematic representations of ScInp1 and HpInp1. The diagrams show an 
overview of the predicted domain structures of Inp1 in S. cerevisiae (ScInp1) and H. 
polymorpha (HpInp1). Diagrams are not to scale. For ScInp1, Green, N-terminal domain 1-100 
shown to bind to lipids and localise to the plasma membrane; Purple box, the predicted PH-
like domain 80-260 based on structural analysis of HpInp1, Blue, the C-terminal domain 281-
420 shown to bind to be required for peroxisome association through direct binding with 
peroxisomal Pex3. For HpInp1, Green, the N-terminus with conserved positive charges; Red, 
MHD/predicted PH-like domain; Blue, C-terminal domain shown to be required for 
association of Inp1 with peroxisomes. Predictions for HpInp1 are based upon work by Krikken 
et al., 2020. 
 
 
6.2 Other factors may be involved in peroxisome tethering 
 
As reported in Chapter 5 (Fig. 5.10), peroxisomal localisation to the cell periphery can be 
restored in Δinp1 cells upon expression of artificial peroxisome tethers which contain a 
plasma membrane-binding domain. However, the positioning of these peroxisomes is not 
restored to that of wildtype cells with peroxisomes frequently seen ‘clustering’ at the bud 
neck. A possible explanation for this, briefly discussed in Section 5.5, is that additional 
contacts at the mother cell periphery are required in order to fix peroxisomes in the correct 
position. Inp1 as a native tether could possess additional functionality and mediate tethering 
by interactions with the plasma membrane and as yet unidentified cortical factors or other 
organelles such as the cortical ER. Alternatively, peroxisome tethering and accurate 
peroxisome distribution at the cell periphery could involve contact with organelles or cortical 
factors independent of Inp1. This has been previously suggested by (Knoblach and 
Rachubinski, 2019) who hypothesise that additional components, independent of Inp1, are 



























6.2.1 Could Inp1 interact with the actin cytoskeleton? 
 
There is dynamic cellular interplay between the plasma membrane and the underlying cortical 
actin cytoskeleton. Formation and elongation of actin filaments first requires actin nucleation 
and many of the proteins required for nucleation of actin at cortical patches are actin binding 
proteins which associate with PI(4,5)P2 in the plasma membrane. PI(4,5)P2 is considered to 
promote formation of actin filament structures through direct interaction with actin binding 
proteins and scaffolding proteins which control their sub-cellular localisation (Saarikangas et 
al., 2010). 
 
This study finds Inp1 to be a PI(4,5)P2 binding protein and this, combined with its sub-cellular 
localisation to cortical patches at the plasma membrane means that it is a plausible concept 
that Inp1 is also an actin binding protein. This idea is supported by observations made by 
Krikken et al who suggest that Inp1’s cortical localisation is dependent on an intact actin 
cytoskeleton, as treatment of cells with latrunculin A results in a loss of cortical Inp1 patches, 
especially close to the bud neck (Krikken et al., 2020).  
 
As a hypothetical actin binding protein, Inp1 could be involved in the marking of cortical 
patches from which actin nucleation can occur. Peroxisomes could then be anchored to these 
cortical patches in the mother cell, positioned at the ‘start of the track’ at points from which 
actin filaments then polymerise and form the track along which peroxisomes are transported. 
According to the Saccharomyces Genome Database, Inp1 genetically interacts with Las17, an 
actin assembly factor which nucleates actin filaments at cortical patches (Urbanek et al., 
2013). Additionally, observations were made by the Schuldiner group that Bni1, a formin 
which nucleates the formation of linear actin filaments (Kohno et al., 1996; Pruyne et al., 
2002), co-localises with peroxisomal markers (Personal communication). These observations 
were confirmed by the Hettema lab who then also observed that overexpression of mCherry-
Bni1 affects normal peroxisomal distribution with most peroxisomes present in the mother 
as would be seen with Inp1 overexpression or in Δinp2 cells (Personal communication).  
 
This hypothetical dual role of Inp1 as an organelle tether protein and cortical actin nucleation 
site is reminiscent of the two roles carried out by the mitochondrial tether protein Num1. 
Num1 forms the core component of the mitochondrial ER cortical anchor (MECA) and is 
required for tethering mitochondria to the mother cell cortex during cell division. It does this 
through a coiled-coil domain which exhibits specificity to negatively charged, cone-shaped 
lipids characteristic of the mitochondrial outer membrane and a C-terminal PH domain, which 
binds to the plasma membrane via high specificity interactions with PI(4,5)P2 (Yu et al., 2004; 
Ping et al., 2016). Additionally, Num1 has been shown to have an independent role in nuclear 
migration. In this role, Num1 is a cortical anchor for dynein and harnesses dynein-mediated 
microtubule sliding along the cell cortex for nuclear migration into buds (Heil-Chapdelaine et 
al., 2000; Farkasovsky and Küntzel, 2001). The potential link between Inp1 and actin seems 






6.2.2 Could Pex23 family proteins be required for correct peroxisome positioning? 
 
In S. cerevisiae, the Pex23 family of proteins is comprised of Pex28, 29, 30, 31, 32 (Kiel et al., 
2006). Although named as peroxins, this family of proteins localise to the ER and Pex29 and 
Pex30 have been shown to form complexes with the ER reticulon proteins Rtn1, Rtn2 and 
Yop1 (David et al., 2013; Joshi et al., 2016; Mast et al., 2016).  Although present throughout 
the ER, Pex30 has been observed primarily in peripheral puncta in subdomains of the cortical 
ER, sandwiched between ER tubules and peroxisomes (Figure 5C of David et al., 2013). 
Peroxisomes have been observed to dynamically associate with subdomains of the ER which 
contain Pex29 and Pex30 and it has been reported that the absence of Pex30 and its 
paralogues results in increased mobility of peroxisomes, but peroxisomes are still retained at 
the mother cell periphery. Conversely, peroxisomes which co-localise with ER-associated 
Pex30 foci lack rapid movement (Munck et al., 2009; David et al., 2013; Mast et al., 2016; 
Knoblach and Rachubinski, 2019). 
 
Additionally, peroxisomes are reported to cluster in Δrtn1/Δrtn2/Δyop1 cells, (David et al., 
2013), an observation which was also made during this study. Peroxisomes are still present at 
the cell periphery in Δrtn1/Δrtn2/Δyop1 mutants, (Fig. 5.1, 5.2) but an absence of the 
reticulon proteins may disrupt the Pex30-dependent ER-peroxisome contact and this could 
affect peroxisome positioning. Interestingly, it has also been reported that Pex30 is capable 
of directly interacting with Inp1 (Fagarasanu et al., 2005). Taken together, these observations 
could indicate a role for Pex30 and its paralogues in the positioning and distribution of 
peroxisomes at the mother cell cortex which occurs in addition to the plasma membrane-
peroxisome tethering achieved by Inp1.  
 
During the writing up period of this study, an investigation into the Pex23 family orthologues 
in H. polymorpha was published which supports this hypothesis (Wu et al., 2020). The authors 
observe that the Pex23 family proteins HpPex24 and HpPex32 localise to ER-peroxisome 
contact sites and that these contacts are disrupted upon deletion of HpPex24 and HpPex32. 
In the absence of HpPex24 and HpPex32 defects in peroxisomal positioning and segregation 
are observed, and this defect is supressed upon introduction of an artificial ER-peroxisome 
tether. As was observed in this study (Fig. 5.3C), deletion of H. polymorpha Inp1 seems to 
have no effect on the proximity between ER and peroxisomal membranes at contact sites. 
The authors propose that Inp1 and the ER-localised Pex23 family proteins contribute together 
to peroxisome positioning at the cell cortex (Krikken et al., 2020). 
 
ER-peroxisome contacts are also extensively observed in mammalian cells, (Valm et al., 2017), 
and the proteins which tether the ER and Peroxisomes at their MCS in mammalian cells were 
described by two independent groups. The ER resident proteins known as Vesicle associated 
membrane protein (VAMP)-associated proteins A and B (VAP-A and VAP-B) interact with the 
FFAT-like motifs of the peroxisomal membrane proteins ACBD4 and ACBD5 (Loewen and 
Levine, 2003; Hua et al., 2017; Costello et al., 2017a; Costello et al., 2017b).  
 
Function of the tether has been proven as overexpression of ACBD5/VAPB increases the 
amount of ER-peroxisome contact sites whilst depletion of the tether reduces contact sites. 
The primary function of ER-peroxisome contact is proposed to be lipid transfer between the 
two organelles as disruption of these tethers results in decreased plasmalogen, cholesterol 
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and fatty acid b-oxidation levels, although direct lipid transfer activity by VAP-ACBD5 has not 
yet been demonstrated.  (Hua et al., 2017; Yagita et al., 2017). However, both groups report 
that disruption of the ACBD5-VAPA/B tether results in increased motility of peroxisomes 
whilst attaching peroxisomes to the ER artificially appears to restrict their movement. This 
perhaps suggests that membrane contact sites may also regulate peroxisome motility through 
anchoring to the ER in mammalian cells (Hua et al., 2017; Costello et al., 2017). These 
observations that proteins present at peroxisome-ER contact sites affect peroxisome 
positioning has now been made independently in two yeast species and in mammalian cells 
and supports the ideas presented by Knoblach and Rachubinski, that factors, independent of 
Inp1, are required for correct and proper peroxisome tethering to the cell cortex (Knoblach 
and Rachubinski, 2019) 
 
6.3 Final remarks 
 
Whilst the relative contribution of other cortical components in peroxisome tethering 
remains unclear, Inp1 is absolutely required for peroxisome retention. The data obtained in 
this study identify Inp1 as a peroxisome-plasma membrane tether and demonstrates that this 
function allows Inp1 to fulfil its role in peroxisome retention. Looking ahead, questions remain 
which need to be addressed in order obtain the complete picture of how peroxisomes are 
retained at the cell cortex. Is the cortical ER involved, or do other cortical factors such as actin 
or as yet unidentified factors contribute to peroxisome positioning? If so, which domains of 
Inp1 do they interact with? Or are there additional cortical-peroxisomal interactions required 
for peroxisome tethering which occur independent of Inp1? These questions and more could 
all be addressed by further research in the field in order to clarify how peroxisomes are 
properly tethered and positioned. This work provides the first molecular description of a 
peroxisome-plasma membrane tether and characterises how Inp1 interacts with the 
opposing membranes. This is a major development in elucidating the mechanisms of 
peroxisome tethering at the cell cortex and has allowed for the proposal of a new model for 
























Figure 6.2 – Models of peroxisome tethering to the mother cell cortex (Hulmes et al., 2020). 
Inp1 is a PM-PER tether which bridges peroxisomes and the plasma membrane by interacting 
with peroxisomal Pex3 via a conserved LNYLL motif and with the plasma membrane via an N-
terminal domain that binds PI(4,5)P2. This PM-PER tether is required for peroxisome 
retention. Additional peroxisome contacts with cortical structures may contribute to 
peroxisome positioning or distribution at the mother cell cortex. Interaction with the cortical 
ER (cER) could occur via Inp1 and not-yet-identified factors (indicated by black question 
mark). Inp1 could also be in contact with cortical structures/factors independent of the cER 
such as actin (indicated by the red oval and red question mark). Peroxisome contact with the 
cER could also occur independently of Inp1 and via additional unidentified factors such as 
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